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Summary
The aetiological fraction methodology and the associated fraction estimates enable
estimation of the proportion of cases of an illness or injury that can be attributed to a risk
factor. This report presents aetiological fraction estimates attributing deaths and hospital
separations resulting from a range of specific illnesses or injuries to tobacco, alcohol and
illicit drugs. The fractions represent a revision of the fractions originally presented by
Holman et al. (1990) and later revised by English et al. (1995). Also presented here are
estimates of 1998 mortality and 1997–98 hospital separations attributable to alcohol, tobacco
and illicit drugs based on the revised fractions.
Deaths attributable to alcohol, tobacco and illicit
drugs
In 1998 an estimated 19,019 people died in Australia as a result of tobacco smoking. A
further 1,023 deaths can be attributed to illicit drugs. For tobacco smoking, the majority of
deaths (14,799) occurred at ages 65 and over. However, because of the time lag between
exposure to tobacco smoke and the onset of many diseases, particularly cancer and chronic
obstructive pulmonary disease, many of these deaths represent the result of tobacco
smoking at a much earlier age. The majority of deaths attributed to illicit drugs (649)
occurred between the ages of 15 and 34 years.
The effect of alcohol consumption on illness and injury is more complex. In 1998 an
estimated 3,271 people died as a consequence of hazardous and harmful levels of alcohol
consumption. In addition to the harmful effects, however, when consumed at moderate
levels alcohol appears to be associated with a decrease in heart disease and stroke. The
number of people in Australia who drink at moderate levels far outweighs the number who
drink at hazardous or harmful levels, so this apparent protective effect is greater for the
overall population than the harmful effect for deaths, though not for potential years of life
lost. Thus the estimated net reduction in deaths associated with alcohol consumption in 1998
was 2,371 but the estimated net potential years of life lost due to alcohol consumption in
1998 was 21,147.
The reason that alcohol appears to be associated with a net decrease in deaths but a net
increase in potential years of life lost is because the decrease applies to illnesses which occur
at older ages while the harmful effects apply across all ages. Deaths at younger ages
contribute more potential years of life lost than deaths at older ages. Thus in 1998 the net
effect of alcohol consumption at ages below 65 years was to cause an estimated 2065 deaths,
leading to 47,887 potential years of life lost, while the net effect at ages 65 years and over
was associated with a decrease of 4,436 deaths or 26,739 potential years of life lost.
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Hospital separations attributable to tobacco, alcohol
and illicit drugs
In 1997–98, 142,525 hospital separations in Australia were attributable to tobacco smoking
and 14,471 to illicit drugs. For tobacco, the majority of separations (74,379) occurred at ages
65 and over; for illicit drugs the majority of separations (10,876) occurred at ages 15 to 34.
In 1997–98 an estimated 71,422 separations could be attributed to harmful and hazardous
levels of alcohol consumption. However, once the estimate is adjusted for the decrease in
heart disease and stroke associated with moderate alcohol consumption, the net overall
number of separations was 43,033.
Revision of the aetiological fractions
Aetiological fractions depend on the prevalence of a risk factor and the associated relative
risk of a particular illness or injury. The fractions presented here have been revised where
possible—from the earlier reports of Holman et al. (1990) and English et al. (1995)—to
incorporate the most recent estimates of the prevalence of use of tobacco, alcohol and illicit
drugs. In addition, the relative risk estimates for some conditions have been revised to
incorporate the results of recent research. The following conditions were selected for this
detailed study and risk-ratio revision:
• in relation to alcohol—breast cancer, stroke, road injuries and fall injuries;
• in relation to tobacco—cervical cancer and peptic ulcer;
• in relation to illicit drugs—road injuries.
The relative risk of breast cancer associated with alcohol consumption was examined
because recent research suggests that the risk varies with age. However, the analyses
presented in this report failed to show a statistically significant difference in the risk for
older women compared with younger women, and the overall risk-ratio estimate
incorporating the results of recent research was similar to that derived by English et al.
The relative risk of stroke associated with alcohol consumption was examined because
recent research suggests that the risk differs between ischaemic and haemorrhagic stroke.
The analyses presented in this report support this, so different fractions were estimated for
the two different types of stroke.
The relative risk of road injuries associated with alcohol consumption was examined using
only Australian data—rather than a combination of Australian and international data, as
used by English et al. Separate fractions were derived for motor vehicle drivers or
motorcycle riders and for pedestrians, and these in turn were derived separately for hospital
separations and deaths.
The relative risk of fall injuries associated with alcohol consumption was examined because
of evidence that the risk varies with age. The analyses presented in this report support this,
so separate fractions were derived for people aged 65 years and over and for people aged
less than 65.
The relative risk of cervical cancer associated with tobacco smoking was examined because
of recent research results on the causes of this cancer. Similarly, the relative risk of peptic
ulcer associated with tobacco smoking was examined because of recent research results on
the causes of peptic ulcer.
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English et al. did not derive a fraction road injuries associated with illicit drug use because
of the lack of suitable Australian data. More recent research has, however, provided such
data so an estimate of this aetiological fraction is presented here.
In addition to using recent prevalence data and relative risk estimates, the aetiological
fraction methodology for tobacco was revised in two ways. The first was to adjust for the
time lag between tobacco exposure and the onset of related illnesses. English et al. used an
estimate of current smoking prevalence in their calculation of aetiological fractions for
tobacco. But for, many conditions there is a long time lag between exposure to tobacco
smoke and the associated ill-effects—in the case of cancer it may be many decades. So for
these conditions estimates of the current prevalence of smoking are not helpful in
understanding the current associated disease burden.
We followed the Australian Burden of Disease Study (Mathers et al. 1999) in using the
method proposed by Peto et al. (1992) to adjust for this time lag. Peto et al. proposed using
an artificial compound prevalence measure of tobacco exposure, derived from a comparison
between lung cancer rates in the country of interest and lung cancer rates among non-
smokers observed in a large long-term follow-up study in the United States. This method
was used here to determine tobacco exposure for cancer and chronic obstructive pulmonary
disease. The mean time between tobacco exposure and the other illnesses and injuries
discussed in this report is considerably shorter than that for cancer and chronic obstructive
pulmonary disease, so estimates of current tobacco exposure were used for these other
conditions.
The second modification to the methodology for tobacco involved the inclusion of estimates
of passive exposure to tobacco smoke and its health effects in pregnancy and childhood.
These estimates were based on data in the National Health and Medical Research Council’s
report on passive smoking (NHMRC 1997).
As with tobacco, current exposure to alcohol does not reflect the relevant exposure for some
current outcomes, such as cirrhosis and cancers. There is, however, no equivalent of the
method used by Peto et al. to adjust for this time lag. This report followed English et al. in
using current prevalence estimates for alcohol consumption in calculating the aetiological
fractions. The prevalence of alcohol consumption, particularly of heavy drinking, has
declined in recent decades, so it is likely that these methods underestimate the true
aetiological fractions of some current health outcomes attributable to alcohol consumption.
The final modification to the methodology of English et al. was to estimate the full
attributable effect of alcohol consumption, including the apparent benefits of moderate
consumption. English et al. calculated aetiological fractions for hazardous and harmful
alcohol consumption (as defined by the NHMRC) relative to low alcohol consumption.
These differed from the earlier estimates derived by Holman et al., which were calculated
with abstention as the reference category. Using low alcohol consumption as the reference
category, English et al. sought to reflect more accurately the idea that unsafe drinking—as
opposed to low alcohol consumption, which may be protective—is the cause for concern.
Even at low levels of consumption, however, alcohol raises the risk of some conditions.
Further, the approach taken by English et al. does not allow for the quantification of
conditions prevented as a result of the beneficial effects of low levels of alcohol
consumption. This report followed the earlier approach of Holman et al. and derived
fractions to reflect both the risks and benefits of alcohol at all levels of consumption relative
to abstaining from alcohol. Hence the estimates of alcohol-related deaths and hospital
separations represent the net effect of both the alcohol-related harm and the alcohol-related
benefit. The only exception to this is the fraction for the effect of alcohol on road traffic
accidents: although there is some evidence that low levels of alcohol consumption raise the
xvi
risk of road traffic accidents at some ages, we followed English et al. in deriving the
aetiological fraction with the legal level of alcohol consumption in drivers as the reference
level.
Public health efforts in Australia are directed towards reducing unsafe alcohol consumption,
rather than alcohol consumption per se. Therefore, although the primary purpose of this
report is to estimate the total effect of alcohol consumption, it also presents, as Appendix A,
a separate calculation using the approach taken by English et al. These data represent the
extra effect of alcohol consumption for the ‘unsafe’ drinker compared with the ‘responsible’
drinker (English et al. 1995, p. 58), where unsafe and responsible consumption are defined
by the NHMRC guidelines for responsible drinking (NHMRC 1992).
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11 Introduction
In 1987 the Department of Community Services and Health (now the Department of Health
and Aged Care) commissioned a study to determine methods for quantifying drug caused
morbidity and mortality in Australia. The study was undertaken by Dr D’Arcy Holman
(then director of the Epidemiology Branch of the Health Department of Western Australia)
and Professor Bruce Armstrong (then Professor of Epidemiology and Cancer Research and
Director of the National Health and Medical Research Council’s Research Unit in
Epidemiology and Preventive Medicine at the University of Western Australia). The primary
objective of the project was to estimate the number of drug-caused deaths, hospital
separations, patient days and years of life lost.
The resultant report was released by the Department of Community Services and Health in
1990 in conjunction with a departmental document that included modifications to the
methods and time-series estimates of drug-caused deaths in Australia (Holman et al. 1990).
The report dealt with harmful (and protective) effects attributed to three main drug
groupings: alcohol, tobacco, and illicit drugs. It presented the proportion of cases attributed
to the drug (called the aetiological fraction) for a comprehensive list of illnesses and causes of
death or injury.
In view of the considerable research knowledge that accumulated after the publication of the
Holman et al. report, the Department of Human Services and Health (as it was then known)
commissioned a second study to revise and update the original methods and to apply the
updated methods to more recent data. This study was undertaken by Dr Dallas English
(Senior Lecturer in the Department of Public Health in the University of Western Australia)
and Professor D’Arcy Holman (by this time Professor in the Department of Public Health in
the University of Western Australia). Their report presented fully revised aetiological
fractions for tobacco, alcohol and illicit drugs, along with estimates of the attributable
hospital separations and patient days, deaths and potential years of life lost in Australia in
1992 (English et al. 1995).
In 1997 the Department of Health and Family Services (as it was then known) commissioned
a further revision of the aetiological fractions methodology as part of the Memorandum of
Understanding between the Department and the Institute. This report presents the results of
the revision, along with estimates for 1998 (for mortality) and 1997–98 (for hospital
separations). As with the previous two studies, this report uses the ninth revision of the
World Health Organization’s International Classification of Diseases (ICD-9) to classify
causes of death, illness and injury.
22 Methods
2.1 Methods of quantification of drug caused
morbidity and mortality
2.1.1 Aetiological fractions
An aetiological fraction—also known as an attributable proportion or attributable risk—is a
form of indirect quantification of morbidity and mortality due to a specified risk factor. In
this case the risk factor is the consumption of tobacco, alcohol or an illicit drug. Indirect
methods involve the estimation of a probability measure of the likelihood of causation by
the risk factor which is then applied to the total number of deaths, illnesses or injuries
resulting from a specific cause. The distinguishing characteristic of indirect methods is that
individual risk factor-caused cases are not identified. For example, if there is a probability of
0.22 that a case of low birthweight is caused by smoking, then the product of this probability
(the aetiological fraction) and the total number of low-birthweight babies in a population
gives an estimate of the number of low-birthweight cases attributable to smoking.
The aetiological fractions used in this report were developed using the methodology
outlined by English et al. (1995). There are two major sources of aetiological fractions for
drug-caused illnesses and injuries. First, the fractions can be estimated directly from a series
of cases where each case can be identified as caused or not caused by the drug in question.
For example, from a representative series of fire deaths subjected to review, an estimated
17% were caused by cigarette smoking. Thus, an aetiological fraction of 17% can be applied
to all fire deaths in the population to estimate the number attributable to cigarette smoking.
The second, and more common, source of aetiological fractions is from studies of the
comparative rates of death, illness or injury in groups of people exposed and not exposed, or
exposed at varying levels, to the drug in question. English et al. present the following
formulae for the fractions in two such cases. Each formula uses the ratio of the incidence rate
of the condition among those exposed to the drug to the incidence rate of the condition
among those not exposed, designated RR.
The first case applies where we have an estimate of the proportion of the total population
exposed to the risk factor. In this case the formula for the aetiological fraction among those
exposed to the risk factor is
( )
RR
RRFr
1−
= (1)
and among the total population is
( ) ( ) 111 +−−= RRpRRpF eea (2)
where ep  is the proportion of the total population exposed to the risk factor.
This can be extended to the situation where the factor has several categories. If, say,the
factor has k categories, then the partial aetiological fraction for category i ( ki ≤≤1 ) among
those exposed to the risk factor is
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where i = 0 is the baseline (non-exposed) category, pi is the prevalence of the ith category of
exposure in the total population and RRi is the rate ratio for the ith category relative to the
baseline category.
These fractions can be combined into a single fraction for all categories of exposure relative
to the baseline category in the following formula:
( )
( )∑
∑
=
=
+−
−
= k
i
ii
k
i
ii
a
RRp
RRp
F
0
1
11
1
(5)
The second case is where we have an estimate of the prevalence of exposure to the factor
among cases of the disease, rather than among the total population. In this case the
aetiological fraction for the general population is
( )
RR
RRpF ca
1−
= (6)
where pc is the prevalence of exposure among cases of the disease.
In some cases, where the ‘risk’ factor has a protective effect against a specific disease, the
aetiological fraction can take negative values. We followed Holman et al. (1990) in
interpreting this as allowing an estimate of the number of prevented cases.
In some cases we calculated pooled relative risk estimates from a number of studies. In these
cases we followed English et al. (1995) in using an estimate based on precision-based
weighting. The formula for the pooled estimate of the relative risk from N studies using
precision based weighting is as follows:
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where ( )( )RRVarWi ln1= .
A 95% confidence interval around the pooled estimate is
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A full discussion of pooling multiple study results is beyond the scope of this report. Such a
discussion, along with details of estimates of Var(ln(RR)), can be found in the report of
English et al. (1995, pp. 25–38).
42.1.2 Measures of mortality
This report uses two measures of mortality: the number of people who die in Australia from
a specific cause; and the potential years of life lost (PYLL) as a result of each cause. Both
these measures are derived from the Institute’s mortality database. The data are compiled on
a calendar-year basis, the most recent year being 1998.
The number of deaths—the National Mortality Database
The National Mortality Database comprises data on all registered deaths in Australia. The
data are collected by the State and Territory Registrars of Births, Deaths and Marriages,
processed by the Australian Bureau of Statistics, and provided to the Institute by the Bureau.
Registration of deaths is a legal requirement in Australia and is virtually complete; with the
exception of deaths of foreign diplomatic personnel, all deaths that occur in Australia are
within the scope of the Institute’s mortality collection.
The mortality data held by the Institute for the period covered by this report are coded
according to the World Health Organization’s ninth revision of the International
Classification of Diseases. The ICD-9 aims to derive a single cause of death based on strict
rules for determining the underlying cause from the sequence of events leading to death.
This single underlying cause of death is used as the basis for applying the aetiological
fraction in this report.
Potential years of life lost
Potential years of life lost, or PYLL, is an alternative to a simple count of deaths as a measure
of mortality. It provides a measure of the time lost because of premature mortality. It can be
calculated in two ways: by choosing an arbitrary limit to life, in which case the PYLL is the
difference between this limit and the actual age at death; or by equating the PYLL with a
measure of average community life expectancy at the actual age of death. The PYLL
presented in this report are calculated using the latter method.
The usual source of average life expectancy is a life table. It is possible to derive Australian
PYLL estimates using a life table based on the actual population mortality experience in the
year under study. But this leads to variation in the PYLL estimates over time and between
different study populations because of differences in the specific life tables. For example, the
death of a woman aged 30 from a drug-related cause in 1988 contributes around two years
less to the drug-related mortality burden, measured in terms of PYLL, than if it had occurred
in 1998 purely because of changes in life expectancy over that period.
An alternative approach is to derive the average life expectancy from a standard life table.
This has the disadvantage that the PYLL estimates do not relate exactly to the population
under study, but it has the advantage that each death in a specific age–sex group contributes
the same amount to the measure of mortality irrespective of the year of death. The PYLL
presented in this report are based on the life table used in the Australian Burden of Disease
study to derive years of life lost (YLL) as a result of premature mortality (Mathers et al.
1999). This is a life table of projected cohort life expectancies for Australians alive in 1996.
Unlike the usually quoted ‘period’ life expectancies (ABS 1999), which synthesise the
currently observed mortality patterns across all age groups in the population, cohort life
expectancies use projected trends in mortality rates to estimate the average life expectancies
likely to be achieved by people currently alive.
The cohort life table gives estimates of life expectancy at birth as 85.69 years for women and
81.45 years for men. By comparison, the ABS life table representing the Australian mortality
5experience for 1996 to 1998 gives a life expectancy at birth of 81.52 years for women and
75.86 years for men. Nevertheless, the specific choice of life table makes little difference to
the results presented in this report in terms of comparisons between specific causes of death
and between different risk factors.
Both English et al. (1995) and Holman et al. (1990) used a method of calculating PYLL due to
a specific condition that adjusted the life expectancy for removal of that condition. We have
followed the practice of the Australian Burden of Disease study by allocating the age-
specific population average life expectancy to all deaths, regardless of the cause of death.
This simplification allows easier comparison of PYLL between conditions and risk factors,
and it allows the PYLL estimates to be added together across conditions. It does, however,
mean that reduction of a risk factor cannot be taken as leading to a proportional reduction in
PYLL. Those people saved from death due to the risk factor reduction would still remain at
risk of death from other conditions, so they would be subject to a modified life expectancy
that would be less than the average life expectancy used in the PYLL calculations.
The method used by English et al. allocated the PYLL to the age at which a person would
have lived had they not died. We followed the Australian Burden of Disease Study in
allocating the PYLL to the age at which death occurred. We also followed that study in
applying a 3% time discount rate to years of life lost in the future to estimate the net present
value of PYLL. This is standard practice in economic analysis, and, among other things, it
avoids the tendency of PYLL calculations to over-emphasise deaths at young ages. The use
of 3% a year as the discount rate follows the recommendation of the US Panel on Cost-
Effectiveness in Health and Medicine (Gold et al. 1996). The discounted mean life
expectancy at each age was calculated as
( )( )
03.0
1 03.0 LePYLL
−
−
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where L is the corresponding undiscounted mean life expectancy.
2.1.3 Measures of morbidity
This report uses two measures of morbidity: the number of hospital separations attributable
to a specific principal diagnosis; and the number of patient days attributable to a specific
principal diagnosis. Both these measures are derived from the Institute’s hospital morbidity
database, which is compiled on a financial-year basis.
These two measures do not provide a complete picture of morbidity in the community
because they do not cover morbidity where no medical care was sought or where medical
care was provided outside the hospital system—by, for example, general practitioners.
However, more complete national measures of cause-specific morbidity are not available in
Australia at present.
Hospital separations—the National Hospital Morbidity Database
The National Hospital Morbidity Database is a collection of confidentialised records for
admitted hospital patients provided to the Institute by the State and Territory health
departments. Data on patients admitted in one year but separated (discharged, transferred
or died) in another are included in the database for the year in which the separation
occurred.
The database includes data from public acute hospitals and Department of Veterans’ Affairs
hospitals, public psychiatric hospitals, private acute and psychiatric hospitals, and private
free-standing day hospital facilities. Exceptions in the public sector are public hospitals not
6within the jurisdiction of a State or Territory health authority or the Department of Veterans’
Affairs—for example, hospitals operated by the Department of Defence and hospitals
located in offshore territories. In addition, in 1997–98, public hospital data were not available
for a mothercraft hospital in the Australian Capital Territory, one small ‘outpatient clinic’ in
Queensland, and for most separations from three small district public hospitals in Tasmania.
In the private sector, about 4,500 hospital separations were not included for New South
Wales private hospitals, and separations were not available for two private free-standing
day hospital facilities and one other private hospital in Tasmania, private free-standing day
hospital facilities in the Australian Capital Territory, and the private hospital in the
Northern Territory.
A person can have had multiple stays in hospital in one year, but it is not possible to identify
such people on the database. Thus, a count of hospital separations will be an accurate guide
to the number of episodes of hospital care in a year but will generally be an overestimate of
the number of people treated in hospital in a year.
English et al. (1995) recommended that hospital separations for conditions relating to
complications of pregnancy and birth be excluded if the birth occurred during the hospital
stay. This is because the separation would probably have taken place even if the
complication had been absent, so to include it would lead to an overestimate of the total
attributable separations. We have followed that recommendation in this report.
2.2 Conditions included in this report
The conditions included in this report are those identified by English et al. (1995) as having a
causal relationship with alcohol, tobacco or illicit drugs (Tables 2.1 to 2.3). To these we have
added conditions identified by the National Health and Medical Research Council as related
to environmental tobacco smoke (NHMRC 1997).
The mortality data are coded to the underlying cause of death, which is defined as the
disease or injury that initiated the train of morbid events leading directly to death. These are
coded according to version 9 of the International Classification of Diseases. Accidental and
violent deaths are classified according to the external cause—that is, to the circumstances of
the accident or violence that produced the fatal injury—rather than to the nature of the
injury. These are coded using the ICD-9 external cause codes (denoted by the letter ‘E’ at the
start of the code number).
Hospital separations and patient days are coded in most cases to the principal diagnosis,
which is the diagnosis established after study to be chiefly responsible for occasioning the
patient’s episode of care in hospital. It does not include codes for external causes so in some
cases—falls related to alcohol, for example—an external cause coding is used instead. The
hospital data are coded using the clinical modification of the ICD-9 codes (ICD-9-CM), but
the differences between ICD-9 and ICD-9-CM are small for the conditions included in this
report and may be disregarded.
One consequence of this use of the principal diagnosis and the underlying cause of death is
that the analysis takes no account of other conditions recorded on the death certificate or the
hospital record. This is a limitation inherent in using the aetiological fractions derived by
English et al. because the fractions were estimated on the basis of primary diagnosis and
underlying cause of death.
In most cases the conditions included in the analyses for deaths and for hospital separations
are coded in the same way. For some conditions, however, English et al. used an external
7cause code when analysing mortality data but a principal diagnosis code for the
corresponding condition when analysing data on hospital separations. We followed this
practice for these cases, which are identified by footnotes in Tables 2.1 to 2.3. This sometimes
leads to the conditions for each analysis not being directly comparable. For example, the
data for deaths due to psychostimulant poisoning relate only to accidental poisoning, while
the corresponding hospital separations also relate to deliberate poisoning. This also leads to
some conditions being analysed differently for different risk factors. For example, suicide
and self-inflicted injury are included in both the mortality and morbidity analyses for
alcohol but only in the mortality analyses for illicit drugs. In the latter case, the self-inflicted
injury is classified under the principal diagnosis according to the drug used. For example,
attempted suicides using opiates are counted under opiate poisoning.
English et al. did not distinguish between types of hepatitis other than types A and B.
Instead, they calculated a fraction for all non-A, non-B cases pooled together. Thus, although
some forms of non-A, non-B hepatitis (such as type E) are not transmitted by injecting drug
use, we followed their practice and pooled all non-A, non-B hepatitis into one group. The
aetiological fraction for this condition identifies the proportion of the pooled group that is
attributable to injecting drug use.
8Table 2.1: Causes of death and principal diagnoses identified as alcohol-related
conditions
Condition ICD-9 code
Cancer
Oropharyngeal cancer 141, 143–146, 148–149
Oesophageal cancer 150
Liver cancer 155
Laryngeal cancer 161
Female breast cancer 174
Alcoholism and alcoholic liver cirrhosis
Alcoholic psychosis 291
Alcohol dependence/abuse 303, 305.0
Alcoholic liver cirrhosis 571.0–571.3
Road injuries E810–E819
Other
Epilepsy 345
Alcoholic poly-neuropathy 357.5
Hypertension 401–405
Ischaemic heart disease 410–414
Alcoholic cardiomyopathy 425.5
Supraventricular cardiac dysrhythmias 427.0, 427.2, 427.3
Heart failure 428–429
Stroke 430–438
Oesophageal varices 456.0–456.2
Gastro-oesophageal haemorrhage 530.7
Alcoholic gastritis 535.3
Unspecified liver cirrhosis 571.5–571.9
Cholelithiasis 574
Pancreatitis, acute and chronic 577.0, 577.1
Low birthweight 656.5, 764, 765
Psoriasis 696.1
Ethanol/methanol toxicity 980.0(a) , 980.1(a)
Alcoholic beverage poisoning E860.0(b)
Other ethanol and methanol poisoning E860.1, E860.2(b)
Fall injuries E880–E888
Fire injuries E890–E899
Drowning E910
Aspiration E911
Occupational and machine injuries E919,E920
Suicide and self-inflicted injury E950–E959
Assault E960,E965,E966,E968,E969
Child abuse E967
(a) Diagnosis code used only for calculating numbers of drug-caused hospital separations and patient days.
(b) External cause code used only for calculating numbers of drug-caused deaths and PYLL.
Source: English et al. (1995).
9Table 2.2: Causes of death and principal diagnoses identified as tobacco-related
conditions
Condition ICD-9 code
Cancer
Oropharyngeal cancer 141,143–146, 148–149
Oesophageal cancer 150
Stomach cancer 151
Anal cancer 154.2, 154.3
Pancreatic cancer 157
Laryngeal cancer 161
Lung cancer 162
Endometrial cancer 179, 182
Cervical cancer 180, 233.10
Vulvar cancer 184.4
Penile cancer 187.1–187.4
Bladder cancer 188
Renal parenchymal cancer 189.0
Renal pelvic cancer 189.1
Respiratory carcinoma in situ 231
Ischaemic heart disease
Ischaemic heart disease 410–414
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease 490–492, 496
Other direct effect of smoking
Tobacco abuse 305.1
Parkinson’s disease 332
Pulmonary circulation disease 415.0, 416–417
Cardiac dysrhythmias(a) 427
Heart failure(a) 428–429
Stroke 430–438
Atherosclerosis 440–448
Pneumonia 480–487
Peptic ulcer 531–534
Crohn’s disease 555
Ulcerative colitis 556
Ectopic pregnancy 633, 761.4
Spontaneous abortion 634, 761.8
Antepartum haemorrhage 640, 641, 762.0, 762.1
Hypertension in pregnancy 642, 760.0
Low birthweight 656.5, 764, 765
Premature rupture of membranes 658.1–658.2, 761.1
(continued)
10
Table 2.2 (continued): Causes of death and principal diagnoses identified as
tobacco-related conditions
Condition ICD-9 codes
SIDS (and smoking during pregnancy) 798.0
Fire injuries E890–E899
Environmental tobacco smoke
Lung cancer 162
Ischaemic heart disease 410–414
Asthma (under 15 years) 493
Lower respiratory illness (under 18 months) 464, 466, 480–486, 487 and 490
SIDS (and post natal smoking) 798.0
(a) The majority of heart failure and cardiac dysrhythmias are secondary to ischaemic heart disease.
Source: English et al. (1995).
11
Table 2.3: Causes of death and principal diagnoses identified as illicit
drug-related conditions
Condition ICD-9 code
Directly attributable to opiates
Opiate dependence 304.0, 304.7
Opiate abuse 305.5
Opiate poisoning 965.00, 965.01, 965.02(a)
Accidental opiate poisoning E850.0, E850.1(b)
Antepartum haemorrhage due to opiates 640, 641
Low birthweight due to opiates 764, 765, 656.5
Directly attributable to other illicit drugs
Cannabis dependence 304.3
Cannabis abuse 305.2
Amphetamine dependence 304.4
Amphetamine abuse 305.7
Cocaine dependence 304.2
Cocaine abuse 305.6
Psychostimulant poisoning 969.7(a)
Accidental poison by psychostimulants E854.2(b)
Hallucinogen dependence 304.5
Hallucinogen abuse 305.3
Hallucinogen poisoning 969.6(a)
Other psychotropic drug poisoning 969.8, 969.9(a)
Accidental poisoning by hallucinogens E854.1(b)
Anabolic steroid poisoning 962.1(a)
Antepartum haemorrhage due to cocaine 640, 641
Low birthweight due to cocaine 764, 765, 656.5
Attributable to unclassifiable injecting drug use
Hepatitis B 070.2, 070.3
Hepatitis non A, non B 070.4, 070.5
AIDS 279.1, 042–044
Infective endocarditis 421
Other related causes
Drug psychoses 292
Maternal drug dependence 648.3
Newborn drug toxicity 760.7, 779.5
Road injuries E810–E819
Suicide E950–E959(b)
(a) Diagnosis code used only for calculating numbers of drug-caused hospital separations and patient days.
(b) External cause code used only for calculating numbers of drug-caused deaths and PYLL.
Source: English et al. (1995).
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2.3 Aetiological fractions selected for revision
The estimated values of the fractions for most conditions depend on both the prevalence of
the risk factor and on the risk ratio associated with the specific condition. In all cases where
data were available, the fractions have been revised to reflect the most recent estimation of
risk factor prevalence. In addition, some fractions have been revised to reflect the effect of
recent research results on our knowledge of the risk ratios.
English et al. (1995) used estimates of the current prevalence of tobacco smoking and alcohol
consumption in their calculation of aetiological fractions for tobacco and alcohol. But many
conditions have a long time lag between exposure to tobacco smoke or alcohol consumption
and their associated ill-effects—in the case of cancers it may be many decades. So for these
conditions estimates of current prevalence are not helpful in understanding the current
associated disease burden. We followed the Australian Burden of Disease Study in using the
method proposed by Peto et al. (1992) to adjust for this time lag for tobacco smoke. In the
case of alcohol, however, there is no equivalent of the method used by Peto et al. to adjust
for this time lag so we followed English et al. in using the current prevalence estimates for
alcohol consumption in the calculation of the alcohol fractions. The prevalence of alcohol
consumption, particularly of heavy drinking, has declined in recent decades, and it is thus
likely that these methods underestimate the true aetiological fractions for some current
health outcomes attributable to alcohol consumption.
Given the time and the resources available for this study, it was impossible to examine in
detail examination all the conditions with which the three risk factors have been linked.
Instead, we selected for detailed study those conditions that made the largest contribution to
mortality and morbidity, as identified by English et al., and for which there was clear
epidemiological evidence of a need to revise the risk ratios. These conditions are listed in
Table 2.4. We used the risk ratios or case study estimates identified by English et al. or by the
National Health and Medical Research Council environmental smoking study (NHMRC
1997) for the remaining fraction estimates.
Table 2.4: Conditions selected for detailed study and risk ratio revision
Cause/condition ICD-9 code
Alcohol
Female breast cancer 174
Stroke 430–438
Road injuries E810–E819
Fall injuries E880–E888
Tobacco
Cervical cancer 180, 233.10
Peptic ulcer 531–534
Illicit drugs
Road injuries E810–E819
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2.4 Literature search
We followed English et al. (1995) in searching for articles from the CD-ROM MEDLINE
National Library of Medicine 1988–98 database supplied by Silver Platter. As with English et
al., in all instances searches were restricted to articles published in English. The
overwhelming majority of the relevant studies would be published in English, so few
studies of relevance would have been excluded. Furthermore, the restriction to literature
published in English increases the relevance of the studies to the Australian population. The
search strategies were applied to conditions identified by English et al.
Much of the literature relating to illicit drugs in Australia is unlikely to be indexed on
MEDLINE. It is more likely to be published in technical reports and monographs or in more
specific CD-ROM collections. Our search strategy included the libraries of the National Drug
and Alcohol Research Centre, the National Centre for Research into Prevention of Drug
Addiction, and the Alcohol and Drugs Council of Australia. It also included the Victorian
Anti-Cancer Council and the Centre for Behavioural Research in Cancer, the Australian
Institute of Criminology in Canberra, the Australian Institute of Health and Welfare Injury
Surveillance Unit, and the Australian Transport Safety Bureau for research into the
relationship between alcohol consumption and road accidents.
The same methodology as that used for MEDLINE was also used to search specialist CD-
ROM databases such as the Australian Medical Index (AMI), the National Library of
Australia (1968–1998b), the Australian Public Affairs Information Service—Health (APAIS—
Health), the National Library of Australia (1978–1998), the Aboriginal and Torres Strait
Islander Health Bibliography (ATSIhealth), The School of Health Studies and Edith Cowan
University (1988–1998), AusportMed, the National Sports Information Centre and the
Australian Sports Commission (1989–1998), the Drug Database (DRUG), the Alcohol and
Other Drugs Council of Australia (1974–1998), the Health and Society Database, the
Australian Institute of Family Studies (1980–1998b), the Rural and Remote Health Database
(RURAL), the Australian Rural Health Research Institute and Monash University (1966–
1998), the Attorney-General’s Information Service (AGIS), the Attorney-General’s
Department (1975–1998), the Australian Federal Police Digest (AFPD), the Australian
Federal Police (1991–1998), the Australian Public Affairs Information Service (APAIS), the
National Library of Australia (1978–1998a), the Australian Criminology Database (CINCH),
the Australian Institute of Criminology (1968–1998), the Australian Family and Society
Abstracts Database (Family), Australian Institute of Family Studies (1980–1998a), and
HealthSTAR, the National Library of Medicine (1997–1998).
2.5 Prevalence of exposure data
2.5.1 Alcohol data
Classification of data on alcohol consumption
The criteria used to classify data on alcohol consumption were equivalent to those used by
English et al. (1995), with the exception of the names used to categorise each level of
consumption. Whereas English et al. refer to alcohol intake categorised according to the
National Health and Medical Research Council’s criteria (abstinence, low, hazardous, and
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harmful), this report refers to these equivalent levels as abstinence, low, medium and high
(Table 2.5).
Table 2.5: Alcohol intake levels used in this report
Standard drinks per day (1 standard drink = 10 grams alcohol)
Intake level Males Females Persons
Abstinence 0.00–0.25 0.00–0.25 0.00–0.25
Low 0.26–4.00 0.26–2.00 0.26–3.00
Medium 4.01–6.00 2.01–4.00 3.01–5.00
High 6.01+ 4.01+ 5.01+
Following English et al., we included alcohol quantities up to one-quarter of a standard
drink per day in the exposure category of ‘abstinence.’ This provided tolerance for the
inclusion of studies with small amounts of baseline contamination (commonly less than one
drink a week or less then one drink a month). Assignment of relative risk to low, medium or
high levels of exposure varied according to whether subjects were males, females or a
combined group of both sexes.
For the purpose of assigning equivalents of exposure, one alcohol drink a day was taken as
equivalent to 10 grams of alcohol a day, 70 grams of alcohol a week, or 300 grams or 10
ounces a month (Table 2.6). In assigning results of published literature to one or more
exposure categories, a median exposure level was estimated for each result in the literature,
based on the exposure interval to which the estimate of relative risk related. These were then
assigned to the abstinence, low, medium and high levels of exposure according to where the
median exposure level fell. Binge drinkers and ex-drinkers were generally excluded.
Table 2.6: Approximate equivalents of alcohol consumption used in this report
Intake level Standard drinks/day grams/day grams/week grams/month ounces/month
Males
Abstinence 0.00–0.25 0.0–2.5 0.0–17.5 0.0–75 0.0–2.5
Low 0.26–4.00 2.6–40.0 17.6–280.0 76–1200 2.6–40.0
Medium 4.01–6.00 41.0–60.0 281.0–420.0 1201–1800 41.0–60.0
High 6.01+ 61+ 421+ 1801+ 61+
Females
Abstinence 0.00–0.25 0.0–2.5 0.0–17.5 0.0–75 0.0–2.5
Low 0.26–2.00 2.6–20.0 17.6–140.0 76–600 2.6–20.0
Medium 2.01–4.00 21.0–40.0 141.0–280.0 601–1200 21.0–40.0
High 4.01+ 41+ 281+ 1201+ 41+
For some conditions—notably falls and motor vehicle injuries—the lack of published
analytical studies necessitates the use of aetiological fractions reported from clinical or blood
alcohol case series data. As did English et al., in these circumstances we assumed that all
attributed cases were due to medium to high drinking levels. For road injuries, blood alcohol
concentration was generally measured directly or estimated with the use of a breathalyser
test. In this case concentrations of over 0.05–0.10 g/100 mL and over 0.10 g/100 mL were
regarded as comparable to medium and high levels of alcohol intake. Thus aetiological
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fractions derived from an exposure contrast between ‘illegal’ and ‘legal’ blood alcohol
concentrations may be interpreted as the proportions of road injuries that might be
avoidable if alcohol exposure were reduced to within the legal limit.
Data on the prevalence of alcohol consumption
English et al. (1995) estimated the prevalence of alcohol consumption from the 1989–90
National Health Survey conducted by the Australian Bureau of Statistics and the 1989
National Heart Foundation Risk Factor Prevalence Survey. Because of limitations in each of
these data sources, they devised the following method of prevalence estimation based on a
combination of the two sources:
• The sex- and age-specific prevalence measures of current drinkers (at any level) were
based on the results of the Risk Factor Prevalence Survey.
• The sex- and age-specific prevalence measures at particular levels of drinkers’ intake
were based on the results of the 1989–90 National Health Survey.
Table 2.7 shows the estimated prevalence of alcohol consumption for Australian males and
females in 1989.
Table 2.7: Prevalence of alcohol consumption among Australians, by gender, 1989
Males Females
Age Abstinence Low Hazardous Harmful Abstinence Low Hazardous Harmful
18–19 0.159 0.658 0.097 0.086 0.202 0.683 0.082 0.032
20–24 0.159 0.623 0.103 0.115 0.202 0.642 0.111 0.044
25–29 0.080 0.688 0.124 0.108 0.185 0.696 0.093 0.026
30–34 0.110 0.726 0.084 0.080 0.240 0.678 0.066 0.016
35–39 0.120 0.708 0.099 0.073 0.221 0.685 0.078 0.016
40–44 0.087 0.743 0.082 0.088 0.233 0.654 0.099 0.015
45–49 0.115 0.716 0.089 0.080 0.219 0.655 0.098 0.028
50–54 0.129 0.678 0.095 0.098 0.328 0.566 0.081 0.025
55–59 0.178 0.662 0.090 0.070 0.327 0.577 0.076 0.020
60–64 0.192 0.650 0.081 0.077 0.331 0.577 0.071 0.021
65–69 0.169 0.696 0.085 0.050 0.335 0.564 0.084 0.017
70–74 0.169 0.739 0.049 0.043 0.335 0.571 0.069 0.025
75–79 0.169 0.784 0.027 0.020 0.335 0.609 0.056 0.000
80+ 0.169 0.806 0.013 0.012 0.335 0.632 0.030 0.004
18+ 0.126 0.699 0.092 0.084 0.247 0.646 0.085 0.023
Source: Derived from the 1989–90 ABS National Health Survey and 1989 National Heart Foundation Risk Factor Prevalence Survey.
In updating the prevalence data using more recent sources of information, a number of
sources were considered, including the 1995 ABS National Health Survey, the ABS 1997
Survey of Mental Health and Wellbeing, and the Department of Health and Aged Care’s
1998 National Drug Strategy Household Survey. Although the most dated, the 1995 National
Health Survey was chosen to represent the alcohol prevalence data for updating the
aetiological fractions. This was because of the more specific nature of the information
collected (seven categories of alcoholic drinks) and the fact that adjustments were made for
the alcohol content of a variety of brands within these categories—for example, low-alcohol
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beer distinguished from full-strength beer (ABS 1995b). Furthermore, the National Health
Survey had a sampling frame of 23,800 households, representing about 1 in 310 of the non-
institutionalised population in Australia. The sample design ensured that within each State
or Territory each person had a known and equal chance of selection. Overall, completed
responses were obtained from 53,751 people (Donath 1999).
However, unlike the 1989–90 National Health Survey, the 1995 Survey asked about the
quantity of alcohol consumed on up to three days of the week before the interview day,
whereas the 1989–90 Survey used a seven-day retrospective diary. Furthermore, the 1995
Survey asked how many days in the previous week had alcohol been consumed. This was
done so as to estimate weekly consumption among those who consumed alcohol on more
than three days a week, by multiplying the number of days alcohol was consumed in the
previous week, dividing that by three, and then multiplying by the total consumption across
the three days on which it was assessed. This relies on the implicit assumption that average
consumption for the three days where it was assessed was the same as on the days for which
data were not obtained. However, as is evident from the 1989–90 Survey data, for those who
consume alcohol on four or more days of the week there are large differences between
consumption from Monday to Thursday and consumption on Fridays, Saturdays and
Sundays (Donath 1999).
Since the 1995 Survey methodology directly estimates consumption for those consuming
alcohol on fewer than four days, only the estimates for those consuming alcohol on four or
more days appear to be problematic. This is important. The proportion of people who drink
alcohol on four or more days is substantial: in 1995 it was estimated to be 26.3% for males
and 11.7% for females (Donath 1999).
In order to obtain reliable estimates using the 1995 methodology, the day of the week of
interview would have to be uniformly distributed for those who drank on four or more days
of the week. But it appears this was not the case. With the 1995 Survey, the data show that,
for people consuming alcohol in the previous week, far more interviews were conducted on
Monday, Tuesday and Wednesday (26%, 24% and 22% respectively) than on weekends (4%
Saturday and 1% Sunday) (Donath 1999).
Because of these difficulties, the 1995 Survey’s data on weekly consumption were
reweighted so as to give equal weight to each of the days of interview. Further, because
there were so few interviews on Saturdays and Sundays, there were too few outcomes for
the moderate and high levels of alcohol intake to allow this to be done by five-year age
groups. Therefore, the average distribution of Saturday and Sunday for broader age groups
(18–34, 35–64 and 65+) was used to provide the estimates to be applied to the five-year age
groups.
As Donath did, we determined the prevalence of consumption for 18–24 year olds and used
this to derive aetiological fractions for both 18–19 and 20–24 year olds. This overcame the
small numbers that occured in trying to estimate prevalence for 18–19 year olds, particularly
females. The resulting 1995 Survey prevalence estimates for updating the aetiological
fractions are described in Table 2.8.
Comparison of the 1995 and 1998 National Drug Strategy Household Survey estimates of
alcohol consumption suggests that levels of alcohol intake remained relatively constant
between 1995 and 1998. We took the prevalence estimates in Table 2.8 as applying to 1998.
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Table 2.8: Prevalence of alcohol consumption among Australians, by gender, 1995
Males Females
Age Abstinence Low Hazardous Harmful Abstinence Low Hazardous Harmful
18–19 0.153 0.697 0.067 0.083 0.225 0.618 0.130 0.027
20–24 0.153 0.697 0.067 0.083 0.225 0.618 0.130 0.027
25–29 0.135 0.717 0.075 0.073 0.258 0.624 0.097 0.021
30–34 0.162 0.680 0.088 0.070 0.222 0.668 0.091 0.020
35–39 0.197 0.675 0.078 0.050 0.363 0.502 0.112 0.023
40–44 0.186 0.660 0.097 0.057 0.346 0.540 0.094 0.021
45–49 0.186 0.649 0.108 0.057 0.392 0.485 0.092 0.031
50–54 0.149 0.707 0.081 0.063 0.386 0.461 0.114 0.038
55–59 0.193 0.0689 0.081 0.037 0.385 0.473 0.117 0.025
60–64 0.169 0.654 0.104 0.073 0.372 0.494 0.123 0.011
65–69 0.184 0.696 0.075 0.045 0.391 0.453 0.141 0.014
70–74 0.162 0.717 0.062 0.059 0.432 0.472 0.085 0.011
75–79 0.185 0.721 0.028 0.066 0.497 0.451 0.043 0.009
80+ 0.204 0.714 0.053 0.030 0.373 0.568 0.043 0.016
18+ 0.176 0.679 0.083 0.063 0.310 0.560 0.108 0.022
Source: AIHW analysis of 1995 ABS National Health Survey
Prevalence data on alcohol consumption during pregnancy
English et al. (1995) provided estimates of the prevalence in Australia of alcohol
consumption during pregnancy. These were based on a 1993 Survey of 6,861 pregnant
women in Tasmania, undertaken by the University of Tasmania’s Department of Obstetrics
and Gynaecology at the Queen Alexandria Hospital. Information on alcohol intake was
provided by 5,417 of the 6,861 respondents (Table 2.9).
Table 2.9: Alcohol intake during pregnancy,
Tasmania, 1993
Drinks Prevalence
None 0.787
<3 per week 0.196
3–6 per week 0.015
2–3 per day 0.0009
4+ per day 0.0004
Source: English et al. (1995).
Thus, by apportioning the prevalence observed at two to three drinks a day equally between
low and hazardous drinking, the total prevalence of low consumption during pregnancy
was estimated at 0.212 and of hazardous or harmful consumption at 0.001.
We used results from the more recent 1998 National Drug Strategy Household Survey to
update these estimates. There is no exact correspondence between the results collected by
the Survey and our categorisation of intake as low, moderate or high, although the Survey’s
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results can be grouped approximately into these categories. The result is an estimated
prevalence of low consumption during pregnancy of 0.293 and of hazardous or harmful
consumption of 0.053.
2.5.2 Data on cigarette smoking
English et al. (1995) derived the prevalence of smoking in the adult Australian population
aged 18 years or more from the 1989–90 National Health Survey. They determined
prevalences for never, former and current cigarette smoking. The prevalence of current
cigarette smoking was described in terms of three categories according to the number of
cigarettes smoked each day (one to 14, 15 to 24, and 25 or more). ‘Current smoking’ was
defined as smoking at the time of interview and ‘former smoking’ as smoking at any time
prior to interview.
This approach, which described as current smokers those smoking a minimum of one
cigarette a day, is consistent with the studies that have uncovered the harmful effects of
smoking, whereby regular or current smoking is quantified in terms of a minimum of one
cigarette a day (Doll 1998). The 1995 National Health Survey defined a regular smoker as
someone smoking a minimum of one cigarette a day (ABS 1995b). A current smoker who
smoked less than one cigarette a day was defined as an occasional smoker. For the purpose
of quantifying smoking status, however, only regular smokers (one or more a day) were
counted as smokers; occasional smokers were classified as ‘never smoked’. The ex-smokers
were those who indicated smoking at some time but who were not occasional or regular
smokers at the time of interview.
Data on cigarette smoking prevalence
The 1995 National Health Survey was not considered as a replacement source for updated
prevalence data because unlike the 1989–90 Survey, it did not assess the number of cigarettes
smoked. Two other recent sources of prevalence data on smoking are the 1995 Australian
survey by the Victorian Anti-Cancer Council (Hill et al. 1998—see Tables 2.10 and 2.11) and
the more recent 1998 National Drug Strategy Household Survey by the Department of
Health and Aged Care.
The Victorian Anti-Cancer Council Survey results are described below. It should be noted
that smoking prevalence is calculated only to age 70 or more years because age was
restricted to this level in the original data collection. This contrasts with the work of English
et al. (1995) who had determined smoking prevalence by five-year age groups and to age 80
and over. Furthermore, for the purpose of analysis the small number of pipe and cigar users
were excluded from the estimates derived from the Victorian Anti-Cancer Council Survey.
As just described above, only regular smokers (one of more a day) were counted as smokers;
occasional smokers were classified as having never smoked.
While the National Drug Household Survey was the more recent and had the ability to be
analysed more completely by five-year age groups, the Victorian Anti-Cancer Council
Survey’s estimates of prevalence by the Centre for Behavioural Research in Cancer were
adopted for the revision of the aetiological fractions. This was because the Anti-Cancer
Council Survey data contained cigarette consumption data that matched the work of
English et al.
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Table 2.10: Smoking prevalence among Australian males, 1995
Current smokers cigarettes per day
Age Never smoked Ex-smoker
All
smokers 1–14 15–24 25+
16–17 75.5  4.3 20.2  9.6 5.3  5.3
18–19 58.5  6.2 35.4 26.2 9.2  0.0
20–24 56.2 12.4 31.3 16.6 9.2  5.5
25–29 52.2 18.3 29.5 16.3 7.2  6.0
30–34 46.7 23.0 30.2 10.3 6.5 13.4
35–39 47.1 27.8 25.1  6.2 7.2 11.7
40–44 49.3 29.3 21.4  6.0 5.4 10.0
45–49 45.2 33.2 21.6  4.6 5.8 11.2
50–54 40.0 34.9 25.1 10.2 6.2  8.7
55–59 37.1 39.4 23.4  7.4 5.7 10.3
60–64 42.4 45.8 11.9  4.0 2.8  5.1
65–69 31.8 56.3 12.0  4.2 4.7  3.1
70+ 37.3 54.5  8.1  3.6 1.2  3.3
Total 16+ 45.9 32.1 22.0  8.5 5.6  7.9
Source: Hill et al. (1998).
Table 2.11: Smoking prevalence among Australian females, 1995
Current smokers cigarettes per day
Age Never smoked Ex-smoker
All
smokers 1–14 15–24 25+
16–17 70.3  9.5 20.3 13.5 5.4 1.4
18–19 47.6 14.3 38.1 25.0 9.5 3.6
20–24 53.7 15.3 31.0 14.0 9.1 7.9
25–29 51.6 16.9 31.5 16.9 8.6 6.0
30–34 45.7 23.7 30.6 13.9 8.2 8.5
35–39 52.1 24.8 23.1 10.0 7.5 5.6
40–44 52.0 23.2 24.7  8.1 8.1 8.5
45–49 62.3 24.1 13.6  3.6 3.6 6.4
50–54 55.5 23.5 21.0  7.0 7.5 6.5
55–59 59.4 24.0 16.6  6.3 5.7 4.6
60–64 67.8 18.0 14.1  5.4 6.3 2.4
65–69 63.3 24.3 12.4  6.5 0.0 5.9
70+ 67.3 26.0  6.8  3.5 1.2 2.1
Total 16+ 56.9 21.7 21.4  9.5 6.2 5.7
 Source: Hill et al. (1998).
Comparison of the 1995 and 1998 National Drug Strategy Household Survey estimates of the
prevalence of tobacco consumption suggests that levels of tobacco use remained relatively
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constant over the period. We took the prevalence estimates in Tables 2.10 and 2.11 as
applying to 1998.
Prevalence data on cigarette smoking during pregnancy
English et al. (1995) provided estimates of the prevalence in Australia of cigarette smoking
during pregnancy. These were based on a 1993 survey of 6,861 pregnant women in
Tasmania, undertaken by the University of Tasmania’s Department of Obstetrics and
Gynaecology at the Queen Alexandria Hospital. Information on cigarette smoking was
provided by 5,428 of the 6,861 respondents (Table 2.12).
Table 2.12: Cigarette smoking during pregnancy, Tasmania, 1993
Smoking status Current smokers cigarettes: per day
Non-smoker Current smoker 1–9 10–20 21+
0.71 0.29 0.13 0.12 0.04
Source: English et al. (1995).
We used results from the 1998 National Drug Strategy Household Survey to update these
estimates. The estimated proportion of women who were either occasional or regular
smokers during pregnancy in 1998 was 0.279.
Cigarette smoking and exposure to environmental tobacco smoke among
infants and children aged less than 16 years
Revised estimates of exposure to environmental tobacco smoke were provided by the Anti-
Cancer Council of Victoria’s Centre for Behavioural Research in Cancer; they were based on
unpublished data from a 1997 survey conducted only in Victoria.
For households with children aged less than 2 years it was estimated that, in 1997, 24.4% of
such households would have had a female smoker (assumed to be the mother). Of the
households with female smokers, 51.6% were households in which there was no restriction
or ban on smoking indoors. Overall, this results in an estimate of 12.6% of households
containing a child aged less than 2 years having a female smoker who was not restricted to
smoking outdoors.
Similarly, for children aged less than 16 years and for whom there was a female smoker
(assumed to be the mother) of 10 or more cigarettes a day in the household, it was estimated
that the prevalence of exposure was 21.3%. Again, of such households, 25.3% were
households in which there was no restriction or ban placed on smoking indoors. Overall,
this results in an estimate of 5.4% of households containing a child aged less than 16 years
having a female smoker who was not restricted to smoking outdoors.
Cigarette smoking and exposure to environmental tobacco smoke among
non-smoking spouses
The NHMRC’s report on the health effects of passive smoking (NHMRC 1997) used the
proportion of non-smokers with a spouse who was a current smoker as a measure of
exposure to environmental tobacco smoke. That report derived the prevalence measure from
the 1989–90 ABS National Health Survey. We calculated the corresponding estimates from
the 1995 National Health Survey. Details of these estimates are presented in Section 4.2.3.
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3 Alcohol
3.1 Introduction
English et al. (1995) calculated aetiological fractions for hazardous and harmful alcohol
consumption (as defined by the National Health and Medical Research Council) relative to
low alcohol consumption. This was a departure from the earlier estimates derived by
Holman et al. (1990), which were calculated with abstention as the reference category. With
low alcohol consumption as the reference category, English et al. sought to reflect more
accurately the idea that unsafe drinking—as opposed to low alcohol consumption, which
may be protective—is the cause for concern.
However, even at low levels of consumption, alcohol increases the risk of some conditions.
Further, the approach taken by English et al. does not allow for the quantification of
conditions apparently prevented as a result of low levels of alcohol consumption. We
followed the approach of the earlier study by Holman et al. and derived fractions to reflect
both the risks and the benefits of alcohol at all levels of consumption relative to abstaining
from alcohol. Hence our estimates of alcohol-related deaths and hospital separations
represent the net effect of both the alcohol-related harm and the alcohol-related benefit. The
only exception to this is the fraction for the effect of alcohol on road traffic accidents:
although there is some evidence that low levels of alcohol consumption increase the risk of
road traffic accidents at some ages, we followed English et al. in deriving the aetiological
fraction with the legal blood alcohol concentration as the reference level.
Public health efforts in Australia are directed at reducing unsafe alcohol consumption, rather
than alcohol consumption per se. Therefore, although the primary purpose of this report is
to estimate the total effect of alcohol consumption, it also presents, in Appendix A, a
separate calculation using the approach taken by English et al. These data represent the extra
effect of alcohol consumption for the ‘unsafe’ drinker compared with the ‘responsible’
drinker (English et al. 1995, p. 58), where unsafe and responsible consumption are defined
by the NHMRC guidelines for responsible drinking (NHMRC 1992).
As with tobacco, current exposure to alcohol does not reflect the relevant exposure for some
current outcomes, such as cirrhosis and cancers. There is, however, no equivalent of the
method used by Peto et al. (1992) to adjust for this time lag. We followed English et al. in
using current prevalence estimates for alcohol consumption in calculating the aetiological
fractions for alcohol. The prevalence of alcohol consumption, particularly heavy drinking,
has declined in recent decades, so it is likely that these methods underestimate the true
aetiological fractions of some current health outcomes attributable to alcohol consumption.
3.2 Revised aetiological fractions for alcohol
3.2.1 Alcohol and breast cancer among females
Drinking alcohol increases the risk of breast cancer, and it appears the mechanism may be a
result of increased levels of oestradiol in the circulation (Davis et al. 1997). Reichman (1993)
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demonstrated an increase in both total oestrogen levels and the amount of bioavailable
oestrogens in association with alcohol consumption (30 g/day) among pre-menopausal
women aged 21–40 years. This relationship between alcohol intake and increased levels of
oestradiol in the circulation was confirmed more recently by Muti et al. (1998).
Ginsberg et al. (1996) demonstrated the effect that alcohol ingestion (0.7 g/kg) for a number
of consecutive days can have on circulating levels of oestradiol among post-menopausal
women receiving oral oestrogen as part of hormone replacement therapy when compared
with women not on hormone replacement therapy. Alcohol did not significantly raise
oestradiol levels among post-menopausal women not on hormone replacement therapy, but
acute alcohol ingestion resulted in sustained and significant elevation in circulating
oestradiol, to levels 300% higher than the level targeted for post-menopausal women on
hormone replacement therapy (Ginsburg et al. 1996; Ginsburg et al. 1995a; Ginsburg et al.
1995b). While the alcohol dose (0.7 g/kg) used in this study was quite high, making the
results less definitive, the study does demonstrate that in certain circumstances alcohol may
have extreme effects on oestrogen levels and identifies a potential mechanism for increased
breast cancer risk among post-menopausal women (Davis et al. 1997).
The epidemiological data on alcohol and breast cancer suggest a dose–response relationship
that is very modest (Longnecker 1995b). While there are three meta-analyses (Longnecker
1994; Longnecker et al. 1988; Roth et al. 1994) that support a weak dose–response
relationship, a causal role for alcohol was at the time still thought debatable (Longnecker
1995a; Longnecker 1995c). The association reported in the most recent meta-analysis (38
studies) by Longnecker (1994), however, was statistically significant, albeit very modest. The
weighted average dose–response curve found in the 38 studies shows that, while results
varied markedly between studies, on average for each alcoholic drink consumed daily the
risk increased by 10% (Davis et al. 1997; Longnecker 1995b). A later study by Longnecker
(1995a), which assessed risk based on cumulative (lifetime) alcohol intake, found that there
was an almost 40% increase in women who averaged one drink a day and a 70% increase
among those averaging two drinks a day (Davis et al. 1997).
Longnecker (1995a; 1995b) estimated that even if alcohol were causal—because in general
women do not drink much and because the effect on risk, if any, is subtle—only around 4%
of all breast cancers among women would be attributable to alcohol consumption (Davis et
al. 1997). This is consistent with the work of English et al. (1995), who found that some 3% of
breast cancer among females in Australia is caused by medium (≅ >2 ≤4 drinks a day) and
high (≅ >4 drinks a day) levels of alcohol consumption.
A more recent Italian study (Mezzetti et al. 1998) has, however, attributed 10.7% of female
breast cancer to alcohol intake of >20 g/day (95% CI: 4.4–17.0). Furthermore, the
corresponding figure for pre-menopausal women (21.1%; 95% CI: 10.9–31.4) was four times
that for post-menopausal women (5.4%; 95% CI: –2.5–3.4). This contrasts with the finding of
English et al. that the test for heterogeneity in pooled relative risk estimates between pre-
menopausal women (<45 years) and post-menopausal women (≥45 years) was consistent
with no difference between the two groups. English et al. combined the two groups for
subsequent analysis, and pooled relative risks were determined for use in calculating the
aetiological fraction.
Epidemiological evidence for reviewing the aetiological fraction for alcohol and
female breast cancer
Ferraroni et al. (1998) reported on 19 studies that examined heterogeneity due to age or
menopausal status in the association of alcohol intake and the risk of female breast cancer.
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Eight of the studies (Ewertz 1991; Kato et al. 1989; Katsouyanni et al. 1994; La Vecchia et al.
1989; Meara et al. 1989; Schatzkin et al. 1989; Sneyd et al. 1991; Willett et al. 1987) are
reported to show no substantial heterogeneity. However, five studies (Friedenreich et al.
1993; Levi et al. 1996; Rohan & McMichael 1988; Schatzkin et al. 1987; van’t Veer et al. 1989)
reported an association that was stronger at a younger age or in pre-menopausal women. On
the other hand, one study was indicative of a trend in risk only among peri-menopausal
women (Chu et al. 1989), and four case-control studies (Ferraroni et al. 1991; Longnecker et
al. 1995a; Martin Moreno et al. 1993; Richardson et al. 1989) and one prospective
investigation (Hiatt et al. 1988) showed a stronger association among women aged more
than 50 years or who were post-menopausal.
Recent results reported by Mezzetti et al. (1998) and Ferraroni et al. (1998) have found the
elevation in risk for female breast cancer among alcohol drinkers to be significant among
pre-menopausal women, rather than post-menopausal women. Mezzetti et al. found that the
proportion of breast cancer cases attributable to alcohol for pre-menopausal females (21.1%;
95% CI: 10.9–31.4) was four times that for post-menopausal women (5.4%; 95% CI: –2.5–
13.4).
Studies used to revise the aetiological alcohol and female breast cancer
The studies used to revise the aetiological alcohol and female breast cancer are listed in
Appendix B. The literature search identified 52 papers for detailed review; this yielded 17
studies with data suitable for inclusion in the review of the fractions. Only 16 of the 17
studies were, however, included in the calculations: the results reported by Mezzetti et al.
(1998) appeared to be based on the same data used by Ferraroni et al. (1998) and were
therefore excluded (Appendix B, Tables B.3 and B.4). The 16 studies were combined with the
studies reviewed by English et al. (1995) (Appendix B, Tables B.1 and B.2) and used to
recalculate the aetiological fraction.
Revised pooled relative-risk estimates for alcohol exposure and female breast
cancer
While English et al. (1995) found that the test for heterogeneity between studies of the
association between alcohol and female breast cancer was consistent with no difference for
the effect of menopausal status, this was inconsistent with the more recent literature
(Ferraroni et al. 1998; Mezzetti et al. 1998). Therefore, those studies reviewed by English et
al. and the studies from our review were classified into studies that examined women of all
ages, of pre-menopausal age (<45 years) and post-menopausal age (≥45 years) and separate
risk ratios calculated for each group. The risk ratio estimates for women aged under 45 years
were not statistically significantly different from those for women aged 45 and over, so the
aetiological fractions were based on the combined risk ratio. Table 3.1 shows the revised
risk-ratio estimates.
Revised aetiological fractions for alcohol and female beast cancer
Aetiological fractions for alcohol and female breast cancer were calculated using the
formulae and the prevalence estimates based on the ABS National Health Survey, as shown
in Chapter 2, and the revised pooled estimates of relative risk shown in Table 3.1. Table 3.2
shows the results.
Based on the sum of the partial aetiological fractions for ages 18 and over, the overall female
aetiological fraction for breast cancer caused by low, medium and high drinking levels was
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estimated to be 0.121. Thus, around 12% of female breast cancer for ages 18 years and over
may be attributable to low, medium and high levels of alcohol intake.
Table 3.1: Revised pooled estimates of relative risk for alcohol exposure and female breast cancer
Low Medium High
Sex Age RR 95% CI RR 95% CI RR 95% CI
Female All 1.14 1.09–1.20 1.41 1.32–1.50 1.59 1.43–1.78
Under 45 years 1.15 1.04–1.28 1.41 1.2–1.67 1.46 0.99–2.14
45 years and over 1.14 1.05–1.24 1.38 1.24–1.53 1.62 1.24–2.13
Source: AIHW analysis of studies listed in Appendix B, Tables B.1 and B.3.
Table 3.2: Revised aetiological fractions for alcohol exposure and breast cancer
Level of exposure
Age Low Medium High
Exposed population
All ages 0.12 0.29 0.37
General population
18–19 0.075 0.046 0.014
20–24 0.075 0.046 0.014
25–29 0.077 0.035 0.011
30–34 0.082 0.033 0.010
35–39 0.062 0.041 0.012
40–44 0.067 0.034 0.011
45–49 0.060 0.033 0.016
50–54 0.057 0.041 0.020
55–59 0.059 0.043 0.013
60–64 0.061 0.045 0.006
65–69 0.056 0.051 0.007
70–74 0.060 0.032 0.006
75–79 0.058 0.016 0.005
80+ 0.072 0.016 0.008
Total (18+) 0.069 0.039 0.012
Source: AIHW analysis of revised relative risk estimates in Table 3.1 and prevalence data from Chapter 2.
3.2.2 Alcohol and stroke
In the past 30 years many studies have linked both habitual and acute heavy drinking to an
increased risk of stroke (Camargo 1996). The role of smaller amounts of alcohol is more
complex (Camargo 1989; Camargo 1996; Sacco et al. 1999).
When limited to observational investigation, epidemiological research on alcohol
consumption presents important methodological problems, given that alcohol consumption
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is a complex and varying phenomenon that is difficult to measure (Camargo 1996).
Epidemiological research on stroke is also complicated by methodological difficulties,
particularly concerning stroke identification and classification (Camargo 1996). Silent or
clinically undetected strokes may contribute to imprecise ascertainment of stroke incidence,
which will tend to weaken any statistical association with true risk factors.
Epidemiological studies of alcohol and stroke should take account of potential confounders.
If alcohol causes increased stroke risk because of alcohol-induced hypertension alone, then
controlling for blood pressure would eliminate the association between alcohol and stroke.
The confounded association may be of greater interest than the adjusted association
(Camargo 1996).
Additional problems can arise if stroke is regarded as a single pathological entity. As a
minimum, ischaemic (thrombo-embolic) strokes should be differentiated from haemorrhagic
strokes (intracerebral haemorrhage and subarachnoid haemorrhage). While some risk
factors, for example age and hypertension, are common to all types of stroke, other factors
may have distinctive associations. Therefore, if a factor is strongly associated with one type
of stroke and weakly (or inversely) associated with another, failure to differentiate between
stroke types would tend to obscure real associations (Camargo 1996). Ischaemic stroke
accounts for 70–80% of all strokes.
Studies in the last 10 years have confirmed that alcohol consumption has a distinctively
different association with haemorrhagic stroke as opposed to ischaemic stroke (Camargo
1996). In the main, they have shown an increased risk of haemorrhagic stroke associated
with increasing alcohol consumption in a dose-dependent fashion (Sacco et al. 1999), so that
even moderate levels of drinking increase the risk of haemorrhagic stroke (Camargo 1996).
On the other hand, Sacco et al. confirmed the findings of a number of earlier case-control
studies that moderate alcohol consumption (up to two drinks a day in the past year) relative
to the absence of any alcohol consumption was significantly protective for fatal or first non-
fatal ischaemic stroke. They found an odds ratio (OR) of 0.51 with a 95% confidence interval
of 0.39 to 0.67. This protective effect was evident for consumption of up to five drinks a day
(OR=0.58; 95% CI: 0.35–0.94).
Kiechl et al. (1994) examined the dose-dependent promotion or deceleration of carotid
atherosclerosis by alcohol. Their findings supported the likelihood of a U-shaped association
with ischaemic stroke. This study of Italian men aged 40–79 years used logistic regression to
examine the potential relationship between alcohol and carotid atherosclerosis. Alcohol
consumption was quantified in terms of grams a day and classified into four categories: no
current use; ≤50 g/day; 51–99 g/day; and ≥100 g/day). (English et al. considered one alcohol
drink a day as equivalent to 10 grams of alcohol a day.)
With alcohol consumption treated as a continuous variable, logistic regression showed that
the age-adjusted overall effect of drinking was moderate disease promotion (slope
coefficient β=+0.0067, df=1, p<0.01). However, classification of alcohol consumption into
four equally spaced groups (50 g/day each) was strongly suggestive of a U-shaped trend.
The quadratic (non-linear) model was confirmed as having the best fit.
Atherosclerotic risk in men who consumed ≥ 100 g/day was more than twice that of
abstainers, but light drinkers fared better than abstainers (OR=0.44; p=0.01). Furthermore,
when the analysis was restricted to the alcohol estimates obtained with diet records (as
opposed to recall for questionnaire responses) this further strengthened the U-shaped trend
(≤ 50 g/day: OR=0.38; ≥100 g/day: OR=3.67). The use of past alcohol consumption, while
continuing to reflect the U-shaped association with carotid atherosclerosis, did so to a lesser
degree. For females, the relationship between low amounts of alcohol (≤50 g/day; n=112)
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and the lowered risk for carotid atherosclerosis was similar to that observed for males (OR:
0.47; p=0.01).
In examining the association between alcohol consumption and carotid atherosclerosis
Kiechl et al. (1994) adjusted for behavioural variables such as social class and physical
activity and for body mass index. The adjustment did not improve the fit of the regression
model and yielded similar risk estimates. Furthermore, adjustment for smoking and
restriction of the analysis to non-smokers (n=310) did not result in major changes to the
adjusted odds ratios.
Given that an ex-drinker might have stopped drinking because of health problems, Kiechl et
al. also took account of the potential effect of the inclusion of past drinkers in the reference
group (current non-drinkers). This was done by excluding previous drinkers and
reclassifying ex-drinkers as light, moderate or severe based on self-reported amounts of
previous alcohol consumption. While both of these tended to lessen the beneficial effects of
low amounts of alcohol compared with no alcohol (OR= 0.52 and 0.51, compared with 0.44),
the residual relationship remained statistically significant.
Carnago (1996) noted that, overall, the reduction in relative risk of ischaemic stroke
associated with low alcohol consumption (up to two drinks a day in the past year), as
opposed to no alcohol consumption, outweighed the increased relative risk for
haemorrhagic stroke. This resulted in reduced total stroke relative risk for low alcohol
consumption as opposed to no alcohol consumption.
However, Carnago also reported studies showing this result may be influenced by factors
associated with race. Studies that differentiated between white and black populations did
not support effect modification by race. But studies of people of Japanese origin found the
reduction in the risk of ischaemic stroke was attenuated to the extent that there was an
absence of reduced relative risk due to low alcohol consumption for all stroke once the
increased risk for haemorrhagic stroke was taken into account. This suggests that the effect
of alcohol on stroke may be different for people of Asian origin. In Australia, 1996 census
data show that some 4.8% of the Australian population had Asia as a place of birth (ABS
1997).
Epidemiological evidence for reviewing the aetiological fraction for alcohol and
stroke
The literature suggests that, as well as updating the current fractions with references for
1994 to 1998, the following matters should also be taken into account where possible.
Distinguishing between studies reporting on ischaemic, haemorrhagic and all
stroke
Since the alcohol – ischaemic stroke relationship has been shown to be U- or J-shaped, low
or medium drinking will confer a health benefit because of a reduction in the incidence of
ischaemic stroke. While there will be an increased incidence of haemorrhagic stroke with an
equivalent increase in the level of alcohol consumption, this should not translate into an
increase in total stroke incidence since, as noted, ischaemic stroke accounts for 70–80% of all
strokes combined (Camargo 1996). This relationship therefore requires that ischaemic and
haemorrhagic stroke be examined separately.
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Inclusion of the protective effect of low alcohol intake on stroke incidence and
death in any quantification of the overall effect of alcohol and stroke
Sacco et al. (1999) confirmed the finding of a number of earlier case-control studies,
conducted predominantly among white subjects, that low alcohol consumption (up to two
drinks a day in the past year) relative to no alcohol consumption was significantly protective
for fatal or first non-fatal ischaemic stroke (OR=0.51; 95% CI: 0.39–0.67). The unadjusted
odds ratio shows this protective effect to be evident for consumption of up to five drinks a
day (OR=0.58; 95% CI: 0.35–0.94).
Among those with low alcohol consumption, continued consumption at this level
(particularly among the elderly) reduces the risk of ischaemic stroke (Sacco et al. 1999),
confirming that the J-shaped association with alcohol is protective for the onset of fatal or
first non-fatal ischaemic stroke. Given that the prevalence of exposure to alcohol at this level
in the community is 60% to 80% among males in all age groups and 55% to 70% among
females (English et al. 1995), this effect would be expected to be substantial. Furthermore,
this is also important because ischaemic stroke accounts for 70–80% of all strokes.
Jamrozik et al. (1994) cited an example of this effect. In this Perth study, heavy consumption
of alcohol (≥61 g/day) was relatively rare, so it was implicated in at most one in nine
strokes, despite its higher relative risk (unadjusted odds ratio=2.51; 95% CI: 1.33–4.74).
However, between 2% and 30% of additional strokes appear to have been avoided by almost
half the study group consuming one or two alcoholic drinks daily.
If possible, distinguishing between studies reporting on incidence as opposed to
death and deriving fractions pertinent to each
The incidence of stroke is largely determined by the distribution of risk factors (including
alcohol) within the population . But case fatality is more likely to be strongly related to the
type of stroke, the severity of the stroke, and the availability of diagnostic procedures and
treatment (Grobbee et al. 1996). Studies that have stroke incidence as an outcome far
outnumber those with stroke death as an outcome (English et al. 1995).
One recent study (He et al. 1995) conducted in the Chinese population sought to
differentiate the association between alcohol consumption and the relative risks for stroke
incidence and stroke mortality. In this instance, the increase in relative risk for alcohol
consumption and stroke incidence was slightly higher than that for stroke death for both the
unadjusted (RR: 1.38; 1.29–1.48 compared with RR: 1.25; 1.15–1.35) and adjusted (RR: 1.36;
1.19–1.56 compared with RR: 1.17; 1.16–1.19) estimates. This suggests that it may be
preferable to have separate risk estimates for incidence and death, but the limited
availability of studies that have examined incidence and death separately makes this
problematic.
Studies used to revise the aetiological fraction for alcohol and stroke
The studies used to revise the aetiological fraction for alcohol and stroke are listed in
Appendix B. The literature search identified 40 papers for detailed review; this yielded 14
studies with usable data (Appendix B, Table B.5). These were combined with the studies
identified by English et al. (1995—see Appendix B, Table B.6) to calculate the risk-ratio
estimates. While English et al. found the test for heterogeneity between studies of ischaemic
and haemorrhagic stroke was consistent with no difference in the effect of alcohol, this was
inconsistent with the literature review just outlined. Therefore, only studies that
differentiated between these types of stroke were used in the calculations.
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The test of heterogeneity between the sexes was consistent with different effects among men
and women, so only studies reporting sex-specific relative risk estimates were used for the
derivation of pooled estimates. We also followed English et al. in excluding studies of Asian
origin. Appendix B, Table B.7 lists the individual risk ratio estimates used in calculating the
pooled risk. In instances where relative risks or odds ratios with 95% confidence intervals
were not reported for a particular study, these were calculated from data presented within
the paper (Hillbom et al. 1995; Juvela et al. 1995).
Revised pooled estimates of relative risk for alcohol exposure and stroke
As with English et al. (1995), our revised pooled estimates of relative risk are based on the
‘fixed-effects’ assumption. While this is not valid in all instances (for example, where the test
for heterogeneity is significant) the alternative random effects estimate is subject to
limitations and disadvantages, the main one being that more weight is given to smaller
studies than occurs under the ‘fixed effects’ assumption. The revised relative risk estimates
are listed in Tables 3.3 and 3.4.
Compared with abstainers, the pooled relative risk of ischaemic stroke for males among low-
level drinkers was 0.94 (95% CI: 0.78–1.13), among medium level-drinkers 1.33 (95% CI:
1.07–1.66) and among high-level drinkers 1.65 (95% CI: 0.95–2.86). Similarly, compared with
abstainers, the pooled relative risk of ischaemic stroke for females among low-level drinkers
was 0.52 (95% CI: 0.42–0.65), among medium-level drinkers 0.64 (95% CI: 0.44–0.95) and
among high–level drinkers 1.06 (95% CI: 0.36–3.12).
Compared with abstainers the pooled relative risk of haemorrhagic stroke among male low
level drinkers was 1.27 (95% CI: 0.83–1.94), among male medium level drinkers 2.19 (95% CI:
1.47–3.28) and among male high level drinkers 2.38 (95% CI: 1.18–4.77). Similarly, compared
with abstainers, the pooled relative risk of haemorrhagic stroke among female low level
drinkers was 0.59 (95% CI: 0.38–0.92), among female medium level drinkers 0.65 (95% CI:
0.36–1.19) and among female high level drinkers 7.98 (95% CI: 3.25–19.6).
 Table 3.3: Revised pooled estimates of relative risk for alcohol exposure and ischaemic stroke
Level of alcohol exposure
Low Medium High
Sex Age RR 95% CI RR 95% CI RR 95% CI
Male All 0.94 0.78–1.13 1.33 1.07–1.66 1.65 0.95–2.86
Female All 0.52 0.42–0.65 0.64 0.44–0.95 1.06 0.36–3.12
Source: AIHW analysis of studies listed in Appendix B, Table B.7.
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Table 3.4: Revised pooled estimates of relative risk for alcohol exposure and haemorrhagic stroke
Level of alcohol exposure
Low Medium High
Sex Age RR 95% CI RR 95% CI RR 95% CI
Male All 1.27 0.83–1.94 2.19 1.47–3.28 2.38 1.18–4.77
Female All 0.59 0.38–0.92 0.65 0.36–1.19 7.98 3.25–19.60
Source: AIHW analysis of studies listed in Appendix B, Table B.7.
Revised aetiological fractions for alcohol and stroke
The overall male aetiological fraction for ischaemic stroke caused by low, medium and high
levels of alcohol consumption was estimated to be 0.027 (Table 3.5). Thus, for males, 2.7% of
ischaemic stroke may be attributable to medium and high levels of alcohol intake after
adjusting for the protective effect due to low-level alcohol intake. The overall female
aetiological fraction for ischaemic stroke caused by low, medium and high drinking levels
was estimated to be –0.441. Thus, relative to abstainers, an overall protective effect for
ischaemic stroke was attributable to low and medium levels of alcohol intake among
females.
Table 3.5: Revised aetiological fractions for alcohol exposure and ischaemic stroke
Male Female
Level of exposure Level of exposure
Age Low Medium High Low Medium High
Exposed population
All ages –0.06 0.25 0.39 –0.91 –0.55 0.06
General population
18–19 –0.040 0.021 0.052 –0.451 –0.071 0.002
20–24 –0.040 0.021 0.052 –0.451 –0.071 0.002
25–29 –0.042 0.024 0.046 –0.449 –0.052 0.002
30–34 –0.039 0.028 0.044 –0.495 –0.051 0.002
35–39 –0.040 0.025 0.032 –0.334 –0.056 0.002
40–44 –0.038 0.031 0.036 –0.366 –0.048 0.002
45–49 –0.038 0.034 0.036 –0.316 –0.045 0.003
50–54 –0.041 0.026 0.040 –0.299 –0.055 0.003
55–59 –0.041 0.027 0.024 –0.310 –0.058 0.002
60–64 –0.038 0.033 0.046 –0.330 –0.062 0.001
65–69 –0.041 0.024 0.029 –0.297 –0.070 0.001
70–74 –0.042 0.020 0.038 –0.304 –0.041 0.001
75–79 –0.043 0.009 0.043 –0.282 –0.020 0.001
80+ –0.043 0.017 0.020 –0.383 –0.022 0.001
Total (18+) –0.040 0.027 0.040 –0.387 –0.056 0.002
Source: AIHW analysis of revised relative risk estimates in Table 3.3 and prevalence data in Chapter 2.
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The overall male aetiological fraction for haemorrhagic stroke was estimated to be 0.269
(Table 3.6). Thus, for males, 27% of haemorrhagic stroke may be attributable to low, medium
and high levels of alcohol intake. The overall female aetiological fraction for haemorrhagic
stroke was estimated to be –0.124. Thus, relative to abstainers, an overall protective effect for
haemorrhagic stroke was attributable to low and medium levels of alcohol intake among
females: this outweighed the harmful effect of alcohol on the risk of haemorrhagic stroke at
high intake levels.
Table 3.6: Revised aetiological fractions for alcohol exposure and haemorrhagic stroke
Male Female
Level of exposure Level of exposure
Age Low Medium High Low Medium High
Exposed population
All ages 0.21 0.54 0.58 –0.69 –0.53 0.87
General population
18–19 0.136 0.058 0.083 –0.285 –0.051 0.212
20–24 0.136 0.058 0.083 –0.285 –0.051 0.212
25–29 0.140 0.065 0.073 –0.300 –0.040 0.169
30–34 0.133 0.076 0.070 –0.329 –0.038 0.166
35–39 0.136 0.069 0.051 –0.225 –0.043 0.175
40–44 0.130 0.084 0.058 –0.249 –0.037 0.161
45–49 0.127 0.093 0.057 –0.202 –0.033 0.220
50–54 0.139 0.070 0.063 –0.182 –0.038 0.257
55–59 0.140 0.072 0.038 –0.206 –0.044 0.185
60–64 0.126 0.088 0.072 –0.245 –0.052 0.089
65–69 0.140 0.066 0.047 –0.215 –0.057 0.113
70–74 0.144 0.055 0.060 –0.227 –0.035 0.088
75–79 0.148 0.025 0.069 –0.215 –0.017 0.072
80+ 0.149 0.048 0.032 –0.271 –0.017 0.127
Total (18+) 0.134 0.072 0.064 –0.258 –0.042 0.176
Source: AIHW analysis of revised relative risk estimates in Table 3.4 and prevalence data in Chapter 2.
3.2.3 Alcohol and road injuries
Alcohol is the main cause of deaths on Australian roads: it is implicated in about one-third
of all motorist deaths (Federal Office of Road Safety (FORS) 1996). However, alcohol has an
even greater involvement in pedestrian fatalities: it is implicated in some 45% of fatalities
among adult and youth pedestrians (FORS 1996).
Crashes involving adult and youth pedestrians tend to have greater alcohol involvement
than other crashes (FORS 1996). In 1992, in cases where the blood alcohol concentration
(BAC) of the parties involved was known, intoxication (BAC >0.05 g/100 mL) was
implicated in 47% of deaths among adult and youth pedestrians, in 43% of single-vehicle
crashes, and in 27% of multiple-vehicle crashes.
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Furthermore, the blood alcohol concentration tends to be more extreme in crashes involving
pedestrians (FORS 1996). In 1992 BACs averaged 0.217g/100 mL among intoxicated
pedestrian victims, 0.181 g/100 mL among intoxicated motorists in fatal single-vehicle
crashes, and 0.164 g/100 mL among intoxicated motorists in fatal multiple-vehicle crashes.
Epidemiological evidence for reviewing the aetiological fraction for alcohol and
motor vehicle accidents
English et al. (1995) used information from case-control studies of relative risk and from
BAC case series to derive the aetiological fraction for alcohol and motor vehicle accidents.
They combined two studies that examined the relationship of motor vehicle deaths (Lloyd
1992) and injuries (McLean et al. 1980) to BAC, using exposure gradations (>0–0.05 g/100
mL, >0.05–0.10 g/100 mL and >0.10 g/100 mL) and the pooled relative risks to determine
the aetiological fraction.
Although BAC data for police-reported hospitalisations associated with motor vehicle and
motorcycle accidents are incomplete for Australia in 1996 (55% unknown), the New South
Wales data are relatively complete (14% unknown). They suggest a less prominent role for
alcohol in hospitalisations compared with accidents with a fatal outcome. If the records with
unknown BAC are excluded, only 9% of hospitalisations recorded a BAC >0.05 g/100 mL.
The corresponding figure with the unknowns included was 8%. This compares with a BAC
>0.05 g/100 mL for 22% (unknowns included) or 24% (unknowns excluded) of fatally
injured motor vehicle drivers and motorcycle riders in the same year (FORS 1997). Based on
this evidence, the relative risk estimates from Lloyd’s (1992) study of deaths caused by
motor vehicle accidents were used to revise the aetiological fraction for motor vehicle driver
and motorcycle rider deaths due to alcohol. The relative risk estimates from McLean’s (1980)
study of serious crashes provided estimates for the aetiological fraction for motor vehicle
driver and motorcycle rider hospitalisations due to alcohol.
The FORS data on pedestrian hospitalisations as a result of accidents is less complete than
the data on motor vehicle driver and motorcycle rider hospitalisations as a result of
accidents. However, a South Australian case study also demonstrates the pattern of a
somewhat higher BAC for pedestrian fatalities when compared with pedestrian
hospitalisations (Holubowycz 1995). A BAC ≥0.10 g/100 mL was evident among 50% of
male and 38% of female pedestrian fatalities for ages 16 and older. This compares with 39%
of male and 30% of female pedestrian hospital admissions for ages 16 years and older. Since
there are no relative risk estimates for the contribution of BAC ≥0.10 g/100 mL to either
pedestrian fatalities or pedestrian hospitalisation, unpublished prevalence data for 1992 to
1996 provided by FORS and the Holubowycz prevalence data are the basis for determining
these fractions.
English et al. used blood alcohol case series publications to calculate a pooled estimate,
weighted by study size, of the aetiological fraction for road injuries caused by alcohol. They
calculated separate fractions for males and females using combined Australian and
international data and based on the criteria of (1) BAC >0.10 g/100 mL and (2) the use of
case series for all road injuries (the majority being drivers), car drivers or motorcycle drivers.
Specific case series of pedestrians, passengers or pedal cyclists were excluded. We modified
this by using Australian case series data only (provided by FORS) and, based on the
evidence just described, derived separate fractions for vehicle driver and motorcycle rider
accidents and pedestrian accidents.
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Revised blood alcohol case series for deaths due to motor vehicle accidents in
Australia, 1996
Fatalities and hospitalisations with BACs of >0.05–<0.10 g/100 mL and ≥0.10 g/100 mL were
obtained from FORS for 1996. The data were used to derive the prevalence of BAC >0.05–
0.10 gms/100 mL and ≥0.10 g/100 mL among fatally injured motor vehicle drivers and
motorcycle riders (Table 3.7) and pedestrians (Table 3.8) in Australia .
Table 3.7: Blood alcohol prevalence for motor vehicle driver and motorcycle rider accident
deaths, 1996
Males Females Persons
Blood alcohol concentration Blood alcohol concentration Blood alcohol concentration
Age >0.05–<0.10 ≥0.10 >0.05–<0.10 ≥0.10 >0.05–<0.10 ≥0.10
16–19 0.03 0.28 0.08 0.08 0.04 0.23
20–29 0.04 0.37 0.02 0.16 0.04 0.33
30–49 0.03 0.38 0.02 0.19 0.03 0.35
50+ 0.01 0.09 0.00 0.00 0.01 0.06
16 + 0.03 0.31 0.02 0.11 0.03 0.27
Source: Federal Office of Road Safety.
Table 3.8: Blood alcohol prevalence for pedestrian accident deaths,
1996
Males Females
Blood alcohol concentration Blood alcohol concentration
Age >0.05–<0.10 ≥0.10 >0.05–<0.10 ≥0.10
16–19 0.06 0.69 0.00 0.50
20–29 0.03 0.58 0.11 0.11
30–49 0.02 0.51 0.00 0.42
50+ 0.03 0.16 0.00 0.06
16+ 0.03 0.40 0.01 0.17
Source: Federal Office of Road Safety.
Revised blood alcohol case series for hospitalisations due to motor vehicle
accidents in Australia, 1994 to 1996
The aetiological fractions for hospitalisations are based on FORS case series data on
hospitalisation due to motor vehicle accidents for 1994 to 1996. The scope of the
hospitalisation crash data provided by police services differs between various Australian
jurisdictions as a result of differing crash reporting requirements and practices. Not all
reportable road traffic accidents come to police attention (in particular, those involving
cyclists and motorcyclists) and classification by police at an accident scene (as to whether or
not hospital admission occurs) is uncertain. Some people sent to hospital may simply be
treated in accident and emergency departments before being sent home (FORS 1998).
Although Australian data are reported in Tables 3.9 and 3.10, it is important to note the
incomplete nature of data on blood alcohol concentration across all age groups. New South
Wales has the lowest level of missing values for road accident victims admitted to hospital;
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Western Australia and Queensland have the highest levels (O’Conner & Trembath 1995).
New South Wales data dominate the Australian data.
Table 3.9: Blood alcohol concentration among motor vehicle drivers and motorcycle riders
hospitalised as a result of accidents, 1994 to 1996
Males Females Persons
Blood alcohol concentration Blood alcohol concentration Blood alcohol concentration
Age >0.05–<0.10 ≥0.10 >0.05–<0.10 ≥0.10 >0.05–<0.10 ≥0.10
16–19 0.07 0.17 0.03 0.08 0.05 0.15
20–29 0.06 0.31 0.03 0.14 0.05 0.26
30–49 0.04 0.23 0.02 0.12 0.03 0.19
50+ 0.03 0.08 0.01 0.02 0.02 0.06
16 + 0.05 0.23 0.02 0.10 0.05 0.08
Source: Federal Office of Road Safety.
Table 3.10: Blood alcohol concentration among pedestrians
hospitalised as a result of accidents, 1994 to 1996
Males Females
Blood alcohol concentration Blood alcohol concentration
Age >0.05–<0.10 >=0.10 >0.05–<0.10 >=0.10
16–19 0.07 0.35 0.07 0.16
20–29 0.07 0.45 0.05 0.19
30–49 0.03 0.46 0.03 0.21
50+ 0.08 0.23 0.00 0.03
16 + 0.06 0.37 0.01 0.06
Source: Federal Office of Road Safety.
Revised relative effect estimates for alcohol exposure and death due to motor
vehicle and motorcycle accidents
The estimates of relative risk are based on data reported by Lloyd (1992) for alcohol and fatal
road accidents. The age range and BAC for females were aggregated so as to provide
sufficient data in the relevant cells.
These relative risk values are presented using abstainers as the base (BAC=0—Table 3.11).
However, we followed English et al. (1995) and based the aetiological fractions on the risk
relative to the lowest exposure category. These rescaled relative risk ratios are presented in
Table 3.12.
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Table 3.11: Risk estimates for alcohol exposure and motor vehicle driver and motorcycle rider
deaths as a result of accident
Blood alcohol concentration
>0–0.05 >0.05–0.10 >0.10
Sex Age RR 95% CI RR 95% CI RR 95% CI
eMale <21 2.01 1.12–3.60 10.38 5.31–20.29  67.35 35.40–128.11
21–29 1.14 0.58–2.23  4.96 2.59– 9.49 113.88 73.24–177.07
30–50 1.33 0.66–2.69  5.74 2.92–11.27 142.43 89.15–227.56
>50 1.44 0.61–3.37  3.75 1.38–10.19  45.15 22.58–90.27
All ages 1.45 1.04–2.04 5.86 4.18–8.23 96.82 75.03–124.94
Blood alcohol concentration
>0.01–0.10 >0.10
RR 95% CI RR 95% CI
FFemale <30 1.78 0.72–4.39 72.59 34.83–151.29
30+ 2.22 0.99–4.96 52.36 18.86–145.37
All ages 2.01 1.10–3.66 65.17 36.19–117.38
Source: Lloyd 1992.
Table 3.12: Rescaled risk estimates for alcohol exposure and motor vehicle driver and motorcycle
rider accident deaths
Blood alcohol concentration
>0–0.05 >0.05–0.10 >0.10
Sex Age RR RR RR
Male <21 1.00 5.16 33.50
21–29 1.00 4.35 99.89
30–50 1.00 4.31 107.09
>50 1.00 2.60 31.35
All ages 1.00 4.03 66.59
Blood alcohol concentration
>0.01–0.10 >0.10
RR RR
Female <30 1.00 40.78
30+ 1.00 23.58
All ages 1.00 32.45
Source: AIHW analysis of data in Table 3.11.
The test of heterogeneity shows that these relative risk values do not vary significantly by
age, so we based the fractions on the relative risk for all ages.
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Revised aetiological fractions for alcohol and motor vehicle and motorcycle
accident deaths
The aetiological fractions were based on the prevalence data in Tables 3.7 and 3.8. The
fraction for motor vehicle driver and motorcycle rider deaths also used the all-ages relative
risk values presented in Table 3.12. The age-specific prevalences from Table 3.7 were applied
at ages over 15 years. However, motor vehicle accident deaths at ages under 15 years
presumably involved passengers rather than drivers, so we followed Holman et al. (1990)
and applied the all-ages fraction to these age groups (Table 3.13).
There are no equivalent relative risk estimates for pedestrians, so the fraction was taken to
be the prevalence value from Table 3.8.
Table 3.13: Revised aetiological fractions for alcohol exposure and
motor vehicle driver and motorcycle rider deaths
Males Females
Blood alcohol concentration Blood alcohol concentration
Age >0.05–<0.10 ≥0.10 ≥0.10
Exposed
All ages 0.752 0.985 0.969
General population
<15 0.023 0.305 0.107
15–19 0.023 0.276 0.078
20–24 0.030 0.364 0.155
25–29 0.030 0.364 0.155
30–34 0.023 0.374 0.184
35–39 0.023 0.374 0.184
40–44 0.023 0.374 0.184
45–49 0.023 0.374 0.184
50–54 0.008 0.089 0.000
55–59 0.008 0.089 0.000
60–64 0.008 0.089 0.000
65–69 0.008 0.089 0.000
70–74 0.008 0.089 0.000
75–79 0.008 0.089 0.000
80+ 0.008 0.089 0.000
All ages 0.023 0.305 0.107
Source: AIHW analyses of data in Tables 3.7 and 3.12.
The overall aetiological fraction for driver and rider road accident deaths caused by driving
or riding with a BAC >0.05 g/100 mL was estimated as 0.328 among males and 0.107 among
females. For those aged 20–29 years of age, the overall aetiological fraction was estimated as
0.395 among males and 0.155 among females. Among 30–50 year olds the overall aetiological
fraction was estimated as 0.397 among males and 0.184 among females and for people aged
50 years and over it was 0.096 among males and nil among females. These numbers differ
slightly from the sums of the corresponding numbers in Table 3.13 because of rounding.
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English et al. (1995) used a blood alcohol criterion of ≥0.10 g/100 mL to identify the
members of a road injuries case series that could be attributed to alcohol. We applied this
criterion to the FORS 1996 case series of pedestrian deaths, so that the prevalence data for
≥0.10 g/100 mL from Table 3.8 were used to estimate the aetiological fraction for pedestrian
road injuries caused by alcohol among males and females (Table 3.14).
Table 3.14: Revised aetiological fractions for alcohol exposure and
pedestrian deaths
Males Females
Blood alcohol concentration Blood alcohol concentration
Age >=0.10 >=0.10
General population
16–19 0.69 0.50
20–29 0.58 0.11
30–49 0.51 0.42
50+ 0.16 0.06
16+ 0.40 0.17
Source: AIHW analysis of data from Table 3.8.
For people aged 16–19 years, the aetiological fraction for pedestrian road accident deaths
caused by driving with a BAC >0.10 g/100 mL was estimated as 0.69 for males and 0.50 for
females. For those aged 20–29 years, the aetiological fraction was estimated as 0.58 for males
and 0.11 for females. Among 30–50 year olds the aetiological fraction was estimated as 0.51
for males and 0.42 for females, and for people aged 50 years or more it was 0.16 for males
and 0.06 for females.
Revised aetiological fractions for alcohol and motor vehicle and motorcycle
accident hospitalisations
The revised fractions for motor vehicle and motorcycle accident hospitalisations were based
on the FORS data in Tables 3.9 and 3.10. Relative risk estimates for drivers and riders were
derived from the study by McLean et al. (1980). As with the fractions for deaths, the
fractions for pedestrian hospitalisations were taken directly from the prevalence estimates in
Table 3.10 using a blood alcohol criterion of ≥0.10 g/100 mL.
Table 3.15: Risk estimates for alcohol exposure and motor vehicle and motorcycle accident
hospitalisations: males and females, all ages
Blood alcohol concentration RR 95% Confidence interval
0.01–0.03 0.69 0.32–1.47
0.04–0.06 1.83 0.87–3.85
0.07–0.09 3.20 1.20–8.48
0.10 and over 12.94 6.60–25.36
Source: Derived from McLean et al. (1980).
For the purposes of calculating the aetiological fractions for driver and rider accident
hospitalisations, the relative risks of 3.13 (95% CI: 1.20–8.48) and 12.94 (95% CI: 6.60–25.36)
were used for BAC >0.05–0.10 and >0.10 g/100 mL respectively.
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Table 3.16: Revised aetiological fractions for alcohol exposure and
driver and motorcycle rider accident hospitalisations
Males Females
Blood alcohol concentration Blood alcohol concentration
Age >0.05–<0.10 ≥0.10 >0.05–<0.10 ≥0.10
Exposed
All ages 0.688 0.923 0.688 0.923
General population
<15 0.034 0.212 0.014 0.092
15–19 0.048 0.157 0.021 0.074
20–24 0.041 0.286 0.021 0.129
25–29 0.041 0.286 0.021 0.129
30–34 0.028 0.212 0.014 0.111
35–39 0.028 0.212 0.014 0.111
40–44 0.028 0.212 0.014 0.111
45–49 0.028 0.212 0.014 0.111
50–54 0.021 0.074 0.007 0.018
55–59 0.021 0.074 0.007 0.018
60–64 0.021 0.074 0.007 0.018
65–69 0.021 0.074 0.007 0.018
70–74 0.021 0.074 0.007 0.018
75–79 0.021 0.074 0.007 0.018
80+ 0.021 0.074 0.007 0.018
All ages 0.034 0.212 0.014 0.092
Source: AIHW analyses of data in Tables 3.9 and 3.15.
For people aged 15–19 years, the aetiological fraction for driver and rider road accident
hospitalisations caused by driving with a BAC >0.05 g/100 mL was estimated as 0.205 for
males and 0.094 for females. For those aged 20–29 years, the aetiological fraction was
estimated as 0.327 for males and 0.150 for females. Among 30–49 year olds, the aetiological
fraction was estimated as 0.240 for males and 0.124 for females, and for people aged 50 years
or more it was 0.094 for males and 0.025 for females. The overall fraction for all ages was
estimated at 0.247 for males and 0.106 for females (Table 3.16). As with driver and rider
accident deaths, this all-ages fraction was applied to deaths at ages below 15. These numbers
differ slightly from the sums of the corresponding numbers in Table 3.16 because of
rounding.
For people aged 16–19 years, the aetiological fraction for pedestrian hospitalisation caused
by walking with a BAC >0.10 g/100 mL was estimated as 0.35 for males and 0.16 for
females. For those aged 20–29 years, the aetiological fraction was estimated as 0.45 for males
and 0.19 for females. Among the 30–49 year olds, the aetiological fraction was estimated as
0.46 for males and 0.21 for females, and for people aged 50 years or more it was 0.23 for
males and 0.03 for females (Table 3.17).
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Table 3.17: Revised aetiological fractions for alcohol exposure and
pedestrian hospitalisations
Males Females
Blood alcohol concentration Blood alcohol concentration
Age >=0.10 >=0.10
General population
16–19 0.35 0.16
20–29 0.45 0.19
30–49 0.46 0.21
50+ 0.23 0.03
16+ 0.37 0.06
Source: AIHW analysis of data in Table 3.10.
3.2.4 Alcohol and fall injuries
Falls are a leading cause of injury hospitalisation across the majority of age groups. In New
South Wales from 1989–90 to 1995–96 falls were the leading cause of injury hospitalisation in
every age group except 15–29 years. Among 5–9 year olds, the main type of fall resulting in
hospitalisation is falling from play equipment (28.0%) (Public Health Division 1997). Falls
among this age group account, however, for very few deaths.
While alcohol does not generally play an aetiological role in fall morbidity and mortality in
people aged less than 15 years, its contribution to fall injury among those aged 18–64 years
has been described as substantial (Mosenthal et al. 1995). The occurrence of falls increases
with age. Among older women living in the community, the proportion having one or more
falls in a year increases from 35.0% for 65–79 year olds to 45.0% for 80–89 year olds and
55.0% for those older than 90 years (NHMRC 1993). Coupled with this greater likelihood of
falling is an increased likelihood of injury and fractures, resulting in disproportionately high
levels of morbidity and mortality attributable to fall injury among the elderly.
In the elderly, fall aetiology is multifactorial. It involves the combination of intrinsic factors
(age-related physiological decline or disease) and extrinsic factors (environmental hazards
or activity-related risk) in conjunction with drugs (pharmaceutical therapy or alcohol
interacting with concurrently administered drugs or on the central nervous system directly)
(NHMRC 1993).
English et al. (1995) calculated an aetiological fraction based on three case series for falls
caused by alcohol. The aetiological fraction estimate was 0.34, which was applied to both
males and females across all age groups. One series included deaths among people aged 15
years or more (Centers for Disease Control 1984), the second included deaths at all ages
(Rutledge & Messick 1992), and the third examined the prevalence of acute intoxication (>0.1
g/100 mL) among trauma patients aged 18 years or more (Rivara et al. 1993).
The main study to contribute to the pooled estimate—and the only study to examine
incidence—was that by Rivara et al. While the proportion of intoxication among the 398 falls
was 0.38, the distribution of intoxication by age group suggests that these falls must have
been skewed towards the young (Rivara et al. 1993, p. 909). Overall, the proportion of
intoxication for the two oldest age groups in the study (55–64 years and greater than 64
years) was 0.28 and 0.13 respectively. Furthermore, only 200 of the 2,657 study participants
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were older than 65 years (57% were younger than 35 years) and the study was
overwhelmingly male (77%).
Rutledge and Messick (1992) examined 6,662 deaths among males and females. Of these, 142
were fall related. Of the fall-related deaths, 41 (29%) were classified as intoxicated (>0.1
g/100 mL). Again, from the distribution of intoxication by age (Rutledge & Messick 1992, p.
738), these fall deaths must have been skewed towards the young. The prevalence of
intoxication beyond age 65–70 years was minimal, irrespective of the cause of death. From
the data presented, it was not possible to differentiate the proportion of males and females
in the study.
The study carried out by the Center for Disease Control (1984) reported on 3,293 deaths
resulting from intentional and unintentional injuries in Erie County, New York, from 1973 to
1983. These deaths were for people aged 15 years or more who died within eight hours of
injury. Intoxication was defined as BAC > 0.1 g/100 mL. Fifty-two deaths were due to falls;
21% of these involved intoxication. From the data presented, it was not possible to
differentiate either the proportion of males and females or the age distribution among the 52
fall deaths.
Epidemiological evidence for reviewing the aetiological fraction for alcohol and
falls
The differential distribution of harmful/hazardous alcohol intake across age
groups
The 1989–90 Australian Bureau of Statistics National Health Survey (ABS 1994) showed that,
while 13.9% of 18–24 year olds reported a level of alcohol intake classified as medium or
high risk, this decreased to 5.5% for respondents aged 65 years or more. For high-risk
consumption the figures were 6.0% and 1.6% respectively. Similar findings were reported for
the 1995 National Health Survey, where the prevalence of high-risk alcohol consumption
was 4.0% for 15–24 year olds, 1.8% for 65–74 year olds and 1.4% for people aged 75 years or
more (ABS 1995a).
Results from the 1997 National Survey of Mental Health and Well-being show the
proportions of respondents identified with an alcohol abuse disorder within the 12 months
preceeding the survey as 10.6% for those aged 18–34 years and 1.9% for those aged 55 years
or more. Similarly, for those with alcohol as a substance abuse disorder, while 13.5% of
18–34 year olds used alcohol in the preceding 12 months, only 3.1% of those aged 55 or more
acknowledged alcohol use (Hall et al. 1998).
Of the studies examined by English et al. (1995), Rivara et al. (1993) reported the overall
prevalence of acute intoxication (BAC ≥ 0.1 g/100 mL) among trauma patients at its highest
among those age 25–34 years (43.2%) and declining to its lowest among those aged 65 years
or more (12.6%).
Review of more recent literature identifies a number of studies (Cumming & Klineberg 1994;
Cummings et al. 1995; Johnell et al. 1995; Nguyen et al. 1996; O’Neill et al. 1996; Sheahan et
al. 1995) that found no association between alcohol consumption and the risk of osteoporotic
fractures (mainly hip or distal forearm) after falls among people aged 45 years or more. In
some instances, however, the studies were restricted to women (Cummings et al. 1995;
Johnell et al. 1995; O’Neill et al. 1996) and none of these studies differentiated between falls
occurring within an institutional or a community setting. These features are associated with
the exposure of interest (alcohol). Nelson et al. (1992), whose study was restricted to
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community-dwelling individuals aged 65 years or more, reported no association between
fall injuries and self-reported average weekly alcohol use.
While English et al. derived one aetiological fraction for all age groups, our aetiological
fraction has been revised by developing separate fractions for people aged less than 65 years
and for people aged 65 years or more, based on the studies reviewed. This is consistent with
the epidemiological evidence of a differential distribution across age groups of harmful and
hazardous alcohol intake, as described.
The differential distribution between the sexes of both alcohol abuse and acute
alcohol intoxication
Both the 1989–90 and 1995 National Health Survey results identified differences in the
prevalence of high-risk alcohol consumption between the sexes. The prevalence of high-risk
consumption for men was 7.1% for 1989–90 and 8.3% for 1995; the corresponding figures for
women were 1.6% and 2.2%. This disparity was apparent across all age groups examined. Of
the studies reported by English et al., Rivara et al. identified the disparity in the occurrence
of overall acute intoxication in the presence of trauma among both males (39.9%) and
females (22.4%).
Again, while English et al. derived one aetiological fraction for both sexes, our aetiological
fraction has been revised by developing fractions specific to both males and females, based
on the studies reviewed. This is consistent with the epidemiological evidence of a
differential distribution of both alcohol abuse and acute intoxication between the sexes.
Falls occurring in individuals aged 65 years or more and living in institutions
The distribution of causes of falls will differ for frail high-risk individuals living in
institutions such as residential aged care facilities when compared with that for falls among
community-living individuals, where acute alcohol intake is more likely to be a cause of
instability.
A number of studies of falls among nursing home residents or the hospitalised elderly have
examined the contribution of medications, rather than alcohol, to the falls (Cumming 1996;
Rubenstein et al. 1994; Salgado et al. 1994; Thapa et al. 1995; Yip & Cumming 1994). In the
residential aged care environment a reduction in psychotropic drug use is likely to be a
higher priority than a reduction in acute alcohol use.
Unpublished data from the Institute’s National Injury Surveillance Unit show that, for
1996–97, almost one-quarter (12,081 or 24.2%) of the 49,867 falls and one-third (216,817 or
38.5%) of the 562,904 patient days attributable to falls among people aged 65 years or more
had their place of occurrence as a residential institution. As might be expected, females
accounted for over two-thirds of the 12,081 falls resulting in hospital admissions (8,499 or
70.3%) and two-thirds (145,084 or 66.9%) of the 216,817 patient days resulting from these
admissions.
For people aged 65–69 years, the mean length of stay for institutional falls (30.7 days) was
four times that for non-institutional falls (7.6 days). Furthermore, the unpublished data from
the Institute’s National Injury Surveillance Unit show that, while less than 10% of the 6,417
falls in this age group were institutional (549 or 8.5%), these falls accounted for over a
quarter (16,616 or 27.0%) of fall injury patient days for this age group. Among people aged
85 years or more, the mean length of stay for institutional falls (15.4 days), while higher, was
close to that for non-institutional falls (13.6 days). However, this is likely to reflect the higher
occurrence and earlier onset of death among very elderly institutionalised people who are
hospitalised for fall injury. Almost one-third (5,551 or 28.4%) of the 19,561 falls in people
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aged 85 years or more occurred in an institution, and a slightly higher proportion (85,637 or
31.0%) of all patient days (276,604 days) were similarly due to institutional falls for this age
group.
The fractions derived in this section relate to the effect of acute intoxication on falls. They
were derived primarily using studies that did not differentiate on the basis of residence.
Hence they can be applied to deaths and hospital separations data collected without
reference to a person’s usual residence. However, given the primacy of drug use, rather than
alcohol, in the aetiology of falls in nursing homes and hospitals, we recommend that the
fractions not be applied to data focusing on falls in institutions.
Although we acknowledge that chronic alcohol abuse results in individuals requiring
institutional care and that disability arising from chronic alcohol abuse will contribute to
falls, the effect of chronic alcohol abuse on falls is beyond the scope of this analysis.
Separate aetiological fractions for reporting on incidence or prevalence as opposed
to death
Alcohol is more likely to be present among fall fatalities than among non-fatal injuries
arising from falls (Hingson & Howland 1993); the severity of the fall injury is also likely to
be related to blood alcohol concentration (Smith & Kraus 1988). As a result, two separate
fractions—one for fall-related injuries and one for fall-related deaths—would seem
desirable.
Studies used to revise the aetiological fraction for alcohol and falls
The studies used to revise the aetiological fraction for alcohol and falls are listed in
Appendix B. The literature search for studies on which to base a revised aetiological fraction
for alcohol and falls was not restricted to blood alcohol concentration as the criterion for
intoxication. English et al. (1995) examined only studies that had BAC as a measure of
exposure, so the literature for both the 1985 to 1993 and 1994 to 1998 periods was reviewed
to locate papers that examined falls and exposure to alcohol.
Ninety papers that met the search criteria were found. Of these, 44 were reviewed in detail
and 15 were chosen as presenting results in a suitable way for use in re-analysis of the
aetiological fraction for alcohol and falls (not including the three papers used by English et
al. ). A range of measures of exposure was allowed for, and where possible data were
derived from within each paper so as to determine exposure by age and sex (Appendix B,
Table B.8).
Revised aetiological fractions for alcohol and falls
Using the data available (Appendix B, Table B.8) and the epidemiological criteria just
discussed, aetiological fractions for falls attributable to alcohol were produced by weighting
the contribution of each study by its size. The aetiological fractions were determined
separately for males and females aged less than 65 years and 65 years or more (Table 3.18).
Overall, among people aged less than 65 years, 22% of male falls and 14% of female falls
were attributable to alcohol; this compares with 12% of male and 4% of female falls among
people aged 65 years or more.
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Table 3.18: Revised aetiological fractions for alcohol and falls
Hazardous/harmful alcohol consumption
Age Males Females
General population
< 65 years 0.22 0.14
  \HDUV 0.12 0.04
Source: AIHW analysis of data presented in sources listed in Appendix B, Table B.8.
Differentiating between exposure resulting in death, as opposed to hospitalisation, resulted
in few studies remaining available for the derivation of aetiological fractions. Hartshorne et
al. (1997) provide prevalence estimates for the contribution of alcohol to falls resulting in
death that are consistent with the assumption that alcohol would be more prevalent as a
cause of more serious falls that might result in death as opposed to injury. While restricted
to 19 males and four females, these results— and those of Rutledge & Messick (1992) and the
Centers for Disease Control (1984)—do suggest the need for separate fractions for falls
leading to mortality, when the results of more studies become available. Given the limited
data having mortality as the sole outcome, the best current estimates of studies pertaining to
falls and fatal outcomes remain those derived above.
3.2.5 Aetiological fractions for alcohol updated with recent
prevalence data
Where possible, the aetiological fractions were revised to incorporate updated estimates of
the prevalence of alcohol consumption. The conditions discussed in sections 3.2.1 to 3.2.4
were also based on revised risk-ratio estimates. Table 3.19 lists the conditions for which the
aetiological fractions were revised to incorporate updated estimates of the prevalence of
alcohol consumption but that were based on the risk-ratio estimates derived by English et al.
(1995). Table 3.20 lists the conditins for which the aetiological fractions were not revised.
Table 3.21 lists the values of the revised aetiological fractions. The remainder of this section
presents a discussion of those fractions whose revision raises difficulties in addition to the
simple application of the updated prevalence estimates to the risk-ratio estimates of English
et al.
Ischaemic heart disease
English et al. found a significant body of evidence to support the attribution of a protective
effect against ischaemic heart disease to moderate alcohol intake. They found that the
protective effect is fully realised within low drinking levels and that no additional benefit is
gained with increasing intake. Further, they found that the small apparent increase in risk of
ischaemic heart disease with high drinking levels relative to low drinking levels was very
weak and not well substantiated with corroborating evidence. They concluded that there
was inadequate evidence that the marginal exposure between low and hazardous or
harmful alcohol intake is either a cause of or protective against ischaemic heart disease.
Since this marginal risk was the focus of their study, they did not calculate an aetiological
fraction for alcohol and ischaemic heart disease.
Our study focuses on both the harms and the benefits of alcohol consumption relative to
abstaining from alcohol, so we calculated an aetiological fraction using the unscaled risk
ratios derived by English et al. and the updated prevalence data.
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Heart failure
The ICD-9 classifications 428 (heart failure) and 429 (ill-defined descriptions and
complications of heart disease) are non-specific categories that do not identify the
underlying pathology. We followed English et al. in assigning deaths and hospital
separations in these categories to specific heart disease codes according to the proportional
distribution of cases in each of the specific codes. Hence the aetiological fraction is
effectively a weighted average of those applying to each specific heart disease condition.
Since ischaemic heart disease was the predominant cause of heart failure, it was the
condition with the largest contribution to the weighted average. English et al. excluded
ischaemic heart disease from their calculations, so they also excluded heart failure.
However, because we included ischaemic heart disease, we also calculated a fraction for
heart failure.
Unspecified liver cirrhosis
While ICD-9 provides a classification for cirrhosis of the liver caused by alcohol, it is
possible that not all cases of alcoholic liver cirrhosis are recorded as such on death
certificates or in morbidity records. English et al. derived relative risk estimates for all liver
cirrhosis and alcohol. These were 1.26 for low alcohol consumption and 9.54 for hazardous
or harmful levels of consumption. They applied their prevalence estimates to derive overall
fractions for liver cirrhosis. If the proportion of total cirrhosis cases assigned to ICD-9 codes
for alcoholic liver cirrhosis is less than the corresponding sex-specific aetiological fraction,
then the fraction to be applied to unspecified liver cirrhosis is calculated so as to make up
the difference. Specifically, the fraction F  for unspecified liver cirrhosis is calculated as
( )[ ]
b
abaFF a −+=
where
aF  = the overall aetiological fraction for liver cirrhosis and alcohol
a = the number of liver cirrhosis cases assigned to alcoholic liver cirrhosis
b = the number of liver cirrhosis cases assigned to unspecified liver cirrhosis.
The numerator of this formula is an estimate of the total liver cirrhosis cases attributable to
alcohol, using the fraction aF , less the number actually coded to alcoholic liver cirrhosis (a).
This is divided by the number of liver cirrhosis cases assigned to unspecified liver cirrhosis
(b). The result is an estimate of the proportion of unspecified liver cirrhosis cases that should
have been attributed to alcohol.
Low birthweight
English et al. derived risk ratios for low birthweight and alcohol and found a small increase
in risk due to hazardous and harmful consumption in pregnancy relative to low
consumption. They found an aetiological fraction of 0.0004, which they omitted from their
calculations because of its small size. However, when the risk of any alcohol consumption is
assessed relative to abstaining, we find an increase in risk resulting from high levels of
consumption that is almost exactly balanced by a decrease in risk resulting from low levels
of consumption. We included this fraction in our calculations, despite the fact that its overall
value is close to zero, to enable estimation of the cases associated with high-level drinking
and the benefits associated with low-level drinking.
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Table 3.19: Conditions where aetiological fractions were based on the English et al.
risk-ratio estimates but revised to incorporate updated prevalence estimates
Condition Source of prevalence data
Oropharyngeal cancer AIHW analysis of 1995 ABS National Health Survey
Oesophageal cancer AIHW analysis of 1995 ABS National Health Survey
Liver cancer AIHW analysis of 1995 ABS National Health Survey
Laryngeal cancer AIHW analysis of 1995 ABS National Health Survey
Hypertension AIHW analysis of 1995 ABS National Health Survey
Ischaemic heart disease AIHW analysis of 1995 ABS National Health Survey
Supraventricular cardiac dysrhythmias AIHW analysis of 1995 ABS National Health Survey
Heart failure AIHW analysis of 1995 ABS National Health Survey
Unspecified liver cirrhosis AIHW analysis of 1995 ABS National Health Survey
Cholelithiasis AIHW analysis of 1995 ABS National Health Survey
Low birthweight 1998 National Drug Strategy Household Survey
Psoriasis AIHW analysis of 1995 ABS National Health Survey
Suicide and self-inflicted injury AIHW analysis of 1995 ABS National Health Survey
3.3 Aetiological fractions for alcohol left unrevised
The aetiological fractions for alcohol that were not revised are listed in Table 3.30. A number
of the conditions have an aetiological fraction of one. They are conditions—for example,
alcoholic psychosis—that are defined by association with alcohol. The remainder are
conditions for which no more recent data could be found on which to base a revision, so
they have been left at the values derived by English et al. (1995). They are discussed in the
following paragraphs.
3.3.1 Epilepsy
English et al. recommended the use of an aetiological fraction for epilepsy of 0.15. This
estimate was derived from four clinical case series and was recommended for use until
further epidemiological evidence accumulates.
3.3.2 Oesophageal varices
Apart from some rare conditions such as portal or hepatic vein occlusion due to thrombosis
or portal lymphadenopathy, virtually all oesophageal varices are a result of liver cirrhosis.
On this basis, English et al. recommended applying the overall liver cirrhosis fraction to
oesophageal varices.
3.3.3 Gastro-oesophageal haemorrhage
English et al. based their fraction for gastro-oesophageal haemorrhage on a case series of 38
patients in Belfast. The estimate was 0.47 and, in the absence of better or more recent data,
we used the same value.
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3.3.4 Pancreatitis, acute and chronic
English et al. did not identify any epidemiological studies that examined the relative risk of
acute pancreatitis in association with alcohol, and none of the corresponding studies they
identified for chronic pancreatitis were in a form suitable for inclusion in a meta-analysis.
Instead, they derived separate fractions for acute pancreatitis and for chronic pancreatitis
from case series—five for acute pancreatitis and another five for chronic pancereatitis. Their
estimates were 0.24 for acute pancreatitis and 0.84 for chronic pancreatitis and, in the
absence of better or more recent data, we used the same values.
3.3.5 Fire injuries
English et al. identified only one epidemiological study in which the risk of fire injuries in
association with alcohol intake was examined, but the results were not presented in a form
suitable for their report. Instead, they used five blood alcohol case series to derive the
fraction. Their estimate was 0.44 and, in the absence of better or more recent data, we used
the same value.
3.3.6 Drowning
English et al. did not identify any epidemiological studies that examined the relative risk of
drowning in association with alcohol. Instead, they used six blood alcohol case series to
derive the fraction. Their estimate was 0.34 and, in the absence of better or more recent data,
we used the same value.
3.3.7 Aspiration
English et al. were advised by staff of the Australian Bureau of Statistics that use of the
aspiration code in adults is virtually confined to cases of aspiration of vomitus in alcoholics.
Hence they assigned the fraction a value of one at ages 15 and over. We used the same value.
3.3.8 Occupational and machine injuries
English et al. did not identify any epidemiological studies that examined the relative risk of
occupational and machine injuries in association with alcohol. Instead, they used two blood
alcohol case series to derive the fraction. Their estimate was 0.07 and, in the absence of better
or more recent data, we used the same value.
3.3.9 Assault
English et al. did not identify any epidemiological studies that examined the relative risk of
assault in association with alcohol. Instead, they used five clinical case series to derive the
fraction. Their estimate was 0.47 and, in the absence of better or more recent data, we used
the same value.
3.3.10 Child abuse
English et al. did not identify any epidemiological studies that examined the relative risk of
child abuse in association with alcohol. Instead, they used eight clinical case series to derive
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the fraction. Their estimate was 0.16 and, in the absence of better or more recent data, we
used the same value.
Table 3.20: Aetiological fractions not revised
Condition Reason for not revising fraction Fraction value
Alcoholic psychosis Fraction = 1 by definition 1.00
Alcohol dependence/abuse Fraction = 1 by definition 1.00
Alcoholic liver cirrhosis Fraction = 1 by definition 1.00
Epilepsy Insufficient information on which to base a revision 0.15
Alcoholic poly neuropathy Fraction = 1 by definition 1.00
Alcoholic cardiomyopathy Fraction = 1 by definition 1.00
Oesophageal varices Use fraction for unspecified liver cirrhosis Males 0.59, females 0.56
Gastro-oesophageal haemorrhage Insufficient information on which to base a revision 0.47
Alcoholic gastritis Fraction = 1 by definition 1.00
Pancreatitis, acute and chronic Insufficient information on which to base a revision Acute 0.24, chronic 0.84
Ethanol/methanol toxicity Fraction = 1 by definition 1.00
Alcoholic beverage poisoning Fraction = 1 by definition 1.00
Other ethanol and methanol poisoning Fraction = 1 by definition 1.00
Fire injuries Insufficient information on which to base a revision 0.44
Drowning Insufficient information on which to base a revision 0.34
Aspiration Fraction assigned the value of 1 1.00
Occupational and machine injuries Insufficient information on which to base a revision 0.07
Assault Insufficient information on which to base a revision 0.47
Child abuse Insufficient information on which to base a revision 0.16
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Table 3.21: Revised values for fractions based on the English et al. risk-ratio estimates
and updated prevalence data
1. Fractions directly updated with population prevalence data
Oropharyngeal cancer (ICD-9 codes 141, 143–146, 148–149)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.310 0.459 0.814 0.310 0.459 0.814
General population
18–19 0.181 0.033 0.210 0.185 0.073 0.079
20–24 0.181 0.033 0.210 0.185 0.073 0.079
25–29 0.189 0.038 0.188 0.193 0.057 0.062
30–34 0.181 0.044 0.182 0.205 0.053 0.059
35–39 0.191 0.042 0.138 0.159 0.067 0.071
40–44 0.182 0.050 0.155 0.172 0.056 0.064
45–49 0.179 0.056 0.154 0.152 0.054 0.095
50–54 0.191 0.042 0.166 0.141 0.066 0.114
55–59 0.201 0.045 0.105 0.150 0.070 0.077
60–64 0.173 0.052 0.188 0.162 0.076 0.034
65–69 0.199 0.040 0.126 0.147 0.087 0.044
70–74 0.197 0.032 0.158 0.159 0.054 0.036
75–79 0.198 0.014 0.177 0.159 0.029 0.030
80+ 0.214 0.030 0.088 0.188 0.027 0.050
Total (18+) 0.185 0.042 0.168 0.175 0.063 0.068
Oesophageal cancer (ICD-9 code 150)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.444 0.578 0.765 0.444 0.578 0.765
General population
18–19 0.290 0.048 0.141 0.281 0.101 0.050
20–24 0.290 0.048 0.141 0.281 0.101 0.050
25–29 0.300 0.054 0.124 0.294 0.078 0.040
30–34 0.288 0.064 0.120 0.310 0.072 0.037
35–39 0.298 0.059 0.090 0.246 0.094 0.046
40–44 0.286 0.072 0.101 0.265 0.079 0.041
45–49 0.280 0.080 0.101 0.240 0.078 0.063
50–54 0.300 0.059 0.109 0.224 0.095 0.076
55–59 0.309 0.062 0.067 0.233 0.099 0.050
60–64 0.275 0.075 0.125 0.247 0.106 0.022
65–69 0.308 0.057 0.082 0.226 0.121 0.028
70–74 0.310 0.046 0.104 0.247 0.076 0.023
75–79 0.315 0.021 0.118 0.249 0.041 0.020
80+ 0.328 0.041 0.056 0.291 0.038 0.033
Total (18+) 0.292 0.061 0.110 0.268 0.088 0.044
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Liver cancer (ICD-9 code 155)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.310 0.670 0.722 0.310 0.670 0.722
General population
18–19 0.188 0.082 0.130 0.172 0.164 0.044
20–24 0.188 0.082 0.130 0.172 0.164 0.044
25–29 0.194 0.092 0.114 0.183 0.128 0.035
30–34 0.184 0.107 0.109 0.196 0.120 0.033
35–39 0.191 0.100 0.082 0.149 0.150 0.040
40–44 0.181 0.119 0.091 0.163 0.128 0.036
45–49 0.176 0.132 0.090 0.147 0.125 0.054
50–54 0.193 0.100 0.099 0.135 0.150 0.065
55–59 0.197 0.105 0.061 0.140 0.157 0.043
60–64 0.174 0.125 0.112 0.148 0.167 0.018
65–69 0.198 0.096 0.074 0.134 0.188 0.024
70–74 0.201 0.079 0.096 0.150 0.122 0.020
75–79 0.209 0.037 0.111 0.155 0.066 0.018
80+ 0.213 0.071 0.052 0.185 0.063 0.029
Total (18+) 0.187 0.102 0.100 0.165 0.143 0.038
Laryngeal cancer (ICD-9 code 161)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.454 0.744 0.797 0.454 0.744 0.797
General population
18–19 0.276 0.093 0.155 0.257 0.189 0.053
20–24 0.276 0.093 0.155 0.257 0.189 0.053
25–29 0.283 0.104 0.137 0.276 0.149 0.043
30–34 0.270 0.122 0.131 0.292 0.139 0.041
35–39 0.282 0.114 0.099 0.227 0.177 0.049
40–44 0.267 0.136 0.110 0.249 0.151 0.045
45–49 0.259 0.151 0.109 0.225 0.148 0.068
50–54 0.283 0.114 0.119 0.205 0.177 0.081
55–59 0.293 0.121 0.074 0.214 0.186 0.053
60–64 0.255 0.142 0.135 0.227 0.198 0.023
65–69 0.293 0.110 0.090 0.204 0.223 0.030
70–74 0.297 0.090 0.115 0.233 0.147 0.025
75–79 0.309 0.042 0.134 0.244 0.081 0.023
80+ 0.318 0.082 0.064 0.285 0.075 0.037
Total (18+) 0.275 0.117 0.121 0.249 0.167 0.047
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Hypertension (ICD-9 codes 410–405)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.020 0.301 0.512 –0.176 0.213 0.441
General population
18–19 0.012 0.025 0.077 –0.096 0.036 0.022
20–24 0.012 0.025 0.077 –0.096 0.036 0.022
25–29 0.013 0.029 0.068 –0.099 0.028 0.017
30–34 0.012 0.034 0.065 –0.107 0.026 0.017
35–39 0.012 0.031 0.048 –0.077 0.031 0.019
40–44 0.012 0.037 0.054 –0.084 0.026 0.017
45–49 0.012 0.041 0.054 –0.075 0.025 0.025
50–54 0.013 0.031 0.059 –0.070 0.031 0.030
55–59 0.013 0.032 0.036 –0.072 0.032 0.020
60–64 0.012 0.039 0.068 –0.077 0.034 0.009
65–69 0.013 0.029 0.043 –0.069 0.039 0.011
70–74 0.013 0.024 0.056 –0.074 0.024 0.009
75–79 0.013 0.011 0.063 –0.071 0.012 0.007
80+ 0.013 0.021 0.030 –0.091 0.012 0.013
Total (18+) 0.012 0.032 0.059 –0.087 0.030 0.018
Ischaemic heart disease (ICD-9 codes 410–414)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages –0.220 –0.190 –0.136 –0.220 –0.190 –0.136
General population
18–19 –0.147 –0.013 –0.012 –0.129 –0.024 –0.004
20–24 –0.147 –0.013 –0.012 –0.129 –0.024 –0.004
25–29 –0.152 –0.014 –0.010 –0.129 –0.018 –0.003
30–34 –0.143 –0.016 –0.010 –0.139 –0.017 –0.003
35–39 –0.141 –0.015 –0.007 –0.102 –0.020 –0.003
40–44 –0.138 –0.018 –0.008 –0.110 –0.017 –0.003
45–49 –0.136 –0.020 –0.008 –0.098 –0.016 –0.004
50–54 –0.149 –0.015 –0.009 –0.093 –0.020 –0.005
55–59 –0.145 –0.015 –0.005 –0.095 –0.021 –0.003
60–64 –0.137 –0.019 –0.010 –0.100 –0.022 –0.001
65–69 –0.146 –0.014 –0.006 –0.091 –0.025 –0.002
70–74 –0.151 –0.012 –0.008 –0.094 –0.015 –0.001
75–79 –0.151 –0.005 –0.009 –0.089 –0.008 –0.001
80+ –0.149 –0.010 –0.004 –0.115 –0.008 –0.002
Total (18+) –0.143 –0.015 –0.009 –0.115 –0.020 –0.003
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Supraventricular cardiac dysrhythmias (ICD-9 codes 427.0, 427.2, 427.3)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.338 0.552 0.552 0.338 0.552 0.552
General population
18–19 –0.147 –0.013 –0.012 –0.129 –0.024 –0.004
20–24 –0.147 –0.013 –0.012 –0.129 –0.024 –0.004
25–29 –0.152 –0.014 –0.010 –0.129 –0.018 –0.003
30–34 –0.143 –0.016 –0.010 –0.139 –0.017 –0.003
35–39 –0.141 –0.015 –0.007 –0.102 –0.020 –0.003
40–44 –0.138 –0.018 –0.008 –0.110 –0.017 –0.003
45–49 –0.136 –0.020 –0.008 –0.098 –0.016 –0.004
50–54 –0.149 –0.015 –0.009 –0.093 –0.020 –0.005
55–59 –0.145 –0.015 –0.005 –0.095 –0.021 –0.003
60–64 –0.137 –0.019 –0.010 –0.100 –0.022 –0.001
65–69 –0.146 –0.014 –0.006 –0.091 –0.025 –0.002
70–74 –0.151 –0.012 –0.008 –0.094 –0.015 –0.001
75–79 –0.151 –0.005 –0.009 –0.089 –0.008 –0.001
80+ –0.149 –0.010 –0.004 –0.115 –0.008 –0.002
Total (18+) –0.143 –0.015 –0.009 –0.115 –0.020 –0.003
Cholelithiasis (ICD-9 code 574)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages –0.220 –0.471 –1.000 –0.220 –0.471 –1.000
General population
18–19 –0.155 –0.026 –0.051 –0.133 –0.050 –0.016
20–24 –0.155 –0.026 –0.051 –0.133 –0.050 –0.016
25–29 –0.159 –0.030 –0.045 –0.133 –0.037 –0.012
30–34 –0.150 –0.035 –0.043 –0.143 –0.035 –0.012
35–39 –0.147 –0.030 –0.030 –0.105 –0.042 –0.013
40–44 –0.145 –0.038 –0.035 –0.113 –0.035 –0.012
45–49 –0.142 –0.042 –0.035 –0.101 –0.034 –0.018
50–54 –0.156 –0.032 –0.038 –0.096 –0.042 –0.022
55–59 –0.149 –0.031 –0.022 –0.098 –0.043 –0.014
60–64 –0.145 –0.041 –0.045 –0.103 –0.046 –0.006
65–69 –0.151 –0.029 –0.027 –0.094 –0.052 –0.008
70–74 –0.157 –0.024 –0.036 –0.096 –0.031 –0.006
75–79 –0.157 –0.011 –0.040 –0.090 –0.015 –0.005
80+ –0.153 –0.020 –0.018 –0.117 –0.016 –0.009
Total (18+) –0.149 –0.032 –0.038 –0.118 –0.040 –0.013
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Psoriasis (ICD-9 code 696.1)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.367 0.375 0.545 0.367 0.375 0.545
General population
18–19 0.262 0.026 0.065 0.244 0.053 0.022
20–24 0.262 0.026 0.065 0.244 0.053 0.022
25–29 0.268 0.029 0.057 0.251 0.040 0.017
30–34 0.258 0.035 0.055 0.264 0.037 0.016
35–39 0.261 0.031 0.040 0.210 0.048 0.020
40–44 0.254 0.038 0.046 0.225 0.040 0.018
45–49 0.249 0.043 0.046 0.205 0.040 0.027
50–54 0.267 0.032 0.049 0.194 0.049 0.033
55–59 0.268 0.033 0.030 0.199 0.051 0.022
60–64 0.248 0.041 0.057 0.209 0.054 0.009
65–69 0.269 0.030 0.036 0.193 0.062 0.012
70–74 0.273 0.024 0.046 0.205 0.038 0.010
75–79 0.276 0.011 0.052 0.202 0.020 0.008
80+ 0.279 0.021 0.024 0.240 0.019 0.014
Total (18+) 0.259 0.033 0.050 0.229 0.046 0.019
Suicide and self– inflicted injury (ICD-9 codes E950–E959)
Male Female
Level of exposure Level of exposure
Age Low Hazardous Harmful Low Hazardous Harmful
Exposed population
All ages 0.286 0.569 0.603 0.286 0.569 0.603
General population
18–19 0.187 0.059 0.084 0.169 0.118 0.028
20–24 0.187 0.059 0.084 0.169 0.118 0.028
25–29 0.192 0.066 0.074 0.177 0.091 0.022
30–34 0.182 0.078 0.071 0.188 0.085 0.021
35–39 0.186 0.071 0.052 0.145 0.107 0.025
40–44 0.179 0.086 0.059 0.158 0.090 0.023
45–49 0.174 0.096 0.059 0.142 0.089 0.035
50–54 0.190 0.072 0.064 0.132 0.108 0.042
55–59 0.192 0.074 0.039 0.137 0.112 0.027
60–64 0.173 0.091 0.073 0.144 0.118 0.012
65–69 0.193 0.068 0.048 0.130 0.134 0.015
70–74 0.197 0.056 0.061 0.143 0.085 0.012
75–79 0.202 0.026 0.071 0.144 0.045 0.011
80+ 0.204 0.050 0.033 0.174 0.043 0.018
Total (18+) 0.184 0.074 0.065 0.160 0.101 0.024
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2. Other updated fractions
Heart failure: deaths (ICD-9 code 428–429)
Male Female
Year Year
Age 1996 1997 1998 1996 1997 1998
General population
18–19 –0.034 –0.016 –0.016 0.005 0.000 0.000
20–24 –0.049 –0.043 0.007 –0.026 –0.026 –0.045
25–29 –0.087 –0.006 –0.049 –0.056 –0.032 0.004
30–34 –0.068 –0.029 –0.081 –0.075 –0.071 0.028
35–39 –0.069 –0.103 –0.132 –0.081 –0.089 –0.043
40–44 –0.103 –0.132 –0.112 –0.049 –0.029 –0.082
45–49 –0.101 –0.096 –0.115 –0.070 –0.081 –0.072
50–54 –0.119 –0.126 –0.119 –0.060 –0.066 –0.084
55–59 –0.126 –0.121 –0.124 –0.088 –0.087 –0.075
60–64 –0.131 –0.126 –0.130 –0.101 –0.102 –0.102
65–69 –0.137 –0.136 –0.136 –0.094 –0.094 –0.083
70–74 –0.143 –0.140 –0.139 –0.088 –0.088 –0.086
75–79 –0.138 –0.139 –0.139 –0.079 –0.077 –0.077
80+ –0.133 –0.135 –0.135 –0.101 –0.101 –0.099
Total (18+) –0.133 –0.135 –0.135 –0.100 –0.101 –0.099
Note: Fractions for heart failure deaths are derived as a weighted average of the fractions for other specified heart conditions.
The weights are derived from the number of deaths coded to each specific condition. Hence the fractions vary by year.
Heart failure: separations (ICD-9 code 428–429)
Male Female
Year Year
Age 1996 1997 1998 1996 1997 1998
General population
18–19 0.048 0.075 0.061 0.053 0.057 –0.038
20–24 0.075 0.072 0.075 0.048 0.046 –0.038
25–29 0.048 0.059 0.055 0.022 0.018 –0.054
30–34 0.019 0.022 0.018 0.010 0.004 –0.064
35–39 –0.051 –0.052 –0.036 –0.004 0.000 –0.028
40–44 –0.083 –0.078 –0.077 –0.027 –0.031 –0.041
45–49 –0.098 –0.094 –0.089 –0.038 –0.035 –0.024
50–54 –0.111 –0.108 –0.102 –0.044 –0.049 –0.008
55–59 –0.107 –0.103 –0.098 –0.050 –0.046 –0.020
60–64 –0.101 –0.098 –0.096 –0.055 –0.051 –0.034
65–69 –0.101 –0.096 –0.092 –0.050 –0.045 –0.019
70–74 –0.097 –0.094 –0.092 –0.043 –0.038 –0.041
75–79 –0.084 –0.083 –0.078 –0.035 –0.033 –0.052
80+ –0.081 –0.077 –0.070 –0.051 –0.048 –0.065
Total (18+) –0.081 –0.077 –0.070 –0.046 –0.044 –0.065
Note: Fractions for heart failure separations are derived as a weighted average of the fractions for other specified heart conditions.
The weights are derived from the number of separations coded to each specific condition. Hence the fractions vary by year.
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Unspecified liver cirrhosis: deaths (ICD-9 code 571.5–571.9)
Male Female
Year Year
Age 1996 1997 1998 1996 1997 1998
General population
18–19 0.000 0.000 0.000 0.059 0.084 0.000
20–24 0.000 0.000 0.000 0.059 0.084 0.000
25–29 0.000 0.000 0.000 0.059 0.084 0.000
30–34 0.000 0.000 0.000 0.059 0.084 0.000
35–39 0.000 0.000 0.000 0.059 0.084 0.000
40–44 0.000 0.000 0.000 0.059 0.084 0.000
45–49 0.000 0.000 0.000 0.059 0.084 0.000
50–54 0.000 0.000 0.000 0.059 0.084 0.000
55–59 0.000 0.000 0.000 0.059 0.084 0.000
60–64 0.000 0.000 0.000 0.059 0.084 0.000
65–69 0.000 0.000 0.000 0.059 0.084 0.000
70–74 0.000 0.000 0.000 0.059 0.084 0.000
75–79 0.000 0.000 0.000 0.059 0.084 0.000
80+ 0.000 0.000 0.000 0.059 0.084 0.000
Total (18+) 0.000 0.000 0.000 0.059 0.084 0.000
Note: Fractions for unspecified liver cirrhosis deaths are derived using the counts of deaths coded to alcoholic liver cirrhosis and
to overall liver cirrhosis. Hence the fractions vary by year.
Unspecified liver cirrhosis: separations (ICD-9 code 571.5–571.9)
Male Female
Year Year
Age 1996 1997 1998 1996 1997 1998
General population
18–19 0.000 0.000 0.000 0.206 0.212 0.205
20–24 0.000 0.000 0.000 0.206 0.212 0.205
25–29 0.000 0.000 0.000 0.206 0.212 0.205
30–34 0.000 0.000 0.000 0.206 0.212 0.205
35–39 0.000 0.000 0.000 0.206 0.212 0.205
40–44 0.000 0.000 0.000 0.206 0.212 0.205
45–49 0.000 0.000 0.000 0.206 0.212 0.205
50–54 0.000 0.000 0.000 0.206 0.212 0.205
55–59 0.000 0.000 0.000 0.206 0.212 0.205
60–64 0.000 0.000 0.000 0.206 0.212 0.205
65–69 0.000 0.000 0.000 0.206 0.212 0.205
70–74 0.000 0.000 0.000 0.206 0.212 0.205
75–79 0.000 0.000 0.000 0.206 0.212 0.205
80+ 0.000 0.000 0.000 0.206 0.212 0.205
Total (18+) 0.000 0.000 0.000 0.206 0.212 0.205
Note: Fractions for unspecified liver cirrhosis separations are derived using the counts of separations coded to alcoholic liver
cirrhosis and to overall liver cirrhosis. Hence the fractions vary by year.
Low birthweight
Level of exposure
Low Hazardous or harmful
Exposed population –0.124 0.383
General population –0.034 0.035
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4 Tobacco
4.1 Introduction
As with alcohol and illicit drugs, we revised the aetiological fractions for tobacco to
incorporate recent data on prevalence wherever such data were available. In addition, we
revised the risk-ratio estimates for tobacco and cervix cancer and tobacco and peptic ulcer.
Finally, we incorporated estimates of aetiological fractions associated with passive smoking,
based on the National Health and Medical Research Council’s report on passive smoking
(NHMRC 1997).
As part of the revision of prevalence data, we also dealt with the question of the time lag
between tobacco exposure and disease onset. This is discussed in detail in section 4.1.1;
briefly it involves the derivation of a synthetic prevalence estimate which represents past
exposure to tobacco rather than current exposure.
4.1.1 Aetiological fractions associated with cancer and chronic
obstructive pulmonary disease
English et al. (1995) used an estimate of current smoking prevalence in their calculation of
aetiological fractions for tobacco. But for many conditions there is a long time lag between
exposure to tobacco smoke and the associated ill-effects—in the case of cancer it may be
many decades—so for these conditions estimates of the current prevalence of smoking are
not helpful in understanding the current associated disease burden.
We have followed the Australian Burden of Disease Study (Mathers et al. 1999) in using the
method proposed by Peto et al. (1992) to adjust for the time lag. Peto et al. proposed using an
artificial compound prevalence measure of tobacco exposure, derived from a comparison
between lung cancer rates in the country of interest and lung cancer rates among non-
smokers observed in a large long-term follow-up study in the United States. This method
was used here to determine tobacco exposure for the cancers on our risk factor list and for
chronic obstructive pulmonary disease. The mean time between tobacco exposure and the
onset of the other illnesses and injuries discussed in this chapter is considerably shorter than
that for cancer and chronic obstructive pulmonary disease, so the estimates of current
tobacco exposure described in Chapter 1 were used for these other conditions.
4.2 Revised aetiological fractions for tobacco
4.2.1 Tobacco and cervix cancer
English et al. (1995) concluded that, while there is limited evidence that smoking causes
cervix cancer, a causal interpretation of the association is credible, although confounding
cannot be ruled out with confidence. Confounding could be due to known risk factors for
cervix cancer, particularly the number of sexual partners and infection with the human
papilloma virus (HPV). If confounding due to HPV infection were to explain the
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relationship between cigarette smoking and the risk of cervix cancer, there would be little
association between cigarette smoking and cervix cancer among women known to be
infected with HPV.
Epidemiological evidence for reviewing the aetiological fraction for tobacco
and cervix cancer
English et al. (1995) found, from a meta-analysis of 14 studies, that female ex-smokers had a
relative risk of 1.31 (95% CI: 1.21–1.43) and female current smokers had a relative risk of 1.75
(95% CI: 1.66–1.85). The results for current smokers were broadly consistent with a
previously published meta-analysis that reported a relative risk of 1.42 (95% CI: 1.33–1.51)
for female smokers after adjusting for age and the number of sexual partners (Sood 1991).
However, another meta-analysis, while confirming that female current smokers were at
increased risk, did not confirm the significantly elevated risk for ex–smokers (Licciardone et
al. 1990).
The overall aetiological fraction derived by English et al. for cervix cancer caused by
smoking was estimated as 0.19. Thus 19% of cervix cancer was attributed to cigarette
smoking.
The major risk factor for cervix cancer has been shown to be the human papilloma virus
(Bosch et al. 1994b; Eluf Neto et al. 1994; Munoz et al. 1994), the association between HPV
infection and cervix cancer being reflected in odds ratios ranging from 15 to 100 (Bosch et al.
1994a). Cervix cancer risk for a woman depends largely on the probability of being infected
with some specific types of HPV (Bosch et al. 1994b).
Risk factors usually strongly associated with cervical neoplasia—such as number of sexual
partners or age at first sexual intercourse—were no longer associated with cervix cancer
among women who were HPV DNA positive, while the association persisted among women
who were HPV DNA negative. Similarly, the odds ratio for the association between smoking
status and cervix cancer ranged from 1.4 to 2.0 after adjustment for confounders including
HPV. However, when HPV-positive women only were analysed (removing confounding
due to undetected HPV), the odds ratio attributable to smoking was not statistically different
from one (Bosch et al. 1994a).
Phillips and Davey Smith (1994) discussed the likelihood that the association between
cigarette smoking and sexual activity makes the evaluation of the role of smoking difficult.
This is because of confounding due to the presence of the aetiological pathogen (HPV),
which is transmitted through sexual activity.
They noted that studies of the association between smoking and cervix cancer have adjusted
for the lifetime number of sexual partners as a proxy measure of the presence of the
aetiological pathogen and, in most cases, the association with smoking has diminished but
remained significant. Use of a proxy tends, however, to result in an underestimation of the
effect of the aetiological pathogen (HPV) on the risk of cervix cancer. Hence the adjustment
is also likely to be insufficient, resulting in an overestimation of the adjusted or
‘independent’ effect of smoking. Using realistic estimates of the association between the
presence of the aetiological pathogen (HPV) and both smoking and the risk of cervix cancer,
Phillips and Davey Smith generated ‘independent’ relative risks for cigarette smoking of
two and above. Thus they concluded that the observed ‘independent’ effect of cigarette
smoking on cervical cancer arises because of residual confounding.
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Revised aetiological fractions for tobacco and cervix cancer
Sexually transmitted viruses of the HPV type have been shown to be present in high grade
squamous pre-cancer and cancer of the cervix. That the ‘independent’ effect of smoking with
regard to cervix cancer as an outcome arises because of residual confounding does not
support a causal relationship between smoking and cervix cancer; as a result the fraction
should be zero.
4.2.2 Tobacco and peptic ulcer
English et al. (1995) and Ashley (1997) claimed that smoking increases the risk of the
occurrence of peptic ulcer, delays healing (with or without treatment) and increases the risk
of recurrence after healing. Thus they said the relationship between smoking and peptic
ulcer is causal. English et al. found that 41% of peptic ulcer disease in males and 33% in
females is caused by cigarette smoking. Studies published before that of English et al. have
also published attributable fractions for cigarette smoking in the aetiology of peptic ulcer
disease. Kurata et al. (1986) found that between 43% and 63% of duodenal ulcer mortality for
males and between 25% and 50% for females could be attributed to smoking. Schoon et al.
(1991) estimated that, among people aged 35–84 years, 24.4% of ulcers diagnosed for the first
time and 42.0% of relapsing ulcers were caused by smoking. Johnsen et al. (1994) found that
53.0% of duodenal ulcer disease and 60.0% of gastric ulcer disease was attributable to daily
cigarette smoking.
Epidemiological evidence for reviewing the aetiological fraction for tobacco
and peptic ulcer
In the last 20 years there has been increasing recognition of the role that Campylobacter pylori
or Helicobacter pylori infection may have as a major contributing factor to peptic ulcer disease
(Everhart et al. 1998). In 1989 it was reported that the use of non-steroidal anti-inflammatory
drugs and the presence of antibodies to C. pylori identified people at risk for peptic ulcer
disease and that smoking increased this risk in subjects with C. pylori (Martin et al. 1989). An
absence of a history of NSAID use and antibody to C. pylori therefore identifies individuals
with a low probability of ulcer disease. This is confirmed in the more recent review by Blum
(1996) that also reported that ulcer development in the absence of H. pylori is extremely rare
in those not taking NSAIDs. While peptic ulcer disease is still described as a multifactorial
condition that is influenced by a number of environmental factors (including smoking), in
the absence of H. pylori infection these factors would not normally lead to ulcer formation
(Blum 1996).
Gastritis induced by H. pylori is a powerful risk factor for peptic ulcer disease. The risk of
developing peptic ulcer is at least 15 times higher in those infected with H. pylori when
compared with those not infected with H. pylori. Furthermore, eradication of C. pylori or H.
pylori leads to the cure of peptic ulcer disease and long-term remission (Blum 1996).
Numerous studies have shown that eradication therapy significantly reduces the rate of
relapse and complication associated with genuine non-NSAID induced duodenal ulcer
(Chan et al. 1997; Hunt & Mohamed 1995; Labenz & Borsch 1994b; Labenz & Borsch 1994c;
Marshall et al. 1988; Rauws & Tytgat 1990; Tytgat & Rauws 1990) or gastric ulcer (Chan et al.
1997; Labenz & Borsch 1994a; Labenz & Borsch 1994b; Labenz & Borsch 1994c). This marked
decrease in the rate of recurrence of peptic ulcer disease following the eradication of
infection provides the strongest evidence for the pathogenic role of H. pylori in peptic ulcer
disease (NIH 1994).
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Since there is no protection from reinfection after the cure of a first infection (Blum 1996),
reinfection in adults can occur at a rate similar to the infection rate in adults. This is,
however, rare (Cullen et al. 1993) and in industrialised countries amounts to about 1% a
year. The four-year follow-up by Labenz (1994b) reported the reinfection rate one year after
successful eradication was 2.6% (ulcer relapse 1.1%) and after two years reinfection had
risen to 3.2% (ulcer relapse 1.6%). No further increase in reinfection was found during the
subsequent two years. More recently, the 1% a year H. pylori infection rate among adults was
confirmed by an Australian study of Sydney and Melbourne residents (Lin et al. 1998).
From the data available, a further difficulty in establishing a causal relationship between H.
pylori and peptic ulcer disease is that only a small proportion of individuals harboring the
organism develop ulceration (National Institute of Health 1994). It is hypothesised that
diversity among H. pylori strains is in part responsible for the observed variability in the
outcome of the infection (Blaser 1994). That only certain strains of H. pylori cause ulceration
and that their ulcerogenic potential appears to be associated with the presence of strain-
specific factors, such as the cagA gene (Blaser 1994), are further evidence for the pathogenic
role of H. pylori in peptic ulcer disease (Blum 1996).
Studies used to revise the aetiological fraction for tobacco and peptic ulcer
The biological evidence cited in support of an aetiological role for cigarette smoking is that
in general nicotine appears to act by potentiating the adverse effects of gastric aggressive
factors such as acid and pepsin secretion, motility, duodenogastric reflux, the risk of H.
pylori infection, levels of free radicals, vasopressin secretion, platelet activating factor
generation, and endothelin generation. At the same time, nicotine attenuates defensive
mechanisms by decreasing mucosal blood flow, prostaglandin synthesis, mucus secretion
and epidermal growth factor secretion (Ashley 1997).
However, none of the studies used by English et al., and four of the six studies they
excluded in deriving the aetiological fraction, considered the direct influence of C. pylori or
H. pylori infection. Of the remaining two studies that did consider the influence of H. pylori,
the most recent (Bateson 1993) found that, while the association of peptic ulcer disease with
both H. pylori infection and cigarette smoking was confirmed, the excess of peptic ulcer
disease in cigarette smokers may have been explained by their increased susceptibility to H.
pylori infection. The other study—by Martin et al. 1989—found that, while smokers (>10
cigarettes/day) were more likely (41%; 11/27) to have an ulcer than non-smokers (20%;
16/80; p < 0.05), this was only because of the increased prevalence of ulcers in smokers who
also had C. pylori (smokers: 73%; 11/15 in contrast with non-smokers: 29%; 13/45).
Therefore, while smoking increased the risk in subjects with C. pylori, absence of a history of
NSAID use and antibodies to C. pylori identified individuals with a low probability of ulcer
disease (Martin et al. 1989).
The literature search found nine further studiesthat accounted for H. pylori infection and
implicated smoking in the aetiology of peptic ulcer disease. Three studies were reviews
(Eastwood 1997; Lam 1994b; Parsonnet 1998). Four papers (Archimandritis et al. 1995; Leoci
et al. 1995; Menzel et al. 1995; Wang et al. 1996) gave estimates of relative risk for smoking
status and H. pylori status. The remaining two papers presented summary (Lam 1994a) and
pooled (Kurata & Nogawa 1997) estimates of relative risk; in one case the data were used to
derive aetiological fractions (Kurata & Nogawa 1997).
Parsonnet (1998) concluded that H. pylori is the single most important cause of both
duodenal ulcer disease and gastric ulcer disease and that in the United States it appears to be
a causative factor in at least 50% to 65% of all duodenal ulcer. While the proportion of gastric
ulcer disease attributable to H. pylori is thought to be lower than that for duodenal ulcer, this
58
could be because NSAIDs contribute disproportionately to gastric ulcer disease (Lam 1994a;
Lam 1994b; McIntosh et al. 1985; Parsonnet 1998; Schubert et al. 1993).
Eastwood (1997) summarised the relationship between smoking and H. pylori infection in
the pathogenesis of peptic ulcer disease as one where smoking appears to increase the risk
for H. pylori infection and may also augment the harmful effects of H. pylori in the
development of peptic ulceration. But smoking does not appear to delay ulcer healing or
increase the risk of recurrence once H. pylori has been eradicated. Furthermore, while the
adverse effects of smoking on aggressive and protective factors qualify it as an important
contributor to the maintenance of peptic ulcer disease, these effects are transient and the
affected physiological functions return to normal within minutes to hours after cessation of
smoking.
Lam (1994b) concluded that circumstantial evidence is supportive of H. pylori playing a role
in the aetiology of duodenal ulcer. Mucosal inflammation appears associated with peptic
ulcer disease in many situations. Conditions associated with severe mucosal inflammation
include the habitual use of NSAIDs, H. pylori infection and, to a lesser degree, cirrhosis of
the liver and chronic renal failure, as well as conditions associated with minimal
inflammation, such as cigarette smoking. Unlike Eastwood, who suggested that smoking
appears to increase the risk of H. pylori infection, Lam cites Maxton et al. (1990) as finding
that the ulcerogenic potential of NSAIDs and smoking is not mediated through a
predisposition to H. pylori infection. A later study by Lee et al. (1994) also reported that there
was no difference between people positive or negative to H. pylori in terms of their tobacco
exposure. With regard to ulcer relapse or the recurrence of H. pylori infection after
eradication, Chan et al. (1997) also found no significant difference between smokers (≥10
cigarettes/day) and non-smokers. They concluded that cigarette smoking does not appear to
increase the recurrence of peptic ulcers after eradication of H. pylori.
The four studies published after 1993—Archimandritis et al. (1995), Leoci et al. (1995),
Menzel et al. (1995) and Wang et al. (1996)—reported that, even after adjustment for H. pylori
infection, smoking status also remained a significant predictor in the aetiology of peptic
ulcer.
The prospective study by Archimandritis (1995) examined the impact of smoking and H.
pylori on 166 duodenal ulcer disease patients and 75 gastric ulcer disease patients.
Individuals having recently used NSAIDs were excluded. Univariate analysis found that
48% of duodenal ulcer and 37% of gastric ulcer patients had a positive family history.
Furthermore, a majority of duodenal ulcer (63%) and gastric ulcer (67%) patients were
smokers of more than 10 cigarettes a day and an even greater majority of duodenal ulcer
(85%) and peptic ulcer (75%) patients were H. pylori positive.
In their prospective study evaluating the incidence and risk factors for duodenal ulcer, Leoci
et al. (1995) found 41 cases of the disease among 526 individuals undergoing
oesophagogastroduodenoscopy. Multiple logistic regression identified maximal acid output,
a history of peptic ulcer in brothers, and smoking more than 10 cigarettes a day as significant
predictors of peptic ulcer disease. Only a subgroup of 178 individuals had had gastric
biopsies in this study, so adjustment for H. pylori infection was not possible in the analysis of
all 526 individuals. Furthermore, this study was not able to use information on consumption
of NSAIDs as an adjustment in the analysis because the data were considered unreliable.
While maximal acid output and cigarette smoking were independent predictors of duodenal
ulcer, Leoci et al. did not demonstrate any interaction between these variables; thus their
findings are consistent with those of another report that found intragastric activity was not
dependent on cigarette smoking (Kaufmann et al. 1990). In another report, however, Harris
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et al. (1996) hypothesised that acid hypersecretion in duodenal ulcer disease is caused by H.
pylori infection.
Menzel et al. (1995) reported on a study of 1299 individuals, of whom 310 had duodenal
ulcer and 157 had gastric ulcer. They did not exclude individuals taking aspirin, steroids
and/or NSAIDs and they used low and high urease activity as a marker for low and high H.
pylori colonisation of the mucosa. (Low and high urease activity reflect low and high H.
pylori colonisation of the mucosa.)
The analysis undertaken by Menzel et al. was by logistic regression and included all two-
way-interactions between urease activity and the other factors considered. For the duodenal
ulcer model there were interactions between urease activity and both presenting gastric
symptoms and nationality. The interaction odds ratios of 87.4 (95% CI: 6.4–1187) for
epigastric pain and high urease activity and 26.4 (95% CI: 9.0–78.0) for epigastric pain and
low urease activity compare with that of 11.1 (95% CI: 4.8–25.9) for epigastric pain and no
urease activity. This compares with an odds ratio of 2.2 (95% CI: 1.3–4.0) for smoking as an
independent predictor of duodenal ulcer disease. Further, there was no apparent interaction
between urease activity and smoking and there was no apparent dose–response relationship
for those smoking more than 20 cigarettes a day and those smoking fewer than 20 cigarettes
a day.
The regression results also showed that smoking was an independent predictor of disease
(OR: 3.4; 95% CI: 2.0–5.7). However, this compared with the odds ratio of 3.4 (95% CI: 2.0–
5.7) for low urease activity and 24.8 (95% CI: 8.5–72.3) for high urease activity when
compared with no urease activity. Again, there was no evidence of a significant interaction
between urease activity and smoking.
A case-control study of 500 factory workers in China with peptic ulcer (85% duodenal) and
500 employees selected from the same factories as controls was undertaken by Wang et al.
(1996). Cases of peptic ulcer were confirmed, by endoscopy or gastrointestinal barium
examination, as either new or recurrent (within the last two years). Cases due to NSAID use
or Zellinger Ellison syndrome were excluded.
Among the cases there were more males (84%) than females (16%). There was a very high
prevalence of smoking among the cases (67%), although there was only one female smoker.
There was a very high prevalence of H. pylori infection among the cases (81.5%) when
compared with the controls (69.9%) and a very high prevalence of a family history of peptic
ulcer disease among the cases (50.4%) when compared with the controls (17.4%).
Multivariate analysis of male workers identified age, family history, H. pylori infection and
cigarette smoking as significant predictors for duodenal ulcer and peptic ulcer. However,
among the females, where there was only one smoker, significant predictors were increasing
age, family history and H. pylori infection.
Wang et al. purported to show that, despite H. pylori infection being almost ubiquitous
within the population studied, male gender, increasing age, low socio-economic status, a
family history of ulcer and cigarette smoking remain risk factors for peptic ulcer. But the
high prevalence of H. pylori infection (81.5%) and cigarette smoking (up to 89% among male
workers with ulcers) in the study may have rendered these factors less specific predictors of
peptic ulcer (Rose 1985). Furthermore, Wang et al. did not examine the interaction between
H. pylori and smoking, so as to assess any effect modification due to smoking between
exposure to H. pylori infection and the outcome of peptic ulcer disease. A further limiting
factor, not restricted to the Wang et al. study, is that, while adjustment was made for the
presence of H. pylori infection, the adjustment did not extend to the specific H. pylori strain
characteristics, which may have an important influence on clinical outcomes (Blaser 1994).
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As did a number of others—such as Archimandritis et al. (1995) and Leoci et al. (1995)—
Wang et al. identified a family history of ulcer as a strong predictive factor for peptic ulcer
disease among both males and females. This is consistent with both the circumstantial
evidence suggestive of person-to-person transmission of H. pylori (Lin et al. 1994; Mitchell et
al. 1993b; Peach et al. 1997) and of genetic factors (Boren et al. 1994), which are evidenced by
H. pylori concordance being higher in monozygotic than dizygotic twins (Parsonnet 1998).
Lam et al. (1994a) reported on summary estimates and Kurata and Nogawa (1997) reported
on pooled estimates of relative risk for the three environmental risk factors—NSAID use,
cigarette smoking and H. pylori infection—for peptic ulcer disease. Lam et al. reported that
NSAID use (RR: 5.0) and cigarette smoking (RR: 5.0) carried a far higher risk for gastric
ulceration than did infection with H. pylori (RR: 1.0). On the other hand, for duodenal ulcer
disease it was cigarette smoking (RR: 2.0) and H. pylori infection (RR: 2.0) that carried a
higher risk than NSAID use (RR: 1.0).
Kurata and Nogawa used meta-analysis techniques to determine overall risk ratios and 95%
confidence intervals for each of the three main environmental risk factors for peptic ulcer
disease. The outcomes of interest for the H. pylori studies incorporated in the meta-analysis
were the presence or development of peptic ulcer and not past history or recurrence of ulcer.
Population-attributable risks were calculated for each of the major risk factors based on two
hypothetical models—no interaction between risk factors and interaction between risk
factors. The no-interaction model assumes that individuals are exposed to only one of the
three risk factors at a time and that the estimates for the population-attributable risk
percentages are additively combined.
The hypothetical interaction model assumes synergistic interaction and overlapping
exposure, producing results consistent with the idea that there are two common forms of
peptic ulcer: that associated with H. pylori infection and that associated with the use of
NSAIDs. This is based on the assumption that NSAIDs do not interact with either cigarette
smoking or H. pylori infection (Schubert et al. 1993) but that there is interaction between H.
pylori infection and cigarette smoking. Therefore, non-smokers who are H. pylori positive are
at increased risk and smokers who are H. pylori positive are at even greater risk. However,
those who smoke and are H. pylori negative are not at increased risk.
Overall, the Kurata and Nogawa interaction model appears the most consistent with the
literature review just discussed. This is supported by Borody et al. (1991), who examined 302
patients with an endoscopic diagnosis of duodenal ulcer and found 94% (284) to have
associated H. pylori gastritis. Of the 18 who were H. pylori negative, eight had been taking
NSAIDs and a further four had recently takeen of antibiotics. Similarly, in a later study of
115 patients with endoscopic diagnosis of gastric ulcer, 62% (71) had H. pylori infection
(Borody et al. 1992). Of these patients, 30% (21) were taking NSAIDs. Of the 44 H. pylori-
negative gastric ulcer cases, 66% (29) were taking NSAIDs. H. pylori infection and NSAID
use accounted for 87% (100) of the 115 gastric ulcer cases.
Revised aetiological fractions for tobacco and the onset of peptic ulcer disease
The Kurata and Nogawa (1997) interaction model was the basis for calculation of the
aetiological fraction. Data from Martin et al. (1989) were used to estimate relative risk for
those exposed to both H. pylori and smoking. Those who were H. pylori positive and who
smoked more than 10 cigarettes a day were 6.8 times more likely to develop peptic ulcer
than H. pylori-positive individuals who did not smoke. This is derived from the fact that 11
out of 15 smokers with H. pylori, as opposed to 13 out of 45 non-smokers with H. pylori, had
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duodenal and/or gastric ulcers. On the other hand, individuals who smoked and were
H. pylori negative were not at increased risk.
The product of the prevalence of H. pylori infection in the general population and the
smoking prevalence (10 or more cigarettes a day) for the general population provides an
estimate of the proportion of the general population who smoke and who are H. pylori
positive (Kurata & Nogawa 1997).
Table 4.1: Relative risk estimates for smoking and H. pylori exposure for peptic ulcer disease
H. pylori + Current smoker, ≥10
cigarettes per day
H. pylori+ and smoker
Sex Age RR 95% CI RR 95% CI RR 95% CI
Male All 3.3 2.6–4.4 1.9 1.7–2.1 6.8 1.8–25.2
Female All 3.3 2.6–4.4 2.3 1.9–2.7 6.8 1.8–25.2
Sources: H. pylori— Kurata and Nogawa 1997; current smoker—Kurata and Nogawa 1997; H. pylori and smoker—Martin et al. 1989.
Lin et al. (1998) estimated that the overall prevalence of H. pylori in the population of
Melbourne was 38% and increased with age from 18% at ages 20-30 years to 53% at ages
over 70 years. The prevalence of H. pylori was 48% in men and 30% in women. The rate of
acquisition of H. pylori infection was 1% per year.
Overall prevalence data from Lin et al. were disaggregated by sex so as to reflect the overall
48% prevalence in men and 30% prevalence in women across all the age groups examined in
the study (Table 4.2).
 Table 4.2: Prevalence of H. pylori infection among Australians, by age and sex, 1998
Age
Sex 20–30 31–40 41–50 51–60 61–70 >70 20 and over
(per cent)
Male 23 30 34 44 58 67 48
Female 14 19 21 28 36 42 30
Total 18 24 27 35 46 53 38
Source: Derived from Lin et al. 1998.
The estimates for the prevalence of current smokers (10 or more cigarettes a day) for the
general population are derived from the 1995 National Smoking and Health Survey
conducted by the Anti-cancer Council of Victoria and analysed by the Council’s Centre for
Behavioural Research in Cancer (Table 4.3).
Table 4.3: Proportion of the population smoking 10 or more cigarettes a day, by age and sex, 1995
Age
Sex 18–19 20–29 30–39 40–49 50–59 60–69 70+ 18 and over
(per cent)
Male 13.8 22.2 23.7 18.6 18.9 10.6 7.2 17.8
Female 21.4 23.8 21.7 16.7 16.8 11.2 4.7 17.1
Source: Unpublished data from the Anti-Cancer Council of Victoria’s Centre for Behavioural Research in Cancer.
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We used the product of the H. pylori infection prevalence from Table 4.2 and the smoking
prevalence from Table 4.3 to estimate the proportion of the population who smoke more
than 10 cigarettes per day and are H. pylori positive. This is the population prevalence figure
used in the aetiological fraction formula (Table 4.4).
The US National Institute of Health has reported 80% to 90% eradication of H. pylori as
achievable with a multi-drug regimen lasting two weeks (NIH 1994). We took 80% as a
conservative estimate of the proportion of people with H pylori infection who are
successfully treated. Accordingly, before determining the aetiological fraction, the H. pylori
prevalence cited above was scaled back by a factor of 0.20.
Overall, 9% of peptic ulcer disease among males and 6% among females is caused by the
interaction between H. pylori and smoking 10 or more cigarettes a day (Table 4.5).
Table 4.4: Proportion of the population who smoke 10 or more cigarettes per day
and who would remain H. pylori positive after therapy to eradicate H. pylori
infection
Age
Sex 20–30 31–40 41–50 51–60 61–70 >70 20 and over
Male 0.010 0.014 0.013 0.017 0.012 0.010 0.017
Female 0.007 0.008 0.007 0.009 0.008 0.004 0.010
Source: AIHW analysis of data in Tables 4.2 and 4.3.
Table 4.5: Revised aetiological fractions for tobacco exposure and peptic
ulcer disease
Age Males Females
Exposed
All ages 0.853 0.853
General population
20–24 0.056 0.037
25–29 0.056 0.037
30–34 0.076 0.046
35–39 0.076 0.046
40–44 0.068 0.039
45–49 0.068 0.039
50–54 0.088 0.052
55–59 0.088 0.052
60–64 0.067 0.045
65–69 0.067 0.045
70–74 0.053 0.022
75–79 0.053 0.022
80+ 0.053 0.022
Total (20+) 0.090 0.056
Source: AIHW analysis of data in Tables 4.1 and 4.4.
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Revised aetiological fractions for tobacco and death due to peptic ulcer
disease
An Australian case-control study that examined the association between, on the one hand,
individual co-existing illnesses, septicaemia, intra-abdominal abscess, marital status,
smoking and alcohol use and, on the other, mortality following perforated peptic ulcer
without pre-operative evidence of haemorrhage did not identify smoking as a risk factor for
mortality (McIntosh et al. 1996). The study found co-existing illnesses, septicaemia and intra-
abdominal abscess as the risk factors predictive of mortality following ulcer perforation.
More recently, in a study examining mortality within one month of peptic ulcer bleed,
elderly patients, those undergoing surgery, or those who were current users of acid-
suppressing drugs or NSAIDs were identified as at increased risk of mortality (Garcia
Rodriguez et al. 1998). After H. pylori, NSAIDs are thought to be the most important cause of
peptic ulcer disease and a major risk factor for ulcer complications and mortality (Kang
1995).
Overall, the mortality rate associated with peptic ulcer disease is in the main attributed to re-
bleeding among the elderly population, who also have more co-existing systemic diseases.
The majority of deaths, therefore, result from non-peptic ulcer diseases (Mueller et al. 1994).
This is reflected in one report—by Ng et al. (1994)—on peptic ulcer disease among the
people aged 60 years or more, which found that bleeding is a frequent and major
complication occurring among 50% of cases and perforation occurs among 2% of cases.
However, while mortality arising from bleeding peptic ulcers in this group is 11%, around
90% of this is due to concurrent medical conditions and only 10% arises directly from
bleeding ulcer. The concurrent medical conditions most frequently encountered were
hypertension and ischaemic heart disease (Ng et al. 1994).
We took 10% as our estimate of deaths coded to peptic ulcer disease that actually arose due
to bleeding peptic ulcer. Hence the attributable fractions in Table 4.5 should be reduced by a
factor of 10% when applied to deaths. This means that less than 1% of peptic ulcer deaths are
attributable to tobacco smoking.
4.2.3 Passive exposure to tobacco smoke and its health effects in
pregnancy and childhood
Environmental tobacco smoke (ETS) consists of exhaled mainstream and sidestream smoke.
In 1993 the National Health and Medical Research Council established a working party to
update the Council’s 1986 report Effects of Passive Smoking on Health. The final review
document (NHMRC 1997) made available a synthesis of relevant scientific knowledge on the
health effects of passive smoking. It contains the estimates that formed the basis for
quantifying and, where possible, revising the aetiological burden of ETS.
Exposure to passive smoking during pregnancy
Studies of women’s exposure to passive smoking during pregnancy show a small detriment
in birthweight among babies born to such women. The size of the effect is, however, small
(30–40g) and so may have little clinical significance for most infants overall but a more
marked significance among socially disadvantaged groups (NHMRC 1997).
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Passive smoking and sudden infant death syndrome
Current evidence supports the conclusion that there is a causal association between sudden
infant death syndrome (SIDS) and exposure to ETS. Nevertheless, the relative importance of
maternal smoking during pregnancy and exposure to ETS after birth remains unclear
(NHMRC 1997).
In examining whether or not postnatal exposure to ETS is associated with SIDS, the NHMRC
report identified eight studies (Bergman & Wieser 1976; Blair et al. 1996; Brooke et al. 1997;
Klonoff Cohen et al. 1995; McGlashan 1989; Mitchell et al. 1993a; Ponsonby et al. 1995;
Schoendorf & Kiely 1992), of which seven were case-control studies. Pooled estimates of
relative risk were, however, not reported. Consistent with later reports that parental
smoking (Henderson Smart et al. 1998), and in particular maternal smoking (Mitchell et al.
1997), were significantly associated with SIDS, a pooled estimate of relative risk was
determined from the study by Mitchell et al. (1997) and the three studies from the NHMRC
report (Klonoff Cohen et al. 1995; Ponsonby et al. 1995; Schoendorf & Kiely 1992) that
examined postnatal maternal smoking.
Table 4.6: Sudden infant death syndrome and maternal smoking
Study Country SIDS Controls
Confounders
controlled OR (95% CI)
Schoendorf and Kiely
1992
US 234 6,000 random Yes 1.75 (1.04–2.95
Klonoff Cohen et al.
1995
US 200 200 matched Yes 2.28 (1.04–4.96)
Ponsonby et al. 1995 Australia  58 101 matched Yes 3.82 (1.43–10.2)
Mitchell et al. 1997 NZ 232 1,200 random Yes 5.01 (2.01–12.46)
The pooled relative risk estimate was 2.44 (95% CI: 1.69–3.51). This compares with a pooled
estimate of relative risk of 2.76 (95% CI: 2.66–2.86) for any smoking during pregnancy, as
determined by English et al. (1995). Based on an exposure prevalence of 0.29 for smoking
during pregnancy, English et al. concluded that 0.338 or 34% of SIDS was attributable to this
exposure.
Revised aetiological fraction for postnatal ETS and SIDS
The estimate of relative risk used was the pooled estimate of 2.44. The proportion of infants
exposed to ETS was 0.126, based on the unpublished Victorian Anti-Cancer Council
prevalence estimate of 12.6% of households where exposure to maternal smoke among
children under 2 years old was likely to occur. This gave an aetiological fraction of 0.153, or
around half that estimated by English et al. This halving of the aetiological fraction for SIDS
is in the main due to the reduced prevalence of exposure to maternal smoking in the
postnatal context. This is because around 50% of female smokers with a child under 2 years
of age will not smoke in their home.
Passive smoking and asthma among children aged less than 15 years
The weight of evidence suggests that exposure to ETS is associated with asthma (ICD-9 code
493) in childhood (<15 years). In the main, it has been reported that exposure to ETS is
associated with an increase in morbidity in young people with pre-existing asthma,
although several studies have also reported an increase in the number of new cases of
asthma among children. Furthermore, exposure to ETS is associated with increased
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bronchial reactivity and the occurrence of atopy. The association of ETS with childhood
asthma is most consistent at high exposures, and the evidence is supportive of a causal
relationship (NHMRC 1997).
Aetiological fraction for passive smoking and asthma among children aged less
than 15 years
Studies of childhood asthma and passive smoking have commonly reported on the
association with heavy exposure (where mothers smoke more than 10 cigarettes a day). It is
less clear whether exposure to lower levels of ETS increases the risk of asthma. Accordingly,
children are defined as exposed if they had a mother who smoked more than 10 cigarettes a
day. This is comparable with the definition of exposure applied in some of the studies
reviewed in the NHMRC report. The 1989–90 ABS National Health Survey found that 22.2%
of children aged less than 15 years had mothers who smoked more than 10 cigarettes a day.
The NHMRC report based its aetiological fraction on this prevalence estimate. The
corresponding estimate from the 1995 National Health Survey was 21.3%.
The median of the 50 estimates of relative risk summarised from the peer-reviewed literature
in the NHMRC report was 1.40, with an inter-quartile range of 1.20–1.93. This estimate of
1.40 was used in the NHMRC report, along with the 1989–90 prevalence estimate of 0.222, to
derive an aetiological fraction of 0.082 for childhood asthma and ETS (NHMRC 1997).
We used the relative risk estimate of 1.40, but our prevalence estimate was taken from
unpublished results of the Victorian Anti-Cancer Council study described in Chapter 2. This
shows that the proportion of children aged less than 16 years who live in a household with a
female (assumed to be their mother) who smokes 10 or more cigarettes a day and who is not
restricted to smoking outdoors is 0.054. The aetiological fraction derived from these
estimates is 0.021. Again, the reduction in the fraction is a result of only some 25% of such
households allowing smoking indoors.
Passive smoking and lower respiratory illness among children under
18 months
‘Lower respiratory illness’ refers to the illnesses principally affecting the respiratory tract
below the epiglottis that correspond to ICD-9 codes 464, 466, 490, 480–486 and 487—but
excluding asthma, which is considered separately. The NHMRC report indicates that, based
on the peer-reviewed scientific literature, passive smoking is most strongly associated with
lower respiratory illness in early life—in particular, the first 18 months after birth. The
aetiological fraction calculation assumes that there is no increase in risk of lower respiratory
illness for children exposed to ETS if they are over the age of 18 months (NHMRC 1997).
Aetiological fraction for passive smoking and lower respiratory illness among
children aged less than 18 months
The median of the 26 estimates of relative risk from 25 published papers summarised in the
NHMRC report was 1.60, with an inter-quartile range of 1.40–2.10. The report’s estimate of
the proportion of children aged less than 18 months and exposed to maternal smoking was
0.25. This was the mid-point of a range of estimates from the research literature. These
estimates led to an aetiological fraction of 0.130 (NHMRC 1997).
We used the relative risk estimate of 1.60, but our exposure prevalence was based on the
Victorian Anti-Cancer Council study results. This study showed that the proportion of
children under 2 years who live in a household with a female (assumed to be their mother)
who smokes one or more cigarettes a day and who is not restricted to smoking outdoors was
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0.126. This led to an aetiological fraction of 0.070. Again, the reduction in the fraction is a
result of only some 50% of such households allowing smoking indoors.
Passive smoking and lung cancer among adults
The NHMRC report concluded that, despite inherent limitations, the available data on ETS
and lung cancer in humans were sufficiently strong to infer that ETS was a cause of the
disease. Summarising the quantitative data on the relationship was made difficult by the
differences in study methods adopted. However, restricting studies to those that examined
lung cancer among people who never smoked but had a spouse who smoked yielded 34
studies with a median relative risk of 1.32 and an inter-quartile range of 1.10–1.69 (NHMRC
(1997).
The 1998 European multicentre case-control study of lung cancer in non-smokers examined
exposure to spousal smoke among 344 cases and 700 controls and yielded an odds ratio of
1.16 (95% CI: 0.93–1.44). When study subjects were stratified by gender, the odds ratio for
exposure to spousal smoke was 1.47 (95% CI: 0.81–2.66) among men and 1.11 (95% CI: 0.88–
1.39) among women (International Agency for Research on Cancer 1998). The study
concluded there was some indication of an increasing risk of lung cancer with increasing
cumulative exposure to ETS from the spouse. No clear trend emerged for average exposure
or for years of exposure but, with duration of exposure expressed as the product of hours a
day and years of exposure, a positive dose response was shown.
Aetiological fraction for passive smoking and lung cancer among adults
The formula for the aetiological fraction used in the NHMRC report is more complex than
that described here in Chapter 2 and used throughout this report. The NHMRC (1997)
formula is:
( ) ( ) ] [[ ( ) ( ) ]{ }111111 +−+−+−−= ccxxssssn RRpRRpRRp
RRppF (1)
where
pn = prevalence of people never having smoked
px = prevalence of ex-smokers
pc = prevalence of current smokers
ps = people never having smoked but who have spouses that are current smokers.
The relative risk estimates for ex-smokers (RRx) and for current smokers (RRc) were those
derived by English et al. (1995). For males, these were RRx = 6.75 and RRc = 13.0; for females,
they were RRx = 5.07 and RRc =11.4. The relative risk for people who have never smoked but
who have spouses that are current smokers (RRs) was the median value found in the
NHMRC report RRs= 1.32.
Smoking prevalence data elsewhere in this report are based on the 1995 Victorian Anti-
Cancer Council study. However, these data do not support an analysis of people who have
never smoked but who have spouses who currently smoke. So the prevalence estimates for
this aetiological fraction (pn, px, pc and ps) are taken from the ABS 1995 National Health
Survey. As with other cancer fractions calculated in this report, estimates are calculated only
for ages 35 and over.
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Table 4.7: Proportion of people who have never smoked but who have spouses that are
current smokers
Year
Males Females
Age 1989–90 1995 1989–90 1995
(per cent)
35–39 11.09 4.0 17.83 15.3
40–44  7.03 2.0 19.89 9.8
45–49  9.18 2.3 20.81 6.9
50–54 11.14 1.6 15.02 10.5
55–59 10.16 0.4 14.39 8.0
60–64  8.03 1.4 15.27 8.1
65–69  4.10 3.7  7.78 7.3
70–74  6.86 3.9  2.99 5.2
75 and over  4.50 3.1  2.04 2.9
Source: 1989–90 data from ABS National Health Survey, as reported in NHMRC (1997); 1995 data derived from 1995 ABS National Health Survey.
Table 4.8: Proportion of the population who are current smokers, ex-smokers or have never
smoked, 1995
Males Females
Age Current smoker Ex-smoker Never smoked Current smoker Ex-smoker Never smoked
(per cent)
35–39 36.8 25.6 37.6 26.1 18.1 55.8
40–44 31.3 29.4 39.3 23.8 17.5 58.6
45–49 33.3 31.9 34.8 24.4 20.6 55.0
50–54 30.5 33.7 35.8 22.1 16.6 61.3
55–59 29.5 41.2 29.3 20.7 17.9 61.4
60–64 26.9 45.8 27.4 17.9 18.4 63.6
65–69 22.2 53.4 24.3 14.0 21.7 64.3
70–74 16.3 54.1 29.7 13.5 21.0 65.4
75–79 11.7 55.9 32.3 9.8 18.6 71.6
80+ 10.2 54.6 35.2 2.8 14.6 82.6
Source: Derived from 1995 ABS National Health Survey.
Passive smoking and cardiovascular disease among adults
The NHMRC report concluded that the evidence suggests that passive smoking increases
the risk of ischaemic heart disease and that this excess risk is apparent in both men and
women. While this relationship is unlikely to be explained by the confounding of passive
smoking with other risk factors, some evidence of publication bias was evident and the
excess risk of ischaemic heart disease in passive smokers appears large when compared with
the excess risk in active smokers (NHMRC 1997). Because of these anomalies, although
passive smoking appears to increase the risk of IHD, other non-causal explanations are
possible. Furthermore, there was insufficient evidence to determine whether ETS affects the
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risk of cerebrovascular disease or peripheral vascular disease. Therefore estimates of the
effects of passive smoking are restricted to heart attacks (ICD-9 410) and other deaths from
IHD (ICD-9 codes 411–414).
Table 4.9: People who have never smoked:
revised aetiological fraction for lung cancer
attributable to smoking by a spouse
Age Males Females
35–39 0.00083 0.00530
40–44 0.00041 0.00397
45–49 0.00048 0.00321
50–54 0.00028 0.00484
55–59 0.00007 0.00422
60–64 0.00021 0.00450
65–69 0.00051 0.00455
70–74 0.00050 0.00338
75–79 0.00016 0.00199
80 years and over 0.00103 0.00395
Source: AIHW analysis of prevalence data in Tables 4.7 and 4.8
and relative risk estimates reported by English et al. (1995).
Aetiological fraction for heart attacks and ischaemic heart disease among adults
The formula on page 83 was used for the aetiological fraction for heart attacks and IHD
among adults. The prevalence estimates were those presented in Tables 4.7 and 4.8. The
relative risk estimates for ex-smokers (RRx) and for current smokers (RRc) were those derived
by English et al. (1995). For males aged more than 65 years these were RRx = 1.45 and RRc =
3.06; for females aged more than 65, they were RRx = 0.93 and RRc = 1.67.
Table 4.10: People who have never smoked:
revised aetiological fractions for ischaemic
heart disease attributable to smoking by a
spouse
Age Males Females
30–34 0.0017 0.0143
35–39 0.0022 0.0113
40–44 0.0011 0.0081
45–49 0.0013 0.0063
50–54 0.0008 0.0095
55–59 0.0002 0.0080
60–64 0.0006 0.0084
65–69 0.0022 0.0096
70–74 0.0022 0.0071
75–79 0.0007 0.0037
80 years and over 0.0040 0.0059
Source: AIHW analysis of prevalence data in Tables 4.7 and 4.8
and relative risk estimates reported by English et al. (1995).
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4.2.4 Aetiological fractions for tobacco updated with recent
prevalence data
Where possible, all the aetiological fractions were revised to incorporate updated estimates
of the prevalence of tobacco consumption. The conditions just discussed were also based on
revised risk-ratio estimates. Table 4.11 lists the conditions that were revised to incorporate
updated estimates of the prevalence of tobacco consumption but that were based on the risk-
ratio estimates derived by English et al. (1995). Table 4.12 lists the values of the revised
aetiological fractions.
Most of the fractions listed in Table 4.11 involve a straightforward application of the risk-
ratio to the prevalence estimate derived from the Victorian Anti-Cancer Council study.
However, some of the calculations are more complex and require some explanation.
Table 4.11: Conditions for which aetiological fractions were based on the English et al. risk-ratio
estimates but were revised to incorporate updated estimates of prevalence
Condition Source of prevalence data
Oropharyngeal cancer Synthetic prevalence estimate
Oesophageal cancer Synthetic prevalence estimate
Stomach cancer Synthetic prevalence estimate
Anal cancer Synthetic prevalence estimate
Pancreatic cancer Synthetic prevalence estimate
Laryngeal cancer Synthetic prevalence estimate
Lung cancer Direct calculation
Endometrial cancer Synthetic prevalence estimate
Vulvar cancer Synthetic prevalence estimate
Penile cancer Synthetic prevalence estimate
Bladder cancer Synthetic prevalence estimate
Renal parenchymal cancer Synthetic prevalence estimate
Renal pelvic cancer Synthetic prevalence estimate
Respiratory carcinoma in situ Synthetic prevalence estimate
Ischaemic heart disease 1995 Anti-Cancer Council Survey
Chronic obstructive pulmonary disease Synthetic prevalence estimate
Parkinson’s disease 1995 Anti-Cancer Council Survey
Pulmonary circulation disease Same fraction as chronic obstructive pulmonary disease
Cardiac dysrhythmias Same fraction as ischaemic heart disease
Heart failure Derived from fraction for ischaemic heart disease
Stroke 1995 Anti-Cancer Council Survey
Atherosclerosis 1995 Anti-Cancer Council Survey
Pneumonia 1995 Anti-Cancer Council Survey
Crohn’s disease 1995 Anti-Cancer Council Survey
Ulcerative colitis 1995 Anti-Cancer Council Survey
Ectopic pregnancy 1995 Anti-Cancer Council Survey
Spontaneous abortion 1998 National Drug Strategy Household Survey
Antepartum haemorrhage 1998 National Drug Strategy Household Survey
Hypertension in pregnancy 1998 National Drug Strategy Household Survey
Low birthweight 1998 National Drug Strategy Household Survey
Premature rupture of membranes 1998 National Drug Strategy Household Survey
SIDS (and smoking during pregnancy) 1998 National Drug Strategy Household Survey
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Cancer and chronic obstructive pulmonary disease
Peto et al. (1992) derived an underlying rate of lung cancer among people who never
smoked in the United States. We assumed that this rate applied in Australia and used it to
derive the expected rate of lung cancer in the absence of smoking. Comparison of this with
the observed lung cancer rate gave us the proportion of lung cancer attributable to smoking.
We then used the Peto et al. estimates of lung cancer rates for smokers and non-smokers to
derive a synthetic smoking prevalence rate that represented the historical prevalence which
was consistent with the observed lung cancer rate. Finally, we combined this synthetic rate
with the risk ratios from English et al. to derive aetiological fractions for the remaining
cancers and chronic obstructive pulmonary disease.
Pulmonary circulation disease
We followed English et al. in applying the aetiological fraction for chronic obstructive
pulmonary disease to ICD-9 codes 415.0, 416 and 417 but excluding 415.1 (pulmonary
embolism). This approach is based on the assumption that chronic obstructive pulmonary
disease is the underlying pathology in the vast majority of cases of pulmonary circulatory
conditions other than embolism.
Cardiac dysrhythmias
We followed English et al. in assuming that most cardiac dysrhythmias in Australia—and
especially those causing sudden death or significant morbidity—are the result of ischaemic
heart disease.
Heart failure
We followed English et al. in apportioning heart failure conditions between ischaemic heart
disease and other specific heart disease codes, in accordance with the proportional
distribution of mortality or morbidity associated with the specific condition. The other
specific heart conditions are not caused by cigarette smoking and so have aetiological
fractions of zero. Hence the aetiological fraction for ischaemic heart disease was then
applied to the relevant proportion of heart failure cases while the remainder were discarded.
Ectopic pregnancy
We followed English et al. in applying the prevalence of smoking in the general population
rather among for pregnant women on the grounds that many women give up smoking after
the time of conception.
Spontaneous abortion
English et al. derived a risk ratio and a fraction for the effect of tobacco on spontaneous
abortion. We updated their fraction. However, during the period 1996 to 1998 there were no
deaths coded to spontaneous abortion and no hospital stays longer than the average normal
confinement. Hence if we do not count the separations, as recommended by English et al.,
this condition makes no contribution to the attributable mortality or hospital morbidity. The
fractions are given in Table 4.12, but this condition has been excluded from the tables of
results.
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4.3 Unrevised aetiological fractions for tobacco
Only two conditions were left with unrevised fractions. The first was tobacco abuse, which
has a fraction value of one by definition. The second was fire injuries. English et al. derived a
fraction of 0.23 based on six case series of fire injuries. In the absence of better or more recent
data, we used the same estimate.
Table 4.12: Revised values for tobacco fractions based on the English et al. risk-ratio estimates and
updated prevalence data
1. Fractions updated with synthetic prevalence data derived using the Peto et al. method
Oropharyngeal cancer (ICD-9 codes 141, 143–146, 148, 149)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.43 0.78 0.71 0.92 0.83 0.43 0.78 0.71 0.92 0.83
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.302 0.280
45–49 0.533 0.261
50–54 0.479 0.412
55–59 0.513 0.435
60–64 0.570 0.443
65–69 0.584 0.453
70–74 0.583 0.523
75–79 0.548 0.470
80+ 0.569 0.445
Total (35+) 0.464 0.361
Oesophageal cancer (ICD-9 code 150)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.44 0.75 0.69 0.75 0.80 0.44 0.75 0.69 0.75 0.80
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.269 0.248
45–49 0.492 0.230
50–54 0.438 0.373
55–59 0.472 0.395
60–64 0.529 0.403
65–69 0.544 0.413
70–74 0.543 0.482
75–79 0.507 0.429
80+ 0.528 0.405
Total (35+) 0.423 0.324
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Stomach cancer (ICD-9 code 151)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.10 0.29 0.61 0.55 0.68 0.10 0.29 0.61 0.55 0.68
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.048 0.043
45–49 0.117 0.039
50–54 0.096 0.075
55–59 0.109 0.082
60–64 0.133 0.084
65–69 0.140 0.087
70–74 0.139 0.112
75–79 0.123 0.093
80+ 0.132 0.085
Total (35+) 0.091 0.061
Anal cancer (ICD-9 codes 154.2, 154.3)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.45 0.69 0.53 0.78 0.45 0.69 0.53 0.78
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.210 0.193
45–49 0.412 0.178
50–54 0.361 0.301
55–59 0.393 0.321
60–64 0.449 0.328
65–69 0.463 0.337
70–74 0.462 0.403
75–79 0.427 0.352
80+ 0.448 0.330
Total (35+) 0.347 0.258
Note: There were no studies on which to base a risk-ratio estimate for people smoking 15–24 cigarettes a day.
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Pancreatic cancer (ICD-9 code 157)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.13 0.46 0.39 0.41 0.49 0.13 0.46 0.39 0.41 0.49
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.095 0.086
45–49 0.217 0.079
50–54 0.182 0.145
55–59 0.203 0.157
60–64 0.243 0.162
65–69 0.254 0.167
70–74 0.253 0.210
75–79 0.227 0.177
80+ 0.242 0.163
Total (35+) 0.173 0.120
Laryngeal cancer (ICD-9 code 161)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.65 0.87 0.77 0.83 0.92 0.65 0.87 0.77 0.83 0.92
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.442 0.415
45–49 0.676 0.391
50–54 0.626 0.561
55–59 0.658 0.584
60–64 0.708 0.592
65–69 0.719 0.602
70–74 0.719 0.667
75–79 0.689 0.618
80+ 0.707 0.594
Total (35+) 0.613 0.508
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Lung cancer (ICD-9 code 162)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.85 0.92 0.85 0.88 0.93 0.80 0.91 0.87 0.92 0.95
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.449 0.247
45–49 0.659 0.528
50–54 0.798 0.644
55–59 0.866 0.732
60–64 0.906 0.743
65–69 0.920 0.781
70–74 0.927 0.788
75–79 0.917 0.743
80+ 0.903 0.646
Total (35+) 0.903 0.646
Endometrial cancer (ICD-9 codes 179, 182)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages — — — — — –0.10 –0.89 — — —
General population All levels of exposure All levels of exposure
35–39 – 0.000
40–44 — 0.000
45–49 — 0.000
50–54 — –0.102
55–59 — –0.114
60–64 — –0.118
65–69 — –0.123
70–74 — –0.170
75–79 — –0.133
80+ — –0.119
Total (35+) — –0.081
Note: The evidence for the effect of smoking on endometrial cancer supports only estimation of the effect for post-menopausal women. We followed
English et al. in assuming that this corresponds to women aged 50 and over. There were no studies that allowed the separate estimation of risk
ratios by numbers of cigarettes smoked per day for post-menopausal women.
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Vulvar cancer (ICD-9 code 184.4)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages — — — — — 0.27 0.71 0.70 — 0.83
General population All levels of exposure All levels of exposure
35–39 — 0.000
40–44 — 0.209
45–49 — 0.194
50–54 — 0.323
55–59 — 0.344
60–64 — 0.352
65–69 — 0.361
70–74 — 0.428
75–79 — 0.376
80+ — 0.353
Total (35+) — 0.278
Note: There were no studies on which to base a risk-ratio estimate for people smoking 15–24 cigarettes a day
Penile cancer (ICD-9 codes 187.1–187.4)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.38 0.44 0.15 0.55 0.68 — — — — —
General population All levels of exposure All levels of exposure
35–39 0.000 —
40–44 0.089 —
45–49 0.205 —
50–54 0.171 —
55–59 0.192 —
60–64 0.230 —
65–69 0.241 —
70–74 0.240 —
75–79 0.215 —
80+ 0.229 —
Total (35+) 0.163 —
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Bladder cancer (ICD-9 code 188)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.40 0.63 0.49 0.69 0.66 0.40 0.63 0.49 0.69 0.66
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.174 0.158
45–49 0.356 0.146
50–54 0.308 0.254
55–59 0.338 0.272
60–64 0.391 0.278
65–69 0.405 0.286
70–74 0.404 0.347
75–79 0.370 0.300
80+ 0.390 0.280
Total (35+) 0.296 0.215
Renal parenchymal cancer (ICD-9 code 189.0)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.38 0.39 0.15 0.24 0.39 0.38 0.39 0.15 0.24 0.39
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.072 0.065
45–49 0.171 0.060
50–54 0.142 0.112
55–59 0.160 0.122
60–64 0.193 0.125
65–69 0.202 0.130
70–74 0.201 0.165
75–79 0.180 0.138
80+ 0.192 0.126
Total (35+) 0.135 0.092
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Renal pelvic cancer (ICD-9 code 189.1)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.49 0.75 — — — 0.49 0.75 — — —
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.265 0.245
45–49 0.488 0.227
50–54 0.434 0.369
55–59 0.468 0.391
60–64 0.525 0.399
65–69 0.540 0.408
70–74 0.538 0.478
75–79 0.503 0.425
80+ 0.524 0.401
Total (35+) 0.419 0.320
Respiratory carcinoma in situ (ICD-9 code 231)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.85 0.92 0.85 0.88 0.93 0.80 0.91 0.87 0.92 0.95
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.449 0.247
45–49 0.659 0.528
50–54 0.798 0.644
55–59 0.866 0.732
60–64 0.906 0.743
65–69 0.920 0.781
70–74 0.927 0.788
75–79 0.917 0.743
80+ 0.903 0.646
Total (35+) 0.903 0.646
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Chronic obstructive pulmonary disease (ICD-9 codes 490–492, 496)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.85 0.90 0.85 0.79 0.79 0.85 0.90 0.85 0.79 0.79
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.518 0.491
45–49 0.739 0.466
50–54 0.695 0.635
55–59 0.723 0.656
60–64 0.767 0.664
65–69 0.777 0.672
70–74 0.776 0.731
75–79 0.751 0.687
80+ 0.766 0.665
Total (35+) 0.682 0.583
Pulmonary circulation disease (ICD-9 codes 415.0, 416, 417)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.85 0.90 0.85 0.79 0.79 0.85 0.90 0.85 0.79 0.79
General population All levels of exposure All levels of exposure
35–39 0.000 0.000
40–44 0.518 0.491
45–49 0.739 0.466
50–54 0.695 0.635
55–59 0.723 0.656
60–64 0.767 0.664
65–69 0.777 0.672
70–74 0.776 0.731
75–79 0.751 0.687
80+ 0.766 0.665
Total (35+) 0.682 0.583
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2. Fractions updated with prevalence data derived from the 1995 Anti-Cancer Council Survey
Ischaemic heart disease (ICD-9 codes 410–414)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
Under 65 0.31 0.67 0.60 0.69 0.73 0.31 0.67 0.60 0.69 0.73
65 + 0.11 0.40 — — — 0.11 0.40 — — —
General population
18–19 0.016 0.415 0.244 0.127 0.000 0.035 0.424 0.221 0.124 0.059
20–24 0.032 0.390 0.154 0.126 0.095 0.039 0.395 0.128 0.123 0.134
25–29 0.046 0.398 0.154 0.101 0.106 0.042 0.401 0.156 0.117 0.103
30–34 0.057 0.388 0.092 0.086 0.222 0.060 0.380 0.127 0.111 0.145
35–39 0.072 0.351 0.058 0.100 0.205 0.069 0.317 0.101 0.112 0.105
40–44 0.075 0.356 0.060 0.080 0.186 0.063 0.332 0.078 0.116 0.153
45–49 0.088 0.323 0.045 0.084 0.206 0.077 0.218 0.041 0.060 0.135
50–54 0.088 0.350 0.099 0.089 0.157 0.069 0.281 0.072 0.113 0.124
55–59 0.101 0.329 0.072 0.082 0.187 0.073 0.254 0.069 0.093 0.094
60–64 0.144 0.234 0.047 0.049 0.112 0.067 0.217 0.062 0.107 0.052
Total (<65) 0.070 0.358 0.098 0.094 0.159 0.059 0.331 0.105 0.109 0.118
65–69 0.052 0.102 — — — 0.022 0.086 — — —
70–74 0.056 0.081 — — — 0.029 0.049 — — —
75–79 0.056 0.081 — — — 0.029 0.049 — — —
80+ 0.056 0.081 — — — 0.029 0.049 — — —
Total (65+) 0.055 0.088 — — — 0.027 0.059 — — —
Note: There were no data on which to base estimates of risk ratios for different levels of consumption at ages 65 and over.
Parkinson’s disease (ICD-9 code 332)
Male Female
Age Ever smoked cigarettes Ever smoked cigarettes
Exposed
All ages — — –0.75 — — — — –0.75 — —
General population
18–19 — — –0.218 — — — — –0.291 — —
20–24 — — –0.241 — — — — –0.268 — —
25–29 — — –0.295 — — — — –0.287 — —
30–34 — — –0.325 — — — — –0.322 — —
35–39 — — –0.328 — — — — –0.273 — —
40–44 — — –0.345 — — — — –0.272 — —
45–49 — — –0.346 — — — — –0.202 — —
50–54 — — –0.390 — — — — –0.237 — —
55–59 — — –0.408 — — — — –0.222 — —
60–64 — — –0.425 — — — — –0.181 — —
65–69 — — –0.425 — — — — –0.181 — —
70–74 — — –0.418 — — — — –0.171 — —
75–79 — — –0.418 — — — — –0.171 — —
80+ — — –0.418 — — — — –0.171 — —
Total (18+) — — –0.327 — — — — –0.232 — —
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Cardiac dysrhythmias (ICD-9 code 427)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
Under 65 0.31 0.67 0.60 0.69 0.73 0.31 0.67 0.60 0.69 0.73
65 + 0.11 0.40 — — — 0.11 0.40 — — —
General population
18–19 0.016 0.415 0.244 0.127 0.000 0.035 0.424 0.221 0.124 0.059
20–24 0.032 0.390 0.154 0.126 0.095 0.039 0.395 0.128 0.123 0.134
25–29 0.046 0.398 0.154 0.101 0.106 0.042 0.401 0.156 0.117 0.103
30–34 0.057 0.388 0.092 0.086 0.222 0.060 0.380 0.127 0.111 0.145
35–39 0.072 0.351 0.058 0.100 0.205 0.069 0.317 0.101 0.112 0.105
40–44 0.075 0.356 0.060 0.080 0.186 0.063 0.332 0.078 0.116 0.153
45–49 0.088 0.323 0.045 0.084 0.206 0.077 0.218 0.041 0.060 0.135
50–54 0.088 0.350 0.099 0.089 0.157 0.069 0.281 0.072 0.113 0.124
55–59 0.101 0.329 0.072 0.082 0.187 0.073 0.254 0.069 0.093 0.094
60–64 0.144 0.234 0.047 0.049 0.112 0.067 0.217 0.062 0.107 0.052
Total (<65) 0.070 0.358 0.098 0.094 0.159 0.059 0.331 0.105 0.109 0.118
65–69 0.052 0.102 — — — 0.022 0.086 — — —
70–74 0.056 0.081 — — — 0.029 0.049 — — —
75–79 0.056 0.081 — — — 0.029 0.049 — — —
80+ 0.056 0.081 — — — 0.029 0.049 — — —
Total (65+) 0.055 0.088 — — — 0.027 0.059 — — —
Atherosclerosis (ICD-9 codes 440–448)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.45 0.61 0.49 0.61 0.61 0.45 0.61 0.49 0.61 0.61
General population
18–19 0.032 0.342 0.180 0.104 0.000 0.069 0.344 0.166 0.104 0.039
20–24 0.063 0.314 0.115 0.104 0.062 0.076 0.317 0.096 0.102 0.089
25–29 0.089 0.317 0.115 0.083 0.069 0.083 0.321 0.116 0.098 0.068
30–34 0.110 0.306 0.070 0.073 0.150 0.114 0.298 0.095 0.093 0.096
35–39 0.135 0.271 0.044 0.084 0.136 0.128 0.243 0.074 0.091 0.068
40–44 0.141 0.274 0.044 0.066 0.121 0.119 0.256 0.058 0.096 0.100
45–49 0.162 0.244 0.034 0.070 0.135 0.138 0.162 0.029 0.048 0.085
50–54 0.163 0.266 0.073 0.073 0.103 0.127 0.213 0.052 0.092 0.080
55–59 0.184 0.246 0.054 0.068 0.123 0.133 0.191 0.049 0.074 0.059
60–64 0.247 0.165 0.033 0.038 0.069 0.123 0.162 0.044 0.084 0.032
65–69 0.247 0.165 0.035 0.064 0.042 0.123 0.162 0.054 0.000 0.081
70–74 0.268 0.131 0.031 0.017 0.047 0.160 0.092 0.031 0.017 0.031
75–79 0.268 0.131 0.031 0.017 0.047 0.160 0.092 0.031 0.017 0.031
80+ 0.268 0.131 0.031 0.017 0.047 0.160 0.092 0.031 0.017 0.031
Total (18+) 0.145 0.257 0.063 0.068 0.096 0.112 0.232 0.071 0.077 0.070
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Pneumonia (ICD-9 codes 480–487)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.22 0.32 0.31 0.24 0.36 0.22 0.32 0.31 0.24 0.36
General population
18–19 0.015 0.140 0.103 0.026 0.000 0.034 0.147 0.097 0.026 0.017
20–24 0.030 0.129 0.066 0.026 0.027 0.037 0.132 0.055 0.026 0.039
25–29 0.044 0.134 0.065 0.020 0.030 0.040 0.136 0.067 0.024 0.030
30–34 0.054 0.130 0.041 0.018 0.066 0.056 0.126 0.055 0.023 0.042
35–39 0.066 0.114 0.025 0.021 0.059 0.060 0.099 0.041 0.022 0.028
40–44 0.069 0.116 0.025 0.016 0.051 0.056 0.105 0.033 0.023 0.043
45–49 0.079 0.102 0.019 0.017 0.057 0.061 0.062 0.015 0.011 0.034
50–54 0.081 0.115 0.041 0.018 0.044 0.058 0.085 0.029 0.022 0.033
55–59 0.092 0.106 0.030 0.016 0.052 0.060 0.074 0.026 0.017 0.024
60–64 0.120 0.069 0.017 0.008 0.027 0.054 0.061 0.023 0.019 0.013
65–69 0.120 0.069 0.018 0.014 0.017 0.054 0.061 0.028 0.000 0.031
70–74 0.129 0.055 0.016 0.004 0.018 0.068 0.034 0.015 0.004 0.011
75–79 0.129 0.055 0.016 0.004 0.018 0.068 0.034 0.015 0.004 0.011
80+ 0.129 0.055 0.016 0.004 0.018 0.068 0.034 0.015 0.004 0.011
Total (18+) 0.070 0.108 0.035 0.016 0.040 0.052 0.092 0.039 0.018 0.029
Crohn’s disease (ICD-9 code 555)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.48 0.48 0.32 0.84 0.61 0.38 0.69 0.77 0.89 0.67
General population
18–19 0.041 0.236 0.078 0.306 0.000 0.044 0.443 0.312 0.293 0.027
20–24 0.081 0.213 0.048 0.299 0.052 0.049 0.413 0.198 0.318 0.067
25–29 0.113 0.215 0.050 0.249 0.060 0.053 0.419 0.238 0.299 0.050
30–34 0.139 0.205 0.031 0.218 0.131 0.075 0.395 0.202 0.295 0.074
35–39 0.167 0.178 0.019 0.243 0.115 0.087 0.332 0.163 0.302 0.055
40–44 0.174 0.181 0.019 0.197 0.106 0.080 0.346 0.129 0.320 0.081
45–49 0.197 0.158 0.015 0.207 0.116 0.097 0.229 0.079 0.195 0.084
50–54 0.201 0.174 0.032 0.220 0.090 0.087 0.295 0.119 0.315 0.066
55–59 0.224 0.159 0.024 0.205 0.107 0.092 0.266 0.120 0.268 0.052
60–64 0.287 0.102 0.015 0.121 0.064 0.086 0.229 0.104 0.300 0.028
65–69 0.287 0.102 0.015 0.192 0.037 0.086 0.229 0.165 0.000 0.089
70–74 0.307 0.080 0.015 0.057 0.046 0.117 0.136 0.094 0.080 0.034
75–79 0.307 0.080 0.015 0.057 0.046 0.117 0.136 0.094 0.080 0.034
80+ 0.307 0.080 0.015 0.057 0.046 0.117 0.136 0.094 0.080 0.034
Total (18+) 0.178 0.168 0.028 0.206 0.085 0.076 0.317 0.165 0.266 0.059
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Ulcerative colitis (ICD-9 code 556)
Male Female
Ex-
smoker Current smoker (cigarettes per day)
Ex-
smoker Current smoker (cigarettes per day)
Age All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages 0.42 –0.59 –0.20 –1.17 –9.00 0.42 –0.59 –0.20 –1.17 –9.00
General population
18–19 0.048 –0.143 –0.049 –0.055 0.000 0.106 –0.147 –0.049 –0.059 –0.037
20–24 0.091 –0.125 –0.032 –0.057 –0.057 0.110 –0.128 –0.028 –0.057 –0.083
25–29 0.130 –0.128 –0.032 –0.044 –0.061 0.121 –0.131 –0.033 –0.053 –0.062
30–34 0.157 –0.121 –0.021 –0.042 –0.146 0.161 –0.116 –0.028 –0.052 –0.089
35–39 0.181 –0.101 –0.012 –0.046 –0.125 0.163 –0.086 –0.019 –0.045 –0.056
40–44 0.190 –0.103 –0.012 –0.033 –0.103 0.154 –0.092 –0.016 –0.051 –0.088
45–49 0.207 –0.087 –0.009 –0.036 –0.117 0.153 –0.050 –0.007 –0.021 –0.063
50–54 0.218 –0.099 –0.020 –0.038 –0.090 0.153 –0.071 –0.013 –0.046 –0.066
55–59 0.238 –0.088 –0.015 –0.036 –0.107 0.155 –0.061 –0.012 –0.034 –0.045
60–64 0.280 –0.052 –0.007 –0.016 –0.049 0.136 –0.050 –0.010 –0.036 –0.023
65–69 0.280 –0.052 –0.008 –0.027 –0.030 0.136 –0.050 –0.012 0.000 –0.057
70–74 0.290 –0.039 –0.006 –0.007 –0.031 0.160 –0.026 –0.006 –0.007 –0.020
75–79 0.290 –0.039 –0.006 –0.007 –0.031 0.160 –0.026 –0.006 –0.007 –0.020
80+ 0.290 –0.039 –0.006 –0.007 –0.031 0.160 –0.026 –0.006 –0.007 –0.020
Total (18+) 0.189 –0.093 –0.016 –0.034 –0.080 0.139 –0.080 –0.018 –0.037 –0.057
Ectopic pregnancy (ICD-9 codes 633, 761.4)
Age Male Female
Ex-
smoker
Current smoker (cigarettes per day) Ex-
smoker
Current smoker (cigarettes per day)
All 1–14 15–24 25+ All 1–14 15–24 25+
Exposed
All ages — — — — — 0.21 0.32 0.29 0.09 0.17
General population
18–19 — — — — — 0.032 0.144 0.090 0.009 0.006
20–24 — — — — — 0.035 0.130 0.052 0.008 0.015
25–29 — — — — — 0.038 0.133 0.062 0.008 0.011
30–34 — — — — — 0.053 0.125 0.051 0.008 0.016
35–39 — — — — — 0.057 0.098 0.038 0.007 0.011
40–44 — — — — — 0.053 0.103 0.031 0.008 0.016
45–49 — — — — — 0.057 0.061 0.014 0.003 0.012
50–54 — — — — — 0.055 0.083 0.027 0.007 0.012
55–59 — — — — — — — — — —
60–64 — — — — — — — — — —
65–69 — — — — — — — — — —
70–74 — — — — — — — — — —
75–79 — — — — — — — — — —
80+ — — — — — — — — — —
Total (18+) — — — — — 0.048 0.108 0.038 0.008 0.014
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3. Fractions updated with prevalence data derived from
the 1998 National Drug Strategy Household Survey
Spontaneous abortion: female only
(ICD-9 codes 634, 761.8)
Any level of exposure
Exposed
All ages 0.26
General population
All ages 0.091
Antepartum haemorrhage: females and newborn
males (ICD-9 codes 640, 641, 762.0, 762.1)
Any level of exposure
Exposed
All ages 0.38
General population
All ages 0.148
Hypertension in pregnancy: females and newborn
males (ICD-9 codes 642, 760.0)
Any level of exposure
Exposed
All ages –0.28
General population
All ages –0.065
Low birthweight: females and newborn males
(ICD-9 codes 656.5, 764, 765)
Any level of exposure
Exposed
All ages 0.51
General population
All ages 0.225
Premature rupture of membranes: females and
newborn males (ICD-9 codes 658.1, 658.2, 761.1)
Any level of exposure
Exposed
All ages 0.48
General population
All ages 0.206
SIDS (and smoking during pregnancy), males and
females aged less than 5 years (ICD-9 code 798.0)
Any level of exposure
Exposed
All ages 0.64
General population
All ages 0.329
84
5 Illicit drugs
5.1 Introduction
In this chapter we are concerned with quantifying morbidity and mortality in Australia
caused by the following groups of illicit drugs:
• cannabis—for, example marijuana and hashish;
• opiates—for example heroin;
• stimulants—for, example cocaine and amphetamines;
• hallucinogens—for example LSD;
• anabolic steroids.
A full discussion of these drugs is beyond the scope of this report. We adopted the approach
of English et al.—a full discussion of illicit drugs and aetiological fractions can be found in
their report (1995, pp. 497–513).
The majority of conditions associated with illicit drugs have an aetiological fraction of one
by definition. In other words, the illicit drug use is the only cause of the condition. This
means that no fraction value needs to be estimated. These are conditions that are defined by
association with an illicit drug—opiate dependence is an example. They are listed in Table
5.1. In cases where a fraction is estimated, the relevant prevalence data are presented along
with the discussion of the fraction value.
The only condition related to illicit drug use for which we estimated a new risk-ratio was
road injuries. English et al. did not calculate a fraction for road injuries because of the lack of
Australian studies. They found that the great majority of relevant studies were conducted in
the United States and were inappropriate as the basis of an Australian aetiological fraction
because of the different prevalence and patterns of drug use. We found more recent
Australian data on which to base risk-ratio and prevalence estimates.
We found prevalence data to update the fractions for drug-related cases of antepartum
haemorrhage and low birthweight. We also updated the fraction for HIV/AIDS cases related
to injecting drug use based on the most recent data from the Australian HIV Surveillance
Report (National Centre in HIV Epidemiology and Clinical Research 1998). The remaining
fractions were left at the values estimated by English et al.
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Table 5.1: Conditions associated with illicit drug use that have an aetiological
fraction of one
Condition ICD-9 code
Directly attributable to opiates
Opiate dependence 304.0, 304.7
Opiate abuse 305.5
Opiate poisoning 965.00, 965.01, 965.02(a)
Accidental opiate poisoning E850.0, E850.1(b)
 Directly attributable to other illicit drugs
Cannabis dependence 304.3
Cannabis abuse 305.2
Amphetamine dependence 304.4
Amphetamine abuse 305.7
Cocaine dependence 304.2
Cocaine abuse 305.6
Psychostimulant poisoning 969.7(a)
Accidental poison by psychostimulants E854.2(b)
Hallucinogen dependence 304.5
Hallucinogen abuse 305.3
Hallucinogen poisoning 969.6(a)
Other psychotropic drug poisoning 969.8, 969.9(a)
Accidental poisoning by hallucinogens E854.1(b)
Anabolic steroid poisoning 962.1(a)
Other related causes
Drug psychoses 292
Maternal drug dependence 648.3
Newborn drug toxicity 760.7, 779.5
(a) Chapter 17 code used only for calculating numbers of drug-caused hospital episodes and patient days.
(b) E code used only for calculating numbers of drug-caused deaths and PYLL.
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5.2 Revised aetiological fractions for illicit drugs
5.2.1 Illicit drug use and road injuries
English et al. found several case series of road injuries that presented data on the proportion
of cases exposed to illicit drugs. Only one paper (McLean et al. 1987) was of Australian
origin, and it dealt with only a small number of exposed cases. English et al. noted,
As the prevalence and patterns of drug use, particularly cocaine, are very different in
the USA compared with Australia, it would be inappropriate to generalise the results of
these studies to the Australian population…Therefore, no attempt has been made to
pool study results, or to apply them to Australian road injury data. (1995, p. 574)
They did not derive an aetiological fraction for illicit drugs and road injury deaths.
Revised aetiological fractions for illicit drugs and road injuries
Responsibility analysis is a methodology used to make an assessment of the driver’s
culpability, or responsibility, in an accident. Factors (such as the condition of a road,
adherence to road laws, and fatigue) mitigating a driver’s responsibility in each accident are
identified and scored. Given a sufficient number of mitigating circumstances, a driver could
be found to be either partly or totally exonerated from blame and scored as either a
contributory or a non-culpable driver. If drugs present in a driver contributed to accident
causation, it would be expected that they would be over-represented among culpable drivers
(those drivers whose culpability score does not exonerate them from blame) (Robertson &
Drummer 1994).
Drummer (1994) combined death data from separate studies for New South Wales, Victoria
and Western Australia covering the period 1990 to 1993 to determine the culpability of
drivers killed in road traffic accidents, so as to determine if drug use by drivers contributed
to accident causation. The basis of this analysis was to determine the culpability of drivers
after the review of eight mitigating factors in the absence of knowledge of the involvement
of drugs in the accident or the presence of drugs in the body fluids of the deceased. Drivers
were grouped into categories, based on predetermined responsibility guidelines, as culpable,
contributory and non-culpable. The culpability ratio is defined as the ratio of the number of
drivers in the culpable group to the number of drivers in the non-culpable group.
Overall, 1,045 drivers were included in the analysis, representing 57% of all driver deaths
occurring during the period. The exclusions were largely due to a lack of toxicology data or
insufficient information for the purpose of assessing responsibility.
Alcohol was present in 36% of cases; illicit drugs were detected in 22% of cases. Of the illicit
drugs, cannabis was the most common (11%), followed by amphetamines and related
stimulants (3.7%), benzodiazepines (3.1%), and opiates (2.7%). In one case cocaine
metabolites were detected in the urine.
Responsibility analysis showed that in 73% of the accidents the driver was culpable and in
18% not culpable. Drivers who had both alcohol and drugs of any type were more at risk
than the control group, but no more so than the alcohol-only group. Drivers with drugs only
had a slightly higher culpability ratio than the drug-free group, but this was not statistically
significant. No differences were evident when the data were broken down by State.
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Drivers aged less than 25 years and over 60 years had significantly higher (p<0.05)
culpability ratios than did drivers aged 26–59 years. Culpability ratios for drug-free drivers
aged 18–25 years and 26–59 years were 3.2 and 1.8, respectively, compared with an overall
mean culpability ratio of 2.4 for drug-free drivers.
Table 5.2 provides a summary of the demographic information available for the drivers
included in Drummer’s responsibility analysis and gives a breakdown of both licit and illicit
substances detected by toxicology. Alcohol, cannabis and stimulants were more frequently
found among drivers aged less than 25 years.
Table 5.2: Age and sex of drivers included in responsibility analysis
Drug class Mean age Age range Percentage of females
All drivers 34 ± 15 15 – 87 22.0
Alcohol 31 ± 12 16 – 78 10.0
Cannabis 25 ± 6 15 – 47 8.9
Benzodiazepines 40 ± 18 21 – 80 28.0
Amphetamines and related timulants 29 ± 11 18 – 73 13.0
Opiates 36 ± 14 16 – 75 32.0
Miscellaneous drugs 46 ± 20 16 – 87 29.0
Source: Drummer 1994.
The 138 cases involving drugs other than alcohol had a culpability ratio of 3.3. There were
112 cannabis cases in total. The 43 cannabis cases not involving alcohol or any other
psychoactive drug had a culpability ratio of 1.5, which was half that for the control group
(p<0.05).
Of the 39 cases involving amphetamines and related stimulants, 33 were culpable (p<0.05),
although 10 of these cases also involved alcohol. Of the 21 drivers among whom only
stimulants were detected as the psychoactive drug, the culpability ratio of 4.0 was not
significantly different from that of the control group (p>0.05).
Of the 28 cases involving opiates, only 13 did not involve another psychoactive drug. For the
opiate-only cases, the culpability ratio was 5.5 which again was not significantly different
from that of the control group (p>0.05).
Culpability ratios showed an age dependence. For example, for drug-free drivers, the
highest culpability ratios were among the under 25 and over 60 age groups, whereas those
aged 26–35 and 35–39 years had less than average culpability scores.
Table 5.3: Culpability score for drivers involved in motor vehicle accidents, by drug class
Drug class Number Culpable Contributor Nonculpable Ratio
Drug free 532 339 53 140 2.4
Cannabis only 43 21  8 14 1.5
Stimulants only 21 16  1  4 4.0
Opiates only 13 11  0  2 5.5
 Source: Drummer 1994.
Drummer calculated relative risk and confidence intervals for all accident deaths by
dividing the culpability ratio of the drug group by the culpability ratio of the drug-free
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(control) group. The statistical methodology used was that of Fischer’s exact test. The results
are shown in Table 5.4.
Table 5.4: Relative risk and confidence intervals for drivers involved in motor vehicle accidents
Drug group Number Culpability ratio Relative risk 95% CI
Drug free 532 2.4 1.0 —
Cannabis only  43 1.5 0.6 0.3–1.2
Stimulants only  21 4.0 1.6 0.5–5.0
Opiates only  13 5.5 2.3 0.5–10.0
Source: Drummer 1994.
None of the risk estimates in Table 5.4 is statistically significant. For both stimulants and
opiates, this may simply be a function of the small numbers of cases available, leading to an
inability to detect a significant difference. Sample size calculations suggest that for opiates a
sample size of 1,500 cases would be required to show a significant increase in the relative
risk, whereas for stimulants the sample size required would be 6,000 (Drummer 1994).
The apparent protective effect attributed to cannabis-only use may be a result of the fact that
the measurement of inactive carboxy-THC, which can persist in blood for several days or in
urine for several weeks, is a poor proxy for the assessment of psychoactive THC, which is
more difficult to measure. Furthermore, it is generally accepted that the use of cannabis can
cause impairment for up to two to four hours and that there is little compelling evidence
that impairment lasts beyond this time, even among regular users (Drummer 1994).
 For the calculation of the aetiological fraction, the prevalence of exposure among cases was
combined with the relative risk estimates derived by Drummer. Despite the relative risk of
less than one, no protective effect has been ascribed to cannabis use, given the limitations
described.
For stimulant-only use the prevalence was 0.020 (21 out of 1,045). Based on the relative risk
estimate of 1.6, this gave an aetiological fraction of 0.008. For opiate-only use the prevalence
was 0.012 (13 out of 1,045). Based on the relative risk estimate of 2.3, this gave an aetiological
fraction of 0.007.
As noted, the culpability ratios were age dependent, so if the fractions were to be applied to
deaths or hospital separations among drivers, the estimates should vary by age. But the
fractions are intended for application to all deaths and injuries arising from road traffic
accidents so the single estimate of the fraction applied to all ages is more appropriate.
5.2.2 Illicit drug use and HIV/AIDS
Infection with the human immunodeficiency virus—the virus that causes acquired immune
deficiency syndrome—and new cases of AIDS are notifiable in Australia. A standard set of
information is collected on each notification. All identified cases of HIV and AIDS are then
reported to the National Centre in HIV Epidemiology and Clinical Research, which
produces the Australian HIV Surveillance Report, presenting data on HIV infection and cases
of AIDS. We extracted data for 1996, 1997 and 1998. These were reported under a number of
exposure categories, including ‘male homosexual/bisexual contact and injecting drug use’
and ‘injecting drug use’. We followed English et al. (1995) in attributing most of the cases in
the first category to sexual contact rather than drug use and including only the second
category in our calculations. The results are presented in Table 5.5.
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Table 5.5: New cases of HIV infection and AIDS, by sex and exposure category, 1996 to 1998
Males Females
Year
Injecting
drug use
All exposure
categories
Proportion attributable
to injecting drug use
Injecting
drug use
All exposure
categories
Proportion attributable
to injecting drug use
HIV
1996 2 165 0.012 1 7 0.143
1997 2 147 0.014 1 9 0.111
1998 1 141 0.007 2 3 0.667
AIDS
1996 19 629 0.030 5 33 0.152
1997 10 343 0.029 6 26 0.231
1998 15 330 0.045 3 16 0.188
Source: NCHECR (1998).
We followed English et al. in using the reported proportions for AIDS as the aetiological
fraction for both deaths and hospitalisations. Under-reporting of injecting drug use probably
means these are underestimates.
5.2.3 Illicit drug use and antepartum haemorrhage
Opiates
English et al. (1995) derived a relative risk estimate of 2.36 for opiate use and antepartum
haemorrhage, with a 95% confidence interval of 1.35–4.12. A relative risk estimate of this
size is consistent with a moderately strong association between opiate use in pregnancy and
antepartum haemorrhage, although English et al. noted that this result is not adjusted for
any potential confounders. They did not, however, find any reliable Australian data on illicit
drug use during pregnancy, so they used the prevalence of illicit opiate use in women of
child-bearing age. They derived an estimated aetiological fraction of 0.002 but noted that
because of the dearth of prevalence data it is probably inaccurate. Because of this and the
fact that the estimate is substantially less than 1%, they did not apply this fraction to
Australian morbidity or mortality data.
The 1998 National Drug Strategy Household Survey collected data that would enable
estimation of the proportion of pregnant women who take opiates. The final sample count
was, however, too small to allow a meaningful estimate, so we followed English et al. in
using as a prevalence estimate the proportion of women of child-bearing age (14–39 years)
who use opiates. We derived an estimate from the 1995 and 1998 National Drug Strategy
Household Surveys and used linear interpolation to derive estimates for 1996 and 1997
(Table 5.6). These were then combined with the risk-ratio estimate of 2.36 from English et al.
to derive the aetiological fractions (Table 5.7). The fraction estimates for 1996 to 1998 are
higher than 1% because of the higher prevalence estimates. Hence, although we still have
poor prevalence data, we do apply the fractions to the data on mortality and hospital
separations.
Cocaine
English et al. (1995) derived a relative risk estimate of 3.89 for cocaine use and antepartum
haemorrhage, with a 95% confidence interval of 2.80–5.35. Although this estimate is quite
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high, English et al. noted that it is possible that other maternal factors—such as use of other
drugs, inadequate antenatal care, and infection—could account for part of the observed
association. As with opiates, they did not find any reliable Australian data on illicit drug use
during pregnancy. Instead, they used the prevalence of cocaine use in women of child-
bearing age as a basis for the fraction’s estimation. Their estimate of the fraction was 0.02.
Although they noted that this value was probably inaccurate, they did apply it to their data
on mortality and morbidity.
The 1998 National Drug Strategy Household Survey collected data that would enable
estimation of the proportion of pregnant women who take cocaine, but again the sample size
was too small to allow a meaningful estimate. Instead, we again followed English et al. in
using as a prevalence estimate the proportion of women of childbearing age (14–39 years)
who use cocaine. We derived an estimate from the 1995 and 1998 National Drug Strategy
Household Surveys and used linear interpolation to derive estimates for 1996 and 1997
(Table 5.6). These were then combined with the risk ratio estimate of 3.89 from English et al.
to derive the aetiological fractions (Table 5.7).
Table 5.6: Proportion of women aged 14–39 years using
opiates or cocaine, 1995 to 1998
Year Proportion using opiates Proportion using cocaine
(per cent)
1995 0.90 1.14
1996 0.92 1.26
1997 0.93 1.37
1998 0.96 1.60
Source: AIHW analysis of the 1995 and 1998 National Drug Strategy Household Survey data.
Table 5.7: Revised aetiological fractions for antepartum
haemorrhage and opiate or cocaine use
Year
Aetiological fraction
opiates
Aetiological fraction
cocaine
Exposed
All years 0.58 0.74
General population
1995 0.012 0.032
1996 0.012 0.035
1997 0.012 0.038
1998 0.013 0.044
Source: AIHW analysis of prevalence data in Table 5.6 and estimates of relative risk
reported by English et al. (1995).
5.2.4 Illicit drug use and low birthweight
Because of the significant overlap between low birthweight, prematurity and intrauterine
growth retardation, and the difficulty in relating each of these features or combinations of
two or three of these features to specific ICD-9 codes—low birthweight was selected as the
outcome most representative of conditions covered by ICD-9 codes 656.5, 764 and 765.
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Opiates
English et al. (1995) derived a relative risk estimate of 3.34 for maternal opiate use in
pregnancy and low birthweight, with a 95% confidence interval of 3.07–3.64. As with
antepartum haemorrhage, they used the prevalence of illicit opiate use in women of child-
bearing age as a proxy. They derived an estimated aetiological fraction of 0.004 but noted
that because of the dearth of prevalence data it is probably inaccurate. Because of this and
the fact that the estimate is substantially less than 1%, they did not apply this fraction to
Australian morbidity or mortality data.
We followed English et al. in using as a prevalence estimate the proportion of women of
child-bearing age (14 to 39 years) who use opiates (Table 5.6). This was combined with the
risk-ratio estimate of 3.34 from English et al. to derive the aetiological fractions (Table 5.8).
The fraction estimates for 1996 to 1998 are higher than 1% because of the higher prevalence
estimates. Hence, although we still have poor prevalence data, we applied the fractions to
our data on mortality and hospital separations.
Cocaine
English et al. derived a relative risk estimate of 2.97 for maternal cocaine use in pregnancy
and low birthweight, with a 95% confidence interval of 2.31–3.80. As with antepartum
haemorrhage, they used the prevalence of illicit cocaine use in women of child-bearing age
as a proxy. They derived an estimated aetiological fraction of 0.015 but noted that because of
the dearth of prevalence data it is likely to be inaccurate.
We followed English et al. in using the proportion of women of child-bearing age (14 to 39
years) who use cocaine as a prevalence estimate (Table 5.6). This was combined with the
risk-ratio estimate of 2.97 from English et al. to derive the aetiological fractions (Table 5.8).
Table 5.8: Revised aetiological fractions for low birthweight
and opiate or cocaine use
Year
Aetiological fraction
opiates
Aetiological fraction
cocaine
Exposed
All years 0.70 0.66
General population
1995 0.021 0.022
1996 0.021 0.024
1997 0.021 0.026
1998 0.022 0.031
Source: AIHW analysis of prevalence data in Table 5.6 and estimates of relative risk
reported by English et al. (1995).
5.3 Unrevised aetiological fractions for illicit drugs
5.3.1 Opiates and suicide
Unlike suicide and self-inflicted poisoning by barbiturates and by other sedatives, ICD-9
does not distinguish between suicide by opiate overdose and suicide by using any type of
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analgesic, antipyretic or antirheumatic drug. It is therefore necessary to derive an
aetiological fraction for all suicides due to opiates if this cause of mortality is to be
quantified.
Both Holman et al. (1990) and English et al. (1995) used a review of death certificates and
coronial records of suicides in Western Australia from 1974 to 1984 (Swensen 1988) to
estimate the fraction of suicides caused by opiates in Australia. This fraction was 0.09 and
since we found no more recent Australian data, we used the same fraction.
5.3.2 Injecting drug use and viral hepatitis
English et al. derived separate fractions for hepatitis B and hepatitis non-A, non-B. The viral
agent responsible for most non-A, non-B hepatitis has been identified and named the
hepatitis C virus. But hepatitis C is not distinguished from other types of non-A, non-B
hepatitis in mortality data, so English et al. calculated pooled estimates and aetiological
fractions for non-A, non-B hepatitis rather than hepatitis C.
We did not revise this fraction and used the English et al. estimates (Table 5.9).
Table 5.9: Aetiological fractions for injecting
drug use and viral hepatitis
Condition Males Females
Exposed
Hepatitis B 0.98 0.98
Hepatitis, non-A, non-B 0.98 0.98
General population
Hepatitis B 0.29 0.29
Hepatitis, non-A, non-B 0.42 0.42
Source: English et al. (1995).
5.3.3 Injecting drug use and infective endocarditis
Holman et al. derived an estimated aetiological fraction of 0.14 for injecting drug use and
infective endocarditis. English et al. found no additional studies on this association that met
their inclusion criteria and so retained 0.14 as the value for their fraction estimate. We found
no additional studies either, so we also used 0.14 as the aetiological fraction.
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6 Attributable mortality in 1998
Tables 6.1 to 6.3 show the number of deaths attributable to tobacco, alcohol and illicit drugs
in 1998, classified by age, the drug involved and the cause of death, for males, females and
persons. Tables 6.4 to 6.6 show the number of PYLL attributable to tobacco, alcohol and
illicit drugs in 1998, classified by age, the drug involved and the cause of death, for males,
females and persons. These are summary results for groups of causes of death. Detailed
tables for individual causes of death are available from the Institute on request.
6.1 Alcohol
Alcohol has both a causative and an apparent preventive effect on deaths. The largest
number of alcohol-related deaths among men are due to alcoholism and alcoholic liver
cirrhosis. The second largest number are due to cancer. Close to half (44%) of the male
alcohol-related cancer deaths are due to oesophageal cancer, while around a quarter (24%)
are due to liver cancer.
The pattern is different for women. The largest number of female alcohol-related deaths are
due to cancer. More than half of these deaths (55%) are due to breast cancer; oesophageal
cancer and liver cancer account for 24% and 13% of alcohol-related cancer deaths
respectively. Alcoholism and alcoholic liver cirrhosis account for the second-largest number
of alcohol-related deaths among females.
For both men and women the third largest category of alcohol-related deaths is road
injuries. The number of alcohol-related road injury deaths is much larger for men than for
women, with the majority of these deaths occurring in the 15 to 34 years age range.
Alcohol has an apparent protective effect against some conditions classified in the ‘other’
category for both men and women. It should be noted, however, that this estimate is a net
figure that includes an increased death rate due to some causes offset by a reduced death
rate from other causes. The protective effect of alcohol relates mainly to a reduced risk of
death from ischaemic heart disease and stroke with moderate alcohol consumption.
However, as noted in Appendix A, high alcohol consumption is related to an increased risk
of death from a number of causes in this category—including an increased risk of death
from stroke.
The largest cause of alcohol-related PYLL for men is alcoholism and alcoholic liver cirrhosis.
However, the second largest cause of male alcohol-related PYLL is road injuries rather than
cancer. This reflects the fact that, although there are more alcohol-related cancer deaths than
road injury deaths among males, the road injury deaths tend to happen at a younger age and
hence contribute more PYLL.
Alcohol is related to a net increase in PYLL in the ‘other ‘category for men, despite being
related to a net decrease in deaths. This is because of causes such as suicide and assault: they
contribute a moderate number of male alcohol-related deaths at young ages but a large
number of PYLL, which offsets the reduced number of PYLL at older ages related to
ischaemic heart disease and stroke.
The pattern of alcohol-related PYLL for women is similar to that for alcohol-related deaths
for women, with cancer contributing the largest number, followed by alcoholism and
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alcoholic liver cirrhosis. As with female alcohol-related deaths, the net effect of alcohol on
the causes of death in the ‘other’ category is a reduction in PYLL.
6.2 Tobacco
For men, the largest number of tobacco-related deaths are caused by cancer, which is
responsible for around 43% of all male tobacco-related deaths. These cancer deaths are
dominated by lung cancer, which accounts for 77% of male tobacco-related cancer deaths.
The remaining tobacco-related male cancer deaths are caused by several different types of
cancer—including oesophageal cancer (6%), oropharyngeal cancer (4%), bladder cancer (4%)
and pancreatic cancer (3%).
The second- and third- largest causes of male tobacco-related deaths are ischaemic heart
disease and chronic obstructive pulmonary disease, which account for 22% and 19% of male
tobacco-related deaths respectively. The ‘other direct smoking’ category accounts for 15% of
male tobacco-related deaths. This category comprises a variety of causes, the largest
contributors being stroke (43% of the ‘other’ category), atherosclerosis (29%) and pneumonia
(19%).
For women the pattern is a little different. As with men, the largest number of tobacco-
related deaths for women are caused by cancer, which is responsible for around 32% of all
female tobacco-related deaths. This category is also dominated by lung cancer, which
accounts for 75% of female tobacco-related cancer deaths. The remaining tobacco-related
female cancer deaths are caused by several different types of cancer—including oesophageal
cancer (7%), pancreatic cancer (7%), bladder cancer (4%) and oropharyngeal cancer (3%).
Chronic obstructive pulmonary disease accounts for a larger proportion of female tobacco-
related deaths (22%) than does ischaemic heart disease (20%). However, the ‘other direct
smoking’ category is larger than either of these, accounting for 25% of female tobacco-
related deaths. Again, this category comprises a variety of causes, the largest contributors
being stroke (46% of the ‘other’ category), atherosclerosis (23%) and pneumonia (17%).
The tobacco-related PYLL for both men and women follow the same pattern as the tobacco-
related deaths. Hence the largest number of tobacco-related PYLL for both men and women
is due to cancer. However, while more male tobacco-related PYLL are due to ischaemic heart
disease than chronic obstructive pulmonary disease, the reverse is true for female tobacco-
related PYLL.
6.3 Illicit drugs
The patterns of illicit drug-related deaths for men and women are similar. The largest
proportion of these deaths is directly related to opiate dependence, abuse or poisoning (79%
for men and 69% for women). The second-largest proportion is due to suicide (13% for both
men and women). Hepatitis is a slightly larger cause of illicit drug-related deaths for women
(10%) than for men (4%), as are road traffic accidents (4% for women and 2% for men).
However, the absolute number of illicit drug-related hepatitis and road traffic accident
deaths is small, so these proportions should be interpreted with caution.
The pattern of illicit drug-related PYLL is similar to that for illicit drug-related deaths. The
largest proportion of these PYLL is directly related to opiate dependence, abuse or poisoning
(79% for men and 73% for women). The second-largest proportion is due to suicide (14% for
both men and women). Hepatitis is a slightly larger cause of illicit drug-related deaths for
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women (5%) than for men (2%), as are road traffic accidents (3% for women and 2% for
men). However, the proportions for PYLL due to illicit drug-related hepatitis and road
traffic accident deaths should be interpreted with caution because of the small number of
deaths on which they are based.
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Table 6.1: Deaths attributable to drug use, by drug involved, cause of death and age: males, 1998
Age
Drug involved/cause of death 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 3 245 423 672
Alcoholism and alcoholic liver cirrhosis 0 26 451 226 703
Road injuries 12 245 111 19 387
Other 3 406 129 –1,667 –1,129
Total alcohol 15 680 936 –998 633
Tobacco
Direct smoking
Cancer 0 0 1,375 4,207 5,582
Ischaemic heart disease 0 27 1,114 1,707 2,848
Chronic obstructive pulmonary disease 0 0 229 2,275 2,504
Other 43 27 326 1,565 1,961
Environmental tobacco smoke 14 0 2 32 48
Total tobacco 57 54 3,047 9,787 12,944
Illicit drugs
Drug dependence and abuse
Cannabis 0 0 0 0 0
Opiates 0 315 151 0 466
Cocaine 0 3 0 0 3
Amphetamines 0 1 1 0 2
Hallucinogens 0 1 0 0 1
Poisoning 0 0 0 0 0
Opiates 0 126 64 2 192
Psychostimulants 0 2 1 0 3
Hallucinogens 0 0 0 0 0
Suicide 0 86 25 0 111
Antepartum haemorrhage 2 0 0 0 2
Low birthweight 1 0 0 0 1
Hepatitis B 0 0 8 4 12
Hepatitis, non-A, non-B 0 1 12 5 19
AIDS 0 2 4 0 6
Infective endocarditis 0 1 0 0 1
Drug psychoses 0 0 0 0 0
Maternal drug dependence 0 0 0 0 0
Newborn toxicity 1 0 0 0 1
Road traffic accidents 1 9 6 2 18
Total illicit drugs 5 547 272 14 838
Total all drugs 77 1,280 4,254 8,802 14,414
Note: Columns may not add exactly to totals due to rounding.
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Table 6.2: Deaths attributable to drug use, by drug involved, cause of death and age: females, 1998
Age
Drug involved/cause of death 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 8 177 301 485
Alcoholism and alcoholic liver cirrhosis 0 18 132 74 224
Road injuries 3 28 20 3 53
Other 3 80 –34 –3,815 –3,766
Total alcohol 6 134 294 –3,438 –3,004
Tobacco
Direct smoking
Cancer 0 0 454 1,506 1,960
Ischaemic heart disease 0 7 225 954 1,186
Chronic obstructive pulmonary disease 0 0 130 1,205 1,335
Other 33 19 179 1,285 1,515
Environmental tobacco smoke 9 0 8 63 80
Total tobacco 42 26 995 5,012 6,075
Illicit drugs
Drug dependence and abuse
Cannabis 0 0 0 0 0
Opiates 0 67 32 2 101
Cocaine 0 1 0 0 1
Amphetamine 0 1 0 0 1
Hallucinogens 0 0 0 0 0
Poisoning 0 0 0 0 0
Opiates 0 12 13 2 27
Psychostimulants 0 0 0 0 0
Hallucinogens 0 0 0 0 0
Suicide 0 17 7 0 24
Antepartum haemorrhage 2 0 0 0 2
Low birthweight 1 0 0 0 1
Hepatitis B 0 0 1 2 4
Hepatitis, non-A, non-B 0 0 4 11 15
AIDS 0 0 1 0 1
Infective endocarditis 0 0 0 0 0
Drug psychoses 0 0 0 0 0
Maternal drug dependence 0 0 0 0 0
Newborn toxicity 0 0 0 0 0
Road traffic accidents 1 3 2 2 7
Total illicit drugs 4 102 60 19 185
Total all drugs 51 262 1,350 1,593 3,256
Note: Columns may not add exactly to totals due to rounding.
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Table 6.3: Deaths attributable to drug use, by drug involved, cause of death and age: persons, 1998
Age
Drug involved/cause of death 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 11 422 724 1,157
Alcoholism and alcoholic liver cirrhosis 0 44 583 300 927
Road injuries 15 273 130 22 440
Other 6 486 95 –5,482 –4,895
Total alcohol 21 814 1230 –4,436 –2,371
Tobacco
Direct smoking
Cancer 0 0 1,829 5,713 7,542
Ischaemic heart disease 0 34 1,339 2,661 4,034
Chronic obstructive pulmonary disease 0 0 359 3,480 3,839
Other 76 46 505 2,849 3,476
Environmental tobacco smoke 23 0 10 95 128
Total tobacco 99 80 4,042 14,799 19,019
Illicit drugs
Drug dependence and abuse
Cannabis 0 0 0 0 0
Opiates 0 382 183 2 567
Cocaine 0 4 0 0 4
Amphetamine 0 2 1 0 3
Hallucinogens 0 1 0 0 1
Poisoning 0 0 0 0 0
Opiates 0 138 77 4 219
Psychostimulants 0 2 1 0 3
Hallucinogens 0 0 0 0 0
Suicide 0 103 32 0 135
Antepartum haemorrhage 4 0 0 0 4
Low birthweight 2 0 0 0 2
Hepatitis B 0 1 9 6 16
Hepatitis, non-A, non-B 0 2 16 16 34
AIDS 0 2 5 0 7
Infective endocarditis 0 1 0 0 1
Drug psychoses 0 0 0 0 0
Maternal drug dependence 0 0 0 0 0
Newborn toxicity 1 0 0 0 1
Road traffic accidents 2 12 8 4 25
Total illicit drugs 9 649 332 33 1,023
Total all drugs 129 1,542 5,604 10,396 17,671
Note: Columns may not add exactly to totals due to rounding.
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Table 6.4: PYLL attributable to drug use, by drug involved, cause of death and age: males, 1998
Age
Drug involved/cause of death 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 88 4,215 3,695 7,998
Alcoholism and alcoholic liver cirrhosis 0 675 8,418 2,225 11,317
Road injuries 356 6,637 2,418 160 9,570
Other 101 10,845 3,762 –11,841 2,867
Total alcohol 457 18,244 18,812 –5,761 31,752
Tobacco
Direct smoking
Cancer 0 0 22,499 36,169 58,667
Ischaemic heart disease 0 690 19,443 12,667 32,800
Chronic obstructive pulmonary disease 0 0 3,556 17,159 20,715
Other 1,312 720 5,712 10,447 18,191
Environmental tobacco smoke 413 2 39 229 683
Total tobacco 1,725 1,411 51,249 76,670 131,055
Illicit drugs
Drug dependence and abuse
Cannabis 0 0 0 0 0
Opiates 0 8,365 3,489 0 11,853
Cocaine 0 78 0 0 78
Amphetamine 0 28 24 0 52
Hallucinogens 0 28 0 0 28
Poisoning 0 0 0 0 0
Opiates 0 3,354 1,445 12 4,811
Psychostimulants 0 54 23 0 77
Hallucinogens 0 0 0 0 0
Suicide 0 2,297 594 0 2,891
Antepartum haemorrhage 63 0 0 0 63
Low birthweight 29 0 0 0 29
Hepatitis B 0 8 161 36 204
Hepatitis, non-A, non-B 0 32 237 45 315
AIDS 0 44 92 3 139
Infective endocarditis 0 15 7 0 22
Drug psychoses 0 0 0 0 0
Maternal drug dependence 0 0 0 0 0
Newborn toxicity 30 0 0 0 30
Road traffic accidents 28 245 114 20 407
Total illicit drugs 149 14,548 6,185 116 20,998
Total all drugs 2,332 34,203 76,245 71,025 183,805
Note: Columns may not add exactly to totals due to rounding.
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Table 6.5: PYLL attributable to drug use, by drug involved, cause of death and age: females, 1998
Age
Drug involved/cause of death 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 208 3,533 2,701 6,443
Alcoholism and alcoholic liver cirrhosis 0 486 2,779 831 4,095
Road injuries 91 782 473 24 1,369
Other 89 2,221 –288 –24,534 –22,513
Total alcohol 180 3,696 6,496 –20,978 –10,605
Tobacco
Direct smoking
Cancer 0 0 7,532 12,336 19,867
Ischaemic heart disease 0 184 3,849 5,816 9,850
Chronic obstructive pulmonary disease 0 0 2,064 8,861 10,925
Other 995 498 3,261 7,296 12,051
Environmental tobacco smoke 278 2 137 413 830
Total tobacco 1,273 685 16,843 34,723 53,523
Illicit drugs
Drug dependence and abuse
Cannabis 0 0 0 0 0
Opiates 0 1,802 734 20 2,555
Cocaine 0 27 0 0 27
Amphetamine 0 28 0 0 28
Hallucinogens 0 0 0 0 0
Poisoning 0 0 0 0 0
Opiates 0 327 282 14 623
Psychostimulants 0 0 0 0 0
Hallucinogens 0 0 0 0 0
Suicide 0 462 168 0 630
Antepartum haemorrhage 74 0 0 0 74
Low birthweight 19 0 0 0 19
Hepatitis B 0 8 21 22 50
Hepatitis, non-A, non-B 0 11 76 97 184
AIDS 0 5 21 0 26
Infective endocarditis 0 8 3 0 11
Drug psychoses 0 0 0 0 0
Maternal drug dependence 0 0 0 0 0
Newborn toxicity 0 0 0 0 0
Road traffic accidents 18 71 47 14 151
Total illicit drugs 112 2,748 1,352 166 4,377
Total all drugs 1,565 7,129 24,691 13,911 47,295
Note: Columns may not add exactly to totals due to rounding.
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Table 6.6: PYLL attributable to drug use, by drug involved, cause of death and age: persons, 1998
Age
Drug involved/cause of death 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 296 7,748 6,397 14,441
Alcoholism and alcoholic liver cirrhosis 0 1,161 11,196 3,055 15,413
Road injuries 447 7,418 2,890 184 10,940
Other 190 13,066 3,473 –36,375 –19,646
Total alcohol 637 21,941 25,309 –26,739 21,147
Tobacco
Direct smoking
Cancer 0 0 30,030 48,504 78,534
Ischaemic heart disease 0 874 23,292 18,484 42,650
Chronic obstructive pulmonary disease 0 0 5,620 26,020 31,640
Other 2,307 1,218 8,973 17,743 30,241
Environmental tobacco smoke 691 4 176 642 1,513
Total tobacco 2,998 2,096 68,091 111,393 184,579
Illicit drugs
Drug dependence and abuse
Cannabis 0 0 0 0 0
Opiates 0 10,166 4,222 20 14,408
Cocaine 0 104 0 0 104
Amphetamine 0 56 24 0 80
Hallucinogens 0 28 0 0 28
Poisoning 0 0 0 0 0
Opiates 0 3,681 1,727 25 5,434
Psychostimulants 0 54 23 0 77
Hallucinogens 0 0 0 0 0
Suicide 0 2,760 762 0 3,522
Antepartum haemorrhage 137 0 0 0 137
Low birthweight 48 0 0 0 48
Hepatitis B 0 15 181 58 254
Hepatitis, non-A, non-B 0 44 313 142 499
AIDS 0 49 112 3 164
Infective endocarditis 0 23 10 0 33
Drug psychoses 0 0 0 0 0
Maternal drug dependence 0 0 0 0 0
Newborn toxicity 30 0 0 0 30
Road traffic accidents 46 316 161 34 557
Total illicit drugs 261 17,296 7,536 282 25,375
Total all drugs 3,896 41,332 100,936 84,936 231,100
Note: Columns may not add exactly to totals due to rounding.
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7 Attributable hospital separations
in 1998
Tables 7.1 to 7.3 show the number of hospital separations attributable to tobacco, alcohol and
illicit drugs in 1997–98 classified by age, the drug involved and the reason for separation, for
males, females and persons. Tables 7.4 to 7.6 present the number of patient days attributable
to tobacco, alcohol and illicit drugs in 1997–98 classified by age, the drug involved and the
reason for separation, for males, females and persons. These are summary results for groups
of reasons for separation. Detailed tables for individual causes of death are available from
the Institute on request.
7.1 Alcohol
Alcohol has both a causative and an apparent preventive effect on hospital separations. The
largest number of alcohol-related separations among both men and women is due to
alcoholism and alcoholic liver cirrhosis. The second-largest number is due to road injuries
for men and cancer for women. The male cancer separations are due to oesophageal cancer
(37% of attributable cancer separations), oropharyngeal cancer (30%), laryngeal cancer (20%)
and liver cancer (13%). The female cancer separations are mainly due to breast cancer (67%
of attributable cancer separations); the remainder are attributable to oesophageal cancer
(17%), oropharyngeal cancer (9%), liver cancer (4%) and laryngeal cancer (2%).
Alcohol has an apparent protective effect against some conditions classified in the ‘other’
category for both men and women. It should be noted, owever, that the estimate for this
category is a net figure that includes an increased separation rate due to some causes offset
by a reduced separation rate due to other causes. The protective effect of alcohol relates
mainly to a reduced risk of hospitalisation from ischaemic heart disease, stroke,
cholelithiasis and hypertension with moderate alcohol consumption. However, as noted in
Appendix A, high alcohol consumption is related to an increased risk of hospitalisation from
a number of causes in this category—including stroke.
The overall net effect of alcohol on the conditions in the ‘other’ category is to increase
hospitalisations for men. This is because the number of separations averted due to the
protective effect of alcohol is offset by an increase in separations mainly due to unintentional
injuries, assault and attempted suicide among younger men and pancreatitis and
supraventricular cardiac dysrhythmias among middle-aged and older men. The overall
effect for women is a decrease in the number of separations because of the smaller numbers
having these conditions.
7.2 Tobacco
The largest specific cause of hospital separations for males attributable to tobacco is
ischaemic heart disease, with 29% of the attributable separations. This is followed by cancer
(21%) and chronic obstructive pulmonary disease (19%). The cancer category is dominated
by lung cancer (50% of attributable cancer separations) and bladder cancer (23%).
Oropharyngeal and oesophageal cancer each account for 7% of the attributable cancer
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separations; the remaining cancers each account for less than 5% of the attributable cancer
separations.
The ‘other direct smoking’ category accounts for 30% of the attributable separations for
males. No single cause dominates this group, but the largest contributors are atherosclerosis
(27% of other attributable separations), cardiac dysrhythmias (20%), stroke (20%) and
pneumonia (18%).
The largest specific cause of hospital separations for females attributable to tobacco is
chronic obstructive pulmonary disease, with 22% of the attributable separations. This is
followed by ischaemic heart disease (19%) and cancer (14%). The cancer category is
dominated by lung cancer (59% of attributable cancer separations) and bladder cancer (17%).
Oesophageal cancer accounts for 9% of the attributable cancer separations and
oropharyngeal cancer accounts for 6%. The remaining cancers each account for less than 5%
of the attributable cancer separations.
The ‘other direct smoking’ category accounts for 43% of the attributable separations for
females. Again, no single cause dominates this group, but the largest contributors are
atherosclerosis (17% of other attributable separations), stroke (17%), cardiac dysrhythmias
(16%) and pneumonia (16%).
7.3 Illicit drugs
As with the mortality data, the hospital separations attributable to use of illicit drugs are
dominated by opiate dependence, abuse or poisoning, which accounts for 52% of
attributable separations for males and 40% for females. The next-largest category of
attributable separations is due to drug psychoses, which accounts for 30% of attributable
separations for males and 25% for females. For males, cannabis dependence or abuse
contributes 6% of the attributable separations and road traffic accidents contribute 4%; all
other causes contribute less than 3% each. For females, antepartum haemorrhage and
maternal drug dependence each contribute 8% each of the attributable separations; all other
causes contribute less than 3% each.
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Table 7.1: Hospital separations attributable to drug use, by drug, reason for separation and age:
males, 1997–98
Age
Drug involved/reason for separation 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 20 1,460 1,691 3,171
Alcoholism and alcoholic liver cirrhosis 143 3,783 11,564 2,162 17,652
Road injuries 329 3,083 1,145 233 4,790
Other 229 11,813 2,419 –4,873 9,588
Total alcohol 701 18,699 16,588 –786 35,201
Tobacco
Direct smoking
Cancer 0 0 6,961 13,718 20,679
Ischaemic heart disease 0 302 20,685 7,712 28,699
Chronic obstructive pulmonary disease 0 0 3,613 14,656 18,268
Other 94 1,892 11,851 14,917 28,755
Environmental tobacco smoke 873 1 36 127 1,037
Total tobacco 967 2,195 43,146 51,130 97,438
Illicit drugs
Drug dependence and abuse
Cannabis 0 421 47 7 475
Opiates 0 2,363 824 6 3,193
Cocaine 0 21 17 1 39
Amphetamines 0 236 35 0 271
Hallucinogens 0 35 1 0 36
Poisoning 0 0 0 0 0
Opiates 0 814 278 11 1,103
Psychostimulants 0 183 35 0 218
Hallucinogens 0 87 16 1 104
Other psychotropic drugs 0 45 46 5 96
Anabolic steriods 0 1 1 0 2
Antepartum haemorrhage 0 0 0 0 0
Low birthweight 0 0 0 0 0
Hepatitis B and non-A, non-B 0 0 0 0 0
AIDS 0 0 0 0 1
Infective endocarditis 0 15 9 0 24
Drug psychoses 0 1,890 439 144 2,473
Newborn toxicity 0 0 0 0 0
Road traffic accidents 28 160 81 26 295
Total illicit drugs 28 6,271 1,829 201 8,329
Total all drugs 1,696 27,166 61,563 50,545 140,969
Note: Columns may not add exactly to totals due to rounding.
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Table 7.2: Hospital separations attributable to drug use, by drug, reason for separation and age:
females, 1997–98
Age
Drug involved/reason for separation 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 93 1,619 1,158 2,869
Alcoholism and alcoholic liver cirrhosis 135 2,081 5,162 728 8,107
Road injuries 81 628 296 50 1,056
Other 118 3,705 –71 –7,953 –4,200
Total alcohol 334 6,508 7,006 –6,016 7,831
Tobacco
Direct smoking
Cancer 0 0 1,965 4,328 6,293
Ischaemic heart disease 0 96 5,077 3,248 8,421
Chronic obstructive pulmonary disease 0 0 2,286 7,714 10,000
Other 48 4,894 6,779 7,720 19,442
Environmental tobacco smoke 555 2 136 238 931
Total tobacco 603 4,992 16,243 23,249 45,087
Illicit drugs
Drug dependence and abuse
Cannabis 0 153 24 0 177
Opiates 0 1492 466 9 1,967
Cocaine 0 17 3 0 20
Amphetamines 0 126 12 0 138
Hallucinogens 0 15 5 0 20
Poisoning 0 0 0 0 0
Opiates 0 405 97 4 506
Psychostimulants 0 144 21 0 165
Hallucinogens 0 59 15 0 74
Other psychotropic drugs 0 77 70 24 171
Anabolic steriods 0 0 0 0 0
Antepartum haemorrhage 0 549 78 0 627
Low birthweight 0 54 5 0 59
Hepatitis B, and non-A, non-B 0 0 0 0 0
AIDS 0 3 1 1 4
Infective endocarditis 0 11 3 0 14
Drug psychoses 0 958 335 225 1,518
Maternal drug dependence 0 471 40 0 511
Newborn toxicity 0 0 0 0 0
Road traffic accidents 16 71 53 30 170
Total illicit drugs 16 4,605 1,228 293 6,142
Total all drugs 953 16,105 24,477 17,525 59,060
Note: Columns may not add exactly to totals due to rounding.
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Table 7.3: Hospital separations attributable to drug use, by drug, reason for separation and age:
persons, 1997–98
Age
Drug involved/reason for separation 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 113 3,078 2,849 6,040
Alcoholism and alcoholic liver cirrhosis 278 5,864 16,726 2,890 25,759
Road injuries 410 3,711 1,442 283 5,846
Other 346 15,519 2,348 –12,825 5,388
Total alcohol 1,034 25,207 23,594 –6,802 43,033
Tobacco
Direct smoking
Cancer 0 0 8,926 18,046 26,972
Ischaemic heart disease 0 398 25,762 10,960 37,120
Chronic obstructive pulmonary disease 0 0 5,899 22,370 28,268
Other 142 6,787 18,630 22,638 48,196
Environmental tobacco smoke 1,428 2 172 365 1,968
Total tobacco 1,570 7,187 59,389 74,379 142,525
Illicit drugs
Drug dependence and abuse
Cannabis 0 574 71 7 652
Opiates 0 3,855 1,290 15 5,160
Cocaine 0 38 20 1 59
Amphetamines 0 362 47 0 409
Hallucinogens 0 50 6 0 56
Poisoning 0 0 0 0 0
Opiates 0 1,219 375 15 1,609
Psychostimulants 0 327 56 0 383
Hallucinogens 0 146 31 1 178
Other psychotropic drugs 0 122 116 29 267
Anabolic steriods 0 1 1 0 2
Antepartum haemorrhage 0 549 78 0 627
Low birthweight 0 54 5 0 59
Hepatitis B and non-A, non-B 0 0 0 0 0
AIDS 0 3 1 2 5
Infective endocarditis 0 26 12 0 38
Drug psychoses 0 2,848 774 369 3,991
Maternal drug dependence 0 471 40 0 511
Newborn toxicity 0 0 0 0 0
Road traffic accidents 44 231 134 55 465
Total illicit drugs 44 10,876 3,057 494 14,471
Total all drugs 2,604 32,394 82,983 67,576 185,558
Note: Columns may not add exactly to totals due to rounding.
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Table 7.4: Hospital patient days attributable to drug use, by drug, reason for separation and age:
males, 1997–98
Age
Drug involved/reason for separation 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 144 10,321 14,383 24,848
Alcoholism and alcoholic liver cirrhosis 164 15,719 146,136 49,969 211,988
Road injuries 1,187 16,651 7,842 2,286 27,967
Other 938 30,856 10,126 –15,397 26,524
Total alcohol 2,289 63,371 174,425 51,241 291,327
Tobacco
Direct smoking
Cancer 0 0 40,828 96,422 137,249
Ischaemic heart disease 0 1,018 80,705 39,379 121,102
Chronic obstructive pulmonary disease 0 0 24,802 124,576 149,378
Other 28,744 7,841 61,370 112,806 210,760
Environmental tobacco smoke 2,737 3 139 670 3,549
Total tobacco 31,481 8,861 207,844 373,852 622,038
Illicit drugs
Drug dependence and abuse
Cannabis 0 3,118 399 7 3,524
Opiates 0 10,136 4,421 30 14,587
Cocaine 0 109 67 6 182
Amphetamines 0 1,535 251 0 1,786
Hallucinogens 0 86 43 0 129
Poisoning 0 0 0 0 0
Opiates 0 2,082 748 23 2,853
Psychostimulants 0 243 66 0 309
Hallucinogens 0 119 18 1 138
Other psychotropic drugs 0 92 151 42 285
Anabolic steriods 0 2 1 0 3
Antepartum haemorrhage 1 0 0 0 1
Low birthweight 6,578 0 0 0 6,578
Hepatitis B and non-A, non-B 0 0 0 0 0
AIDS 0 5 0 2 7
Infective endocarditis 0 302 106 0 408
Drug psychoses 0 14,212 2,905 1,608 18,725
Newborn toxicity 2,216 0 0 0 2,216
Road traffic accidents 115 831 526 228 1,700
Total illicit drugs 8,909 32,871 9,703 1,948 53,430
Total all drugs 42,680 105,102 391,972 427,041 966,795
Note: Columns may not add exactly to totals due to rounding.
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Table 7.5: Hospital patient days attributable to drug use, by drug, reason for separation and age:
females, 1997–98
Age
Drug involved/reason for separation 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 346 8,116 9,176 17,638
Alcoholism and alcoholic liver cirrhosis 149 7,756 30,202 10,342 48,449
Road injuries 319 3,231 1,667 456 5,673
Other 524 9,751 –3,123 –82,742 –75,590
Total alcohol 991 21,084 36,863 –62,768 –3,830
Tobacco
Direct smoking
Cancer 0 0 12,632 37,151 49,783
Ischaemic heart disease 0 356 19,325 17,377 37,058
Chronic obstructive pulmonary disease 0 0 14,945 72,813 87,757
Other 25,181 15,695 34,021 65,344 140,241
Environmental tobacco smoke 1,738 6 545 1,278 3,567
Total tobacco 26,919 16,057 81,467 193,963 318,406
Illicit drugs
Drug dependence and abuse
Cannabis 0 1,081 156 0 1237
Opiates 0 7,905 2,922 97 10,924
Cocaine 0 132 9 0 141
Amphetamines 0 1,179 105 0 1,284
Hallucinogens 0 56 20 0 76
Poisoning 0 0 0 0 0
Opiates 0 834 256 23 1,113
Psychostimulants 0 220 27 0 247
Hallucinogens 0 82 38 0 120
Other psychotropic drugs 0 255 360 253 868
Anabolic steriods 0 0 0 0 0
Antepartum haemorrhage 2 1,868 452 0 2,322
Low birthweight 5,827 336 53 0 6,216
Hepatitis B and non-A, non-B 0 0 0 0 0
AIDS 0 3 1 9 13
Infective endocarditis 0 229 46 0 275
Drug psychoses 0 5,109 2,415 2,945 10,469
Maternal drug dependence 0 2,782 237 0 3,019
Newborn toxicity 2,449 0 0 0 2,449
Road traffic accidents 74 340 302 263 979
Total illicit drugs 8,352 22,410 7,399 3,590 41,752
Total all drugs 36,262 59,551 125,729 134,785 356,327
Note: Columns may not add exactly to totals due to rounding.
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Table 7.6: Hospital patient days attributable to drug use, by drug, reason for separation and age:
persons, 1997–98
Age
Drug involved/reason for separation 0–14 15–34 35–64 65 and over All ages
Alcohol
Cancer 0 490 18,438 23,558 42,486
Alcoholism and alcoholic liver cirrhosis 313 23,475 176,338 60,311 260,437
Road injuries 1,506 19,883 9,509 2,742 33,640
Other 1,462 40,607 7,003 –98,138 –49,066
Total alcohol 3,281 84,455 211,288 –11,527 287,497
Tobacco
Direct smoking
Cancer 0 0 53,459 133,573 187,032
Ischaemic heart disease 0 1,373 100,030 56,756 158,160
Chronic obstructive pulmonary disease 0 0 39,747 197,388 237,136
Other 53,925 23,536 95,390 178,150 351,001
Environmental tobacco smoke 4,475 9 685 1,948 7,116
Total tobacco 58,399 24,918 289,311 567,815 940,444
Illicit drugs
Drug dependence and abuse
Cannabis 0 4,199 555 7 4,761
Opiates 0 18,041 7,343 127 25,511
Cocaine 0 241 76 6 323
Amphetamines 0 2,714 356 0 3,070
Hallucinogens 0 142 63 0 205
Poisoning 0 0 0 0 0
Opiates 0 2,916 1,004 46 3,966
Psychostimulants 0 463 93 0 556
Hallucinogens 0 201 56 1 258
Other psychotropic drugs 0 347 511 295 1,153
Anabolic steriods 0 2 1 0 3
Antepartum haemorrhage 3 1,868 452 0 2,323
Low birthweight 12,405 336 53 0 12,794
Hepatitis B and non-A, non-B 0 0 0 0 0
AIDS 0 7 1 11 20
Infective endocarditis 0 531 152 0 683
Drug psychoses 0 19,321 5,320 4,553 29,194
Maternal drug dependence 0 2,782 237 0 3,019
Newborn toxicity 4,665 0 0 0 4,665
Road traffic accidents 189 1,170 828 491 2,678
Total illicit drugs 17,262 55,281 17,102 5,537 95,182
Total all drugs 61,680 109,373 500,599 556,288 1,227,940
Note: Columns may not add exactly to totals due to rounding.
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Appendix A Partial aetiological
fractions for alcohol using low
consumption as the reference level
English et al. (1995) calculated aetiological fractions for hazardous and harmful alcohol
consumption (as defined by the National Health and Medical Research Council) relative to
low alcohol consumption. Their rationale was to reflect more accurately the idea that unsafe
drinking—as opposed to low alcohol consumption, which may be protective—is the cause
for concern. The alcohol fractions presented in the body of our report reflect the earlier
approach of Holman et al. (1990) and reflect both the risks and benefits of alcohol at all
levels of consumption relative to abstaining from alcohol. This appendix presents revised
estimates of the alcohol fractions using the approach taken by English et al.
The data in this appendix represent the extra effect of alcohol consumption for the ‘unsafe’
drinker compared with the ‘responsible’ drinker (English et al. 1995, p. 58), where unsafe
and responsible consumption are defined by the NHMRC guidelines for responsible
drinking (NHMRC 1992). The data are presented here in recognition of the fact that public
health efforts in Australia are generally directed towards the reduction of unsafe alcohol
consumption and not alcohol consumption per se. The data may thus be useful in
supporting that policy.
A.1 Methods
The partial fraction for unsafe alcohol consumption is calculated in a similar way to the
partial fractions used in the body of the report, but with a different reference level. We
designated 210 ,, ppp  and 3p  as the population prevalence of abstinence, ‘low’, ‘hazardous’
and ‘harmful’ drinking respectively and 20 , RRRR  and 3RR as the relative risk associated
with abstinence, hazardous and harmful drinking relative to low drinking. By definition,
11 =RR , so the equation for the partial fraction for unsafe drinking (hazardous and harmful
combined) relative to low drinking is
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It is also possible to formulate an aetiological fraction, F0, for the contribution of abstinence
to morbidity and mortality. Its formula is
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This report follows English et al. (1995) and does not calculate F0. The main reason is that the
results in this appendix are presented to support public policy relating to alcohol: abstinence
is not currently an object of public policy. But this does mean that the results presented in
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this appendix represent only a partial view of the total effect of alcohol. In particular, they
do not take account of the benefits ascribed to moderate alcohol consumption or the risks
associated with moderate alcohol consumption and some conditions.
A number of the fractions presented in the body of the report are based on case series using
formula (6) in Chapter 2. These case series did not allow a partitioning of risk into that due
to moderate alcohol intake and that due to high intake. Hence the data do not support the
direct estimation of a fraction for hazardous and harmful levels of drinking. We have
followed English et al. in using these fractions directly as the fractions for hazardous and
harmful levels of drinking. The assumption implicit in this is that most of the alcohol harm
relating to the conditions associated with these fractions arises from hazardous and harmful
levels of drinking.
A.2 Results
Table A1 presents the age- and sex-specific partial aetiological fractions for unsafe alcohol
consumption relative to low alcohol consumption. Tables A2 to A13 present the deaths,
PYLL, hospital separations and patient days attributable to unsafe alcohol consumption
relative to low alcohol consumption for the period 1996 to 1998.
English et al. (1995) found inadequate evidence that the marginal exposure between low and
hazardous or harmful alcohol intake is either a cause of or protective against ischaemic heart
disease. As a result, this condition is omitted from Table A1. English et al. also
recommended the exclusion of heart failure from the analysis since its predominant cause is
ischaemic heart disease, so this condition has also been omitted from Table A1. The fractions
for unspecified liver cirrhosis deaths and separations are derived using the counts of deaths
or separations coded to alcoholic liver cirrhosis and to overall liver cirrhosis. As a result,
both these fractions vary by year. The values presented in Table A1 are those for 1998 for
deaths and those for 1997–98 for hospital separations.
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Table A1: Partial aetiological fractions for harmful and hazardous levels of alcohol consumption relative to moderate levels of consumption, by
condition, age and sex
A1.1: Males
Age
Condition 0–4 5–9 10–14 15–19 20–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+
Oropharyngeal cancer 0.24 0.24 0.22 0.21 0.17 0.19 0.19 0.20 0.13 0.22 0.15 0.19 0.19 0.11 0.11
Oesophageal cancer 0.16 0.16 0.15 0.15 0.12 0.13 0.14 0.14 0.10 0.16 0.11 0.13 0.13 0.08 0.08
Liver cancer 0.20 0.20 0.20 0.20 0.17 0.19 0.20 0.19 0.15 0.22 0.16 0.17 0.14 0.12 0.12
Laryngeal cancer 0.24 0.24 0.24 0.24 0.20 0.23 0.24 0.23 0.18 0.26 0.19 0.20 0.18 0.14 0.14
Female breast cancer n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
Alcoholic psychosis 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Alcohol dependence 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Alcohol abuse 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Epilepsy 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15
Alcoholic polyneuropathy 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Hypertension 0.10 0.10 0.10 0.10 0.08 0.09 0.09 0.09 0.07 0.10 0.07 0.08 0.07 0.05 0.05
Alcoholic cardiomyopathy 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Supraventricular cardiac
dysrhythmias 0.09 0.09 0.09 0.09 0.07 0.09 0.09 0.08 0.07 0.10 0.07 0.07 0.06 0.05 0.05
Haemorrhagic stroke 0.12 0.12 0.12 0.13 0.10 0.12 0.13 0.12 0.10 0.14 0.10 0.10 0.08 0.07 0.07
Ischaemic stroke 0.08 0.08 0.08 0.08 0.06 0.07 0.08 0.07 0.06 0.09 0.06 0.06 0.06 0.04 0.04
Oesophageal varices 0.54 0.54 0.53 0.55 0.49 0.54 0.56 0.53 0.48 0.57 0.48 0.48 0.42 0.39 0.39
Gastro-oesophageal
haemorrhage 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47
Alcoholic gastritis 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Alcoholic liver cirrhosis 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Unspecified liver cirrhosis
(deaths 1998) (a) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Unspecified liver cirrhosis
(separations 1997–98) (a) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(continued)
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Table A1 (continued): Partial aetiological fractions for harmful and hazardous levels of alcohol consumption relative to moderate levels of
consumption, by condition, age and sex
A1.1 (continued): Males
Age
Condition 0–4 5–9 10–14 15–19 20–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+
Cholelithiasis –0.04 –0.04 –0.04 –0.04 –0.03 –0.04 –0.04 –0.03 –0.03 –0.04 –0.03 –0.03 –0.03 –0.02 –0.02
Acute pancreatitis 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24
Chronic pancreatitis 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84
Low birthweight
Psoriasis 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.04 0.02 0.03 0.03 0.02 0.02
Ethanol toxicity (b) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Methanol toxicity (b) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Road injury
Driver etc. death (b) 0.33 0.33 0.33 0.30 0.39 0.39 0.40 0.40 0.40 0.40 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Pedestrian death (b) 0.75 0.61 0.61 0.53 0.53 0.53 0.53 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.19
Driver etc. hospitalisation (c) 0.25 0.25 0.25 0.20 0.33 0.33 0.24 0.24 0.24 0.24 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09
Pedestrian hospitalisation (c) 0.42 0.52 0.52 0.49 0.49 0.49 0.49 0.31 0.31 0.31 0.31 0.31 0.31 0.31 0.31
Alcoholic beverage poisoning (c) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Other ethanol and methanol
poisoning (c)
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Fall injuries 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.12 0.12 0.12 0.12 0.12
Fire injuries 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44
Drowning 0.03 0.32 0.32 0.32 0.50 0.50 0.50 0.42 0.42 0.42 0.31 0.31 0.31 0.31 0.31 0.31
Aspiration 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Occupational/machine injuries 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
Suicide 0.12 0.12 0.12 0.12 0.10 0.12 0.13 0.11 0.09 0.13 0.10 0.10 0.08 0.07 0.07
Assault 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47
Child abuse 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
 (continued)
114
Table A1 (continued): Partial aetiological fractions for harmful and hazardous levels of alcohol consumption relative to moderate levels of
consumption, by condition, age and sex
A1.2: Females
Age
Condition 0–4 5–9 10–14 15–19 20–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+
Oropharyngeal cancer 0.12 0.12 0.09 0.09 0.10 0.09 0.11 0.14 0.10 0.07 0.08 0.06 0.04 0.06 0.06
Oesophageal cancer 0.10 0.10 0.08 0.07 0.08 0.07 0.08 0.10 0.08 0.06 0.07 0.05 0.03 0.04 0.04
Liver cancer 0.18 0.18 0.14 0.14 0.16 0.14 0.15 0.17 0.16 0.15 0.17 0.11 0.07 0.08 0.08
Laryngeal cancer 0.21 0.21 0.17 0.16 0.18 0.16 0.17 0.20 0.18 0.17 0.19 0.13 0.07 0.09 0.09
Female breast cancer 0.04 0.04 0.03 0.03 0.04 0.03 0.03 0.04 0.04 0.03 0.04 0.03 0.01 0.02 0.02
Alcoholic psychosis 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Alcohol dependence 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Alcohol abuse 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Epilepsy 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15
Alcoholic polyneuropathy 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Hypertension 0.08 0.08 0.06 0.06 0.07 0.06 0.07 0.08 0.07 0.06 0.07 0.05 0.03 0.03 0.03
Alcoholic cardiomyopathy 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Supraventricular cardiac
dysrhythmias
0.09 0.09 0.07 0.06 0.07 0.06 0.07 0.08 0.07 0.07 0.08 0.05 0.03 0.03 0.03
Haemorrhagic stroke 0.20 0.20 0.16 0.15 0.18 0.16 0.23 0.27 0.20 0.10 0.13 0.10 0.08 0.13 0.13
Ischaemic stroke 0.04 0.04 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.03 0.03 0.02 0.01 0.02 0.02
Oesophageal varices 0.54 0.54 0.47 0.46 0.50 0.46 0.47 0.53 0.51 0.49 0.53 0.41 0.27 0.30 0.30
Gastro-oesophageal 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47
Alcoholic gastritis 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Alcoholic liver cirrhosis 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Unspecified liver cirrhosis (deaths
1998) (a)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Unspecified liver cirrhosis
(separations 1997–98) (a)
0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
(continued)
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Table A1 (continued): Partial aetiological fractions for harmful and hazardous levels of alcohol consumption relative to moderate levels of
consumption, by condition, age and sex
A1.2 (continued): Females
Age
Condition 0–4 5–9 10–14 15–19 20–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+
Cholelithiasis –0.03 –0.03 –0.02 –0.02 –0.03 –0.02 –0.03 –0.03 –0.03 –0.02 –0.03 –0.02 –0.01 –0.01 –0.01
Acute pancreatitis 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24
Chronic pancreatitis 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84 0.84
Low birthweight
Psoriasis 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.01 0.01
Ethanol toxicity (b) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Methanol toxicity (b) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Road injury
Driver etc. death (b) 0.11 0.11 0.11 0.08 0.16 0.16 0.18 0.18 0.18 0.18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Pedestrian death (b) 0.50 0.22 0.22 0.42 0.42 0.42 0.42 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
Driver etc. hospitalisation (c) 0.11 0.11 0.11 0.09 0.15 0.15 0.12 0.12 0.12 0.12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Pedestrian hospitalisation (c) 0.23 0.24 0.24 0.24 0.24 0.24 0.24 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Alcoholic beverage poisoning (c) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Other ethanol and methanol
( )
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Fall injuries 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.04 0.04 0.04 0.04 0.04
Fire injuries 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44
Drowning 0.03 0.32 0.32 0.32 0.50 0.50 0.50 0.42 0.42 0.42 0.31 0.31 0.31 0.31 0.31 0.31
Aspiration 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Occupational/machine injuries 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
Suicide 0.12 0.12 0.09 0.09 0.10 0.08 0.09 0.11 0.10 0.09 0.11 0.07 0.04 0.05 0.05
Assault 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47
Child abuse 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
n.a. Not available
(a) This fraction depends on the counts coded to alcoholic liver cirrhosis and to overall liver cirrhosis. Hence it is different for separations and deaths and varies by year. The values presented here are those for 1998 for
deaths and those for 1997–98 for hospital separations.
(b) Fractions for this condition apply only to deaths or PYLL.
(c) Fractions for this condition apply only to hospital separations or patient days.
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Table A2: Deaths attributable to hazardous and harmful alcohol consumption relative to low
consumption, by cause of death, age and year: males, 1996 to 1998
Age
Year/cause of death 0–14 15–34 35–64 65 and over All ages
1996
Cancer 0 2 98 151 250
Alcoholism and alcoholic liver cirrhosis 0 32 481 240 753
Road injuries 20 266 116 23 425
Other 9 209 372 455 1,046
Total 1996 30 509 1,067 869 2,474
1997
Cancer 0 2 103 149 254
Alcoholism and alcoholic liver cirrhosis 0 27 512 255 794
Road injuries 16 254 100 21 391
Other 7 220 358 444 1,029
Total 1997 23 503 1,072 870 2,468
1998
Cancer 0 2 100 140 241
Alcoholism and alcoholic liver cirrhosis 0 26 451 226 703
Road injuries 12 245 111 19 387
Other 4 213 355 431 1,004
Total 1998 16 485 1,017 816 2,335
Note: Columns may not add exactly to totals due to rounding.
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Table A3: Deaths attributable to hazardous and harmful alcohol consumption relative to low
consumption, by cause of death, age and year: females, 1996 to 1998
Age
Year/cause of death 0–14 15–34 35–64 65 and over All ages
1996
Cancer 0 1 59 70 130
Alcoholism and alcoholic liver cirrhosis 0 8 138 64 210
Road injuries 4 30 20 2 56
Other 9 46 123 350 528
Total 1996 13 85 339 485 923
1997
Cancer 0 2 58 69 130
Alcoholism and alcoholic liver cirrhosis 0 13 142 57 213
Road injuries 3 37 21 3 63
Other 5 55 130 347 537
Total 1997 8 107 351 477 943
1998
Cancer 0 2 58 66 126
Alcoholism and alcoholic liver cirrhosis 0 18 132 74 224
Road injuries 3 28 20 3 53
Other 3 53 124 353 533
Total 1998 6 101 334 495 936
Note: Columns may not add exactly to totals due to rounding.
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Table A4: Deaths attributable to hazardous and harmful alcohol consumption relative to low
consumption, by cause of death, age and year: persons, 1996 to 1998
Age
Year/cause of death 0–14 15–34 35–64 65 and over All ages
1996
Cancer 0 3 157 221 380
Alcoholism and alcoholic liver cirrhosis 0 40 619 304 963
Road injuries 24 296 136 25 481
Other 18 255 495 804 1,573
Total 1996 42 594 1,407 1,355 3,398
1997
Cancer 0 4 161 218 384
Alcoholism and alcoholic liver cirrhosis 0 40 654 313 1,007
Road injuries 19 291 121 24 454
Other 12 275 487 792 1,566
Total 1997 31 610 1,423 1,346 3,411
1998
Cancer 0 4 158 205 367
Alcoholism and alcoholic liver cirrhosis 0 44 583 300 927
Road injuries 15 273 130 22 440
Other 8 266 479 784 1,537
Total 1998 23 586 1,351 1,311 3,271
Note: Columns may not add exactly to totals due to rounding.
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Table A5: PYLL attributable to hazardous and harmful alcohol consumption relative to low
consumption, by cause of death, age and year: males, 1996 to 1998
Age
Year/cause of death 0–14 15–34 35–64 65 and over All ages
1996
Cancer 0 43 1,649 1,382 3,074
Alcoholism and alcoholic liver cirrhosis 0 837 8,952 2,314 12,103
Road injuries 595 7,218 2,557 186 10,556
Other 286 5,580 7,288 3,494 16,647
Total 1996 881 13,678 20,446 7,376 42,381
1997
Cancer 0 46 1,748 1,366 3,160
Alcoholism and alcoholic liver cirrhosis 0 714 9,594 2,532 12,840
Road injuries 472 6,891 2,197 177 9,737
Other 202 5,887 6,988 3,428 16,505
Total 1997 674 13,538 20,527 7,503 42,242
1998
Cancer 0 45 1,717 1,253 3,014
Alcoholism and alcoholic liver cirrhosis 0 675 8,418 2,225 11,317
Road injuries 356 6,637 2,418 160 9,570
Other 125 5,683 6,920 3,247 15,975
Total 1998 481 13,039 19,472 6,885 39,877
Note: Columns may not add exactly to totals due to rounding.
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Table A6: PYLL attributable to hazardous and harmful alcohol consumption relative to low
consumption, by cause of death, age and year: females, 1996 to 1998
Age
Year/cause of death 0–14 15–34 35–64 65 and over All ages
1996
Cancer 0 36 1,188 717 1,940
Alcoholism and alcoholic liver cirrhosis 0 217 2,849 719 3,785
Road injuries 114 820 475 20 1,428
Other 277 1,283 2,583 2,680 6,822
Total 1996 390 2,356 7,094 4,135 13,976
1997
Cancer 0 63 1,175 708 1,946
Alcoholism and alcoholic liver cirrhosis 0 348 3,019 682 4,049
Road injuries 98 1,024 484 25 1,631
Other 155 1,517 2,760 2,628 7,061
Total 1997 253 2,952 7,438 4,043 14,687
1998
Cancer 0 61 1,165 644 1,870
Alcoholism and alcoholic liver cirrhosis 0 486 2,779 831 4,095
Road injuries 91 782 473 24 1,369
Other 105 1,464 2,611 2,697 6,876
Total 1998 196 2,792 7,027 4,195 14,210
Note: Columns may not add exactly to totals due to rounding.
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Table A7: PYLL attributable to hazardous and harmful alcohol consumption relative to low
consumption, by cause of death, age and year: persons, 1996 to 1998
Age
Year/cause of death 0–14 15–34 35–64 65 and over All ages
1996
Cancer 0 79 2,837 2,099 5,015
Alcoholism and alcoholic liver cirrhosis 0 1,054 11,801 3,032 15,888
Road injuries 709 8,038 3,032 206 11,984
Other 563 6,863 9,870 6,174 23,469
Total 1996 1,271 16,034 27,540 11,511 56,357
1997
Cancer 0 109 2,923 2,075 5,107
Alcoholism and alcoholic liver cirrhosis 0 1,062 12,613 3,213 16,889
Road injuries 570 7,915 2,681 202 11,368
Other 357 7,404 9,748 6,057 23,566
Total 1997 927 16,490 27,965 11,547 56,929
1998
Cancer 0 106 2,882 1,897 4,884
Alcoholism and alcoholic liver cirrhosis 0 1,161 11,196 3,055 15,413
Road injuries 447 7,418 2,890 184 10,940
Other 229 7,147 9,531 5,944 22,851
Total 1998 676 15,831 26,499 11,080 54,087
Note: Columns may not add exactly to totals due to rounding.
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Table A8: Separations attributable to hazardous and harmful alcohol consumption relative to low
consumption, by reason for separation, age and year: males, 1995–96 to 1997–98
Age
Year/reason for separation 0–14 15–34 35–64 65 and over All ages
1995–96
Cancer 0 14 539 536 1,089
Alcoholism and alcoholic liver cirrhosis 127 4,167 11,158 2,226 17,678
Road injuries 336 3,431 1,173 245 5,184
Other 253 11,184 9,840 4,485 25,762
Total 1995–96 716 18,796 22,709 7,492 49,713
1996–97
Cancer 0 15 573 535 1,122
Alcoholism and alcoholic liver cirrhosis 129 3,930 11,232 2,324 17,615
Road injuries 318 3,273 1,224 255 5,071
Other 253 11,014 9,965 4,736 25,968
Total 1996–97 700 18,232 22,994 7,850 49,776
1997–98
Cancer 0 10 607 579 1,196
Alcoholism and alcoholic liver cirrhosis 143 3,783 11,564 2,162 17,652
Road injuries 329 3,083 1,145 233 4,790
Other 229 10,765 9,966 4,819 25,779
Total 1997–98 701 17,640 23,283 7,793 49,417
Note: Columns may not add exactly to totals due to rounding.
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Table A9: Separations attributable to hazardous and harmful alcohol consumption relative to low
consumption, by reason for separation, age and year: females, 1995–96 to 1997–98
Age
Year/reason for separation 0–14 15–34 35–64 65 and over All ages
1995–96
Cancer 0 25 482 248 755
Alcoholism and alcoholic liver cirrhosis 139 2,006 4,000 621 6,766
Road injuries 82 715 330 55 1,182
Other 124 4,032 4,592 3,465 12,213
Total 1995–96 346 6,777 9,404 4,389 20,917
1996–97
Cancer 0 25 482 245 751
Alcoholism and alcoholic liver cirrhosis 124 2,119 4,428 668 7,339
Road injuries 84 661 313 55 1,113
Other 106 3,900 4,499 3,648 12,154
Total 1996–97 314 6,705 9,722 4,616 21,357
1997–98
Cancer 0 25 519 265 808
Alcoholism and alcoholic liver cirrhosis 135 2,071 5,074 668 7,948
Road injuries 81 628 296 50 1,056
Other 118 3,789 4,528 3,759 12,193
Total 1997–98 334 6,513 10,417 4,742 22,005
Note: Columns may not add exactly to totals due to rounding.
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Table A10: Separations attributable to hazardous and harmful alcohol consumption relative to low
consumption, by reason for separation, age and year: persons, 1995–96 to 1997–98
Age
Year/reason for separation 0–14 15–34 35–64 65 and over All ages
1995–96
Cancer 0 39 1,021 784 1,844
Alcoholism and alcoholic liver cirrhosis 266 6,173 15,158 2,847 24,444
Road injuries 419 4,146 1,503 299 6,366
Other 378 15,216 14,431 7,950 37,975
Total 1995–96 1,062 25,574 32,113 11,881 70,630
1996–97
Cancer 0 40 1,055 780 1,874
Alcoholism and alcoholic liver cirrhosis 253 6,049 15,660 2,992 24,954
Road injuries 402 3,935 1,537 310 6,184
Other 359 14,914 14,465 8,384 38,121
Total 1996–97 1,015 24,937 32,716 12,466 71,133
1997–98
Cancer 0 35 1,126 843 2,004
Alcoholism and alcoholic liver cirrhosis 278 5,854 16,638 2,830 25,600
Road injuries 410 3,711 1,442 283 5,846
Other 346 14,553 14,494 8,578 37,971
Total 1997–98 1,034 24,153 33,700 12,535 71,422
Note: Columns may not add exactly to totals due to rounding.
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Table A11: Patient days attributable to hazardous and harmful alcohol consumption relative to low
consumption, by reason for separation, age and year: males, 1995–96 to 1997–98
Age
Year/reason for separation 0–14 15–34 35–64 65 and over All ages
1995–96
Cancer 0 80 4,652 5,190 9,922
Alcoholism and alcoholic liver cirrhosis 145 18,191 89,467 43,782 151,586
Road injuries 1,496 19,671 8,091 2,874 32,132
Other 5,380 30,334 48,033 47,222 130,970
Total 1995–96 7,022 68,277 150,243 99,069 324,610
1996–97
Cancer 0 104 4,449 4,963 9,516
Alcoholism and alcoholic liver cirrhosis 8,576 16,959 118,226 39,357 183,117
Road injuries 1,279 18,482 9,003 3,053 31,817
Other 5,836 36,914 47,185 45,903 135,839
Total 1996–97 15,691 72,459 178,863 93,276 360,289
1997–98
Cancer 0 73 4,376 5,042 9,490
Alcoholism and alcoholic liver cirrhosis 164 15,719 146,136 49,969 211,988
Road injuries 1,187 16,651 7,842 2,286 27,967
Other 6,311 27,387 42,198 44,178 120,073
Total 1997–98 7,662 59,830 200,551 101,475 369,518
Note: Columns may not add exactly to totals due to rounding.
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Table A12: Patient days attributable to hazardous and harmful alcohol consumption relative to low
consumption, by reason for separation, age and year: females, 1995–96 to 1997–98
Age
Year/reason for separation 0–14 15–34 35–64 65 and over All ages
1995–96
Cancer 0 94 2,692 2,111 4,896
Alcoholism and alcoholic liver cirrhosis 162 8,466 31,611 15,788 56,028
Road injuries 361 3,448 1,955 563 6,327
Other 4,712 11,710 23,131 37,649 77,202
Total 1995–96 5,234 23,719 59,389 56,110 144,453
1996–97
Cancer 0 102 2,381 2,027 4,511
Alcoholism and alcoholic liver cirrhosis 155 8,733 32,115 12,129 53,132
Road injuries 299 3,459 1,864 536 6,157
Other 5,214 12,590 26,140 37,390 81,334
Total 1996–97 5,667 24,884 62,500 52,082 145,134
1997–98
Cancer 0 98 2,610 2,027 4,735
Alcoholism and alcoholic liver cirrhosis 149 7,756 30,202 10,342 48,449
Road injuries 319 3,231 1,667 456 5,673
Other 5,283 10,478 21,199 35,590 72,550
Total 1997–98 5,751 21,563 55,679 48,415 131,407
Note: Columns may not add exactly to totals due to rounding.
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Table A13: Patient days attributable to hazardous and harmful alcohol consumption relative to low
consumption, by reason for separation, age and year: persons, 1995–96 to 1997–98
Age
Year/reason for separation 0–14 15–34 35–64 65 and over All ages
1995–96
Cancer 0 174 7,343 7,301 14,818
Alcoholism and alcoholic liver cirrhosis 307 26,658 121,079 59,571 207,614
Road injuries 1,857 23,119 10,046 3,437 38,459
Other 10,092 42,045 71,164 84,871 208,172
Total 1995–96 12,256 91,996 209,632 155,180 469,063
1996–97
Cancer 0 205 6,831 6,990 14,026
Alcoholism and alcoholic liver cirrhosis 8,731 25,692 150,341 51,486 236,249
Road injuries 1,577 21,941 10,867 3,589 37,974
Other 11,050 49,505 73,325 83,293 217,173
Total 1996–97 21,358 97,343 241,363 145,358 505,423
1997–98
Cancer 0 171 6,986 7,068 14,225
Alcoholism and alcoholic liver cirrhosis 313 23,475 176,338 60,311 260,437
Road injuries 1,506 19,883 9,509 2,742 33,640
Other 11,594 37,865 63,397 79,768 192,623
Total 1997–98 13,412 81,394 256,230 149,889 500,925
Note: Columns may not add exactly to totals due to rounding.
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Appendix B Studies reviewed in
revising relative risk estimates
This appendix lists the studies reviewed in revising the aetiological fractions for alcohol and
female breast cancer, stroke and fall injuries.
Risk-ratio estimates were also revised for alcohol and road injuries, tobacco and peptic ulcer,
and illicit drugs and road injuries. However, each of these was based on only a small
number of studies which were listed in the relevant sections of Chapters 3 and 5. Recent
research results do not support a causal relationship between smoking and cervical cancer,
so no new relative risk estimate was calculated.
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Table B.1: Studies used by English et al. to revise aetiological fractions for female breast cancer attributable to alcohol
Reference Age Cases(a) Outcome Country Subjects(b) Adjustments(c) Study type(d)
Chu et al. 1989 20–54 I Breast cancer US 3,217/2,945 Age, T C-C
Ewertz 1991 <70 I Breast cancer Denmark 1,486/1,336 Age C-C
Ferraroni et al. 1991 30–65 I Breast cancer Italy 214/215 Age C-C
Franceschi et al. 1991 <75 I Breast cancer Italy 132/499 Age C-C
Harvey et al. 1987 All I Breast cancer US 1,524/1,896 Age C-C
Hiatt & Bawol 1984 15+ I Breast cancer US 838/838 Age, T Coh
Hiatt et al. 1988 I Breast cancer US 303/69,303 Age, T Coh
La Vecchia et al. 1989 23–74 I Breast cancer Italy 2,402/2,020 Age, T C-C
La Vecchia et al. 1985 26–74 I Breast cancer Italy 437/437 Age, T C-C
Le et al. 1984 I Breast cancer France 500/945 Age C-C
Nasca et al. 1990 20–79 I Breast cancer US 1,617/1,617 Age C-C
O’Connell et al. 1987 I Breast cancer US 275/1,519 Age, T C-C
Rosenberg et al. 1990 <70 I Breast cancer Canada 607/1,214 Age, T C-C
Schatzkin et al. 1987 25–74 I Breast cancer US 121/7,188 Age Coh
31–64 I Breast cancer US 143/2,636 Age, T Coh
Simon et al. 1991 21+ I Breast cancer US 87/87 Age, T Coh
Toniolo et al. 1989 <75 I Breast cancer Italy 250/499 Age C-C
Webster et al. 1983 20–54 I Breast cancer US 1,226/1,279 Age C-C
Adami et al. 1988 <45 I Breast cancer Sweden 422/527 Age, T C-C
(continued)
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Table B.1 (continued): Studies used by English et al. to revise aetiological fractions for female breast cancer attributable to alcohol
Reference Age Cases(a) Outcome Country Subjects(b) Adjustments(c) Study type(d)
Friedenreich et al. 1993 Pre-menopausal I Breast cancer Canada 284/691 Age, T C-C
Harris et al. 1992 Pre-menopausal I Breast cancer US 192/184 Age, T C-C
Martin Moreno et al. 1993 Pre-menopausal I Breast cancer Spain 247/356 Age C-C
Meara et al. 1989 25–44 I Breast cancer UK 351/351 (hosp. study) T C-C
Richardson et al. 1989 25–45 I Breast cancer France 78/140 C-C
Rohan & McMichael 1988 Pre-menopausal I Breast cancer Australia 146/132 Age, T C-C
Sneyd et al. 1991 25–34 I Breast cancer NZ 64/423 Age, T C-C
35–44 I Breast cancer NZ 323/804 Age, T C-C
Willett et al. 1987 34–39 I Breast cancer US 71/20,230 Age Coh
40–44 I Breast cancer US 92/18,175 Age Coh
van’ t Veer et al. 1989 25–44 I Breast cancer Netherland
s
47/89 Age, T C-C
Friedenreich et al. 1993 Post-menopausal I Breast cancer Canada 284/691 Age, T C-C
Gapstur et al. 1992 55–69 I Breast cancer US 459/37,059 Age, T Coh
Garfinkel et al. 1988 45+ D Breast cancer US 2,933/581,321 Age, T Coh
Harris et al. 1992 Post-menopausal I Breast cancer US 412/336 Age, T C-C
Martin Moreno et al. 1993 Post-menopausal I Breast cancer Spain 515/632 Age C-C
Meara et al. 1989 45–69 I Breast cancer UK 647/647 (hosp. study) T C-C
Meara et al. 1989 45–69 I Breast cancer UK 647/647 (screening
study)
T C-C
Richardson et al. 1989 46–55 I Breast cancer France 126/165 C-C
Richardson et al. 1989 56–65 I Breast cancer France 145/154 C-C
(Continued)
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Table B.1 (continued): Studies used by English et al. to revise aetiological fractions for female breast cancer attributable to alcohol
Reference Age Cases(b) Outcome Country Subjects(b) Adjustments(c) Study Type(d)
Rohan & McMichael 1988 Post-menopausal I Breast cancer Australia 281/288 Age, T C-C
Sneyd et al. 1991 45–54 I Breast cancer NZ 501/649 Age, T C-C
Willett et al. 1987 45–49 I Breast cancer US 153/18,661 Age Coh
50–54 I Breast cancer US 146/17,949 Age Coh
55–59 I Breast cancer US 139/14,523 Age Coh
van’ t Veer et al. 1989 55–64 I Breast cancer Netherlands 73/79 Age, T C-C
(a) Cases are classified as incident cases of breast cancer (I) or deaths from breast cancer (D).
(b) Numbers of subjects are presented as m/n, where m is the number of cases and n is the number of controls in a case-control study or the total number of subjects in a cohort study.
(c) This column shows whether results are adjusted for potential confounding by age or tobacco consumption (T).
(d) Studies are classified as either case-control studies (C-C) or cohort studies (Coh).
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Table B.2: Studies used by English et al. and relative effect measures for aetiological fractions for female breast cancer and alcohol
Reference Unit(a) Level 1(b) RR 95% CI Level 2(b) RR 95% CI Level 3(b) RR  95% CI Level 4(b) RR 95% CI Level 5(b) RR  95% CI Level 6(b) RR  95% CI
Chu et al. 1989 d/w <1 1.00 0.80–
1.10
1–3 1.00 0.80–
1.20
4–7 0.90 0.70–
1.10
8–14 1.10 0.90–
1.30
15–21 1.00 0.80–
1.40
22+ 1.20 0.90–
1.60
Ewertz 1991 g/d 1–23 0.74 0.47–
1.15
24+ 0.63 0.34–
1.17
Ferraroni et al. 1991 g/d 0.1–5.3 1.10 0.50–
2.20
5.3–13.1 1.5 0.80–
2.80
13.1–24.3 1.20 0.60–
2.40
24.35+ 2.10 1.10–
3.90
Franceschi et al. 1991 d/d 1 1.30 0.70–
2.60
2 1.40 0.80–
2.70
3+ 1.70 0.90–
3.20
Harvey et al. 1987 g/w 1–13 1.12 0.90–
1.30
14–91 1.06 0.90–
1.30
92–182 1.31 1.00–
1.70
183+ 1.66 1.20–
2.40
Hiatt & Bawol 1984 d/d ≤2 1.19 1.02–
1.38
3–5 1.67 1.28–
2.18
6+ 1.50 0.86–
2.62
Hiatt et al. 1988 d/d 1–2 1.50 0.98–
2.29
3–5 1.47 0.78–
2.79
6+ 3.30 1.18–
9.28
La Vecchia et al. 1989 d/d <1 1.30 1.10–
1.60
1–2 1.30 1.10–
1.50
2–3 1.40 1.20–
2.70
>3 2.20 1.70–
2.70
La Vecchia et al. 1985 d/d ≤3 1.25 0.91–
1.73
>3 2.10 1.12–
3.95
Le et al. 1984 g/w 1–79 1.00 0.70–
1.40
80–159 1.40 1.00–
2.00
160–239 1.50 1.00–
2.10
240+ 1.20 0.70–
2.00
Nasca et al. 1990 g/d <1.4 1.07 0.83–
1.36
1.5–4.9 1.04 0.78–
1.39
5–14.9 1.10 0.87–
1.39
15+ 1.26 0.98–
1.64
O’Connell et al. 1987 d/w 1+ 1.45 0.99–
2.12
Rosenberg et al. 1990 d/w 1–3/m 0.60 0.40–
0.80
1–3 1.0 0.70–
1.40
4–6 0.80 0.60–
1.20
1/d 0.80 0.50–
1.10
2+/d 1.00 0.70–
1.50
(continued)
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Table B.2 (continued): Studies used by English et al. and relative effect measures for aetiological fractions for female breast cancer and alcohol
Reference Unit(a) Level 1(b) RR 95% CI Level 2(b) RR 95% CI Level 3(b) RR  95% CI Level 4(b) RR 95% CI Level 5(b) RR  95% CI Level 6(b) RR  95% CI
Schatzkin et al. 1987 g/d <1.2 1.40 0.80–
2.50
1.3–4.9 1.60 0.90–
3.10
5+ 2.0 1.10–
3.70
g/d <1.4 1.00 0.60–
1.50
1.5–4.9 0.70 0.40–
1.10
5+ 0.60 0.40–
1.00
Simon et al. 1991 d/d <1 1.08 0.64–
1.82
1<2 1.23 0.49–
3.10
2+ 1.12 0.25–
5.01
Toniolo et al. 1989 g/d 1–10 0.90 0.50–
1.50
11–20 1.20 0.80–
1.90
21–30 1.10 0.70–
1.80
31–40 1.30 0.70–
2.70
41+ 1.90 1.10–
3.30
Webster et al. 1983 g/w <50 0.90 0.70–
1.20
50–149 0.90 0.70–
1.20
150–199 1.10 0.70–
1.70
200–249 1.10 0.70–
1.90
250–299 1.00 0.50–
1.70
300+ 1.10 0.60–
1.80
Adami et al. 1988 g/d 0.1–1.2 1.10 0.50–
2.40
1.30–4.90 0.80 0.60–
1.20
5–14.9 0.60 0.40–
0.90
15+ 0.50 0.20–
1.30
Friedenreich et al. 1993 g/d 1–9 1.11 0.71–
1.71
10–19 1.37 0.79–
2.30
20–29 1.51 0.80–
2.86
30+ 1.88 0.96–
3.66
Harris et al. 1992 g/d 1–15 1.20 0.70–
1.90
16+ 0.70 0.30–
1.50
Martin Moreno et al. 1993 g/d <3.01 1.10 0.60–
1.80
3.01–9.20 1.50 0.90–
2.50
9.21–23.0 1.30 0.70–
2.20
>23 1.60 0.90–
2.80
Meara et al. 1989 g/d 3–12 1.20 0.70–
2.10
13–27 0.70 0.30–
1.40
28+ 0.70 0.30–
1.70
Richardson et al. 1989 d/w 1–7 2.00 1.00–
3.80
>7 1.60 0.80–
3.20
Rohan & McMichael 1988 g/d <2.51 0.77 0.28–
2.12
2.51–9.30 1.64 0.62–
4.36
>9.3 2.33 0.85–
6.37
 (continued)
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Table B.2 (continued): Studies used by English et al. and relative effect measures for aetiological fractions for female breast cancer and alcohol
Reference Unit(a) Level 1(b) RR 95% CI Level 2(b) RR 95% CI Level 3(b) RR  95% CI Level 4(b) RR 95% CI Level 5(b) RR  95% CI Level 6(b) RR  95% CI
Sneyd et al. 1991 d/w 1–7 0.66 0.37–
1.19
8+ 1.10 0.36–
3.34
d/w 1–7 0.67 0.50–
0.89
8+ 0.77 0.49–
1.21
Willett et al. 1987 g/d <1.5 1.63 0.82–
3.25
1.5–4.9 1.06 0.54–
2.08
5–14.9 1.27 0.65–
2.50
15+ 1.35 0.59–
3.08
g/d <1.5 1.14 0.57–
2.28
1.5–4.9 0.98 0.53–
1.82
5–14.9 0.81 0.41–
1.59
15+ 2.35 1.35–
4.08
van’ t Veer et al. 1989 g/d 1–4 0.30 0.00–
1.70
5–14 0.50 0.10–
2.90
15–29 0.80 0.10–
4.90
30+ 2.30 0.30–
19.1
Friedenreich et al. 1993 g/d 1–9 1.02 0.72–
1.43
10–19 0.77 0.47–
1.26
20–29 1.16 0.64–
2.12
30+ 0.86 0.46–
1.59
Gapstur et al. 1992 g/d <1.5 1.18 0.86–
1.61
1.5–4.9 1.20 0.93–
1.56
5–14.9 1.25 0.93–
1.68
15+ 1.46 1.04–
2.04
Garfinkel et al. 1988 d/d <1 0.96 0.82–
1.13
1 1.18 1.03–
1.36
2 1.06 0.86–
1.30
3 1.28 0.95–
1.74
4 1.36 0.90–
2.07
5 2.10 1.18–
3.27
Harris et al. 1992 g/d 1–15 1.1 0.80–
1.60
16+ 0.80 0.50–
1.30
Martin Moreno et al. 1993 g/d <1.81 1.2 0.80–
1.70
1.81–6.60 1.60 1.10–
2.40
6.61–18.8 1.80 1.30–
2.70
>18.8 1.90 1.30–
2.80
Meara et al. 1989 g/d <3 1.20 0.40–
3.60
3–12 1.10 0.30–
3.50
13–27 0.70 0.20–
2.90
28+ 1.20 0.10–
9.40
Meara et al. 1989 g/d <3 1.20 0.40–
3.60
3–12 1.10 0.30–
3.50
13–27 0.70 0.20–
2.90
28+ 1.20 0.10–
9.40
Richardson et al. 1989 d/w 1–7 1.30 0.70–
2.20
>7 3.30 1.80–
5.60
 (continued)
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Table B.2 (continued): Studies used by English et al. and relative effect measures for aetiological fractions for female breast cancer and alcohol
Reference Unit(a) Level 1(b) RR 95% CI Level 2(b) RR 95% CI Level 3(b) RR  95% CI Level 4(b) RR 95% CI Level 5(b) RR  95% CI Level 6(b) RR  95% CI
Richardson et al. 1989 d/w 1–7 2.40 1.40–
4.10
>7 3.20 1.70–
6.10
Rohan & McMichael 1988 g/d <2.51 0.84 0.46–
1.53
2.51–9.30 1.12 0.59–
2.15
>9.30 1.27 0.69–
2.33
Sneyd et al. 1991 d/w 1–7 0.96 0.74–
1.24
8+ 1.20 0.77–
1.87
Willett et al. 1987 g/d <1.5 0.83 0.45–
1.54
1.5–4.9 0.61 0.34–
1.08
5–14.9 1.58 1.03–
2.41
15+ 1.88 1.22–
2.90
g/d <1.5 1.00 0.56–
1.80
1.5–4.9 0.88 0.53–
1.47
5–14.9 1.63 1.07–
2.49
15+ 1.14 0.69–
1.87
g/d <1.5 0.78 0.41–
1.48
1.5–4.9 1.23 0.77.1.98 5–14.9 0.66 0.37–
1.17
15+ 1.48 0.93–
2.35
van’ t Veer et al. 1989 g/d 1–4 0.80 0.30–
2.30
5–14 1.00 0.03–
3.60
15–29 1.10 0.30–
4.30
30+ 0.90 0.20–
4.50
(a) Unit of measurement used in the study—drinks per week (d/w), grams per day (g/d) or drinks per day (d/d).
(b) Studies used different classification schemes for levels of alcohol consumption. These columns show the definitions of these levels for each study, from the lowest (level 1) to the highest (level 6).
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Table B.3: Studies reviewed to revise aetiological fractions for female breast cancer attributable to alcohol
Reference Age Cases(a) Outcome Country Subjects(b) Adjustments(c) Study type(d)
Ferraroni et al. 1998 23–74 I Breast cancer Italy 2,569/2,588 Age, P,AR,AB,AM, BMI,
F
C-C
Bowlin et al. 1997 20–79 I Breast cancer US 1,214/1,214 Age,R,I,MS,F,AM,P,A C-C
Royo Bordonada et al. 1997 50–74 I Breast cancer Europe 315/364 Age,BMI,T,AM,P,HRT,+ C-C
Swanson et al. 1997 <45 I Breast cancer US 1,645/1,497 Age,R,P,OCP, C-C
Thun et al. 1997 30–104 D Breast cancer US 691/230,552 Adjusted Coh (prospective)
Haile et al. 1996 <50 I Bilateral breast cancer US 144/232 Age,E,AM,AB,HRT,OCP,
+
C-C
Boice et al. 1995 >30 I Breast cancer US 528/2,640 Age,AM,AB,P,+ C-C
Freudenheim et al. 1995 40–85 I Breast cancer US 740/810 Age,E,BMI,MS,AM, + C-C
Holmberg et al. 1995 40–70 I Breast cancer Sweden 380/525 F,P,AB,E,BMI C-C
Longnecker et al. 1995a <75 I Breast cancer US 6,888/9,424 Age,AB,P,BMI,AM,E+ C-C
Longnecker et al. 1995b 55–64 I Breast cancer US 1,431/1,431 Age
matched,AM,P,BMI,+
C-C
van den Brandt et al. 1995 55–69 I Breast cancer Netherlands 422/62,573 Age,AM,F,OCP,P,AB,E,+ Coh
Katsouyanni et al. 1994 I Breast cancer Greece 820/1,548 Age, AB,P,AM, MS,+ C-C
Nasca et al. 1994 20–79 I Breast cancer (Estrogen receptor +) US 1,152 (792 ER+)/1,617 Age C-C
Begg et al. 1983 I Breast cancer US/Can 75/75 Age, T C-C
Byers & Funch 1982 30–69 I Breast cancer US 1,314/770 Age
(a) Cases are classified as incident cases of breast cancer (I) or deaths from breast cancer (D).
(b) Numbers of subjects are presented as m/n, where m is the number of cases and n is the number of controls in a case-control study or the total number of subjects in a cohort study.
(c) This column shows whether results are adjusted for potential confounding. Potential confounders are age, parity (P), age at first birth (AB), age at menarche (AM), body mass index (BMI), family history (F), area of
residence (AR), education (E), energy intake (EI), physical activity (PA), religion (R), income (I), marital status (MS), tobacco (T), hormone replacement therapy (HRT), oral contraceptive pill (OCP), race (R), and
menopausal status (MS).
(d) Studies are classified as either case-control studies (C-C) or cohort studies (Coh).
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Table B.4: Risk estimates for studies reviewed to revise aetiological fractions for female breast cancer attributable to alcohol
Reference Age Unit(a) Level 1(b) RR 95% CI Level 2(b) RR 95% CI Level 3(b) RR  95% CI Level 4(b) RR 95% CI Level 5(b) RR  95% CI Level 6(b) RR  95% CI
Ferraroni et al. 1998 23–74 g/d 1.00–5.87 1.21 1.00–1.47 5.88–13.4 1.23 1.02–1.50 13.4–
24.55
1.19 0.98–
1.45
24.6–27.6 1.21 0.99–
1.47
>27.60 1.41 1.17–
1.71
Pre-men g/d 1.00–5.87 1.45 1.06–1.97 5.88–13.4 1.12 0.80–1.55 13.4–
24.55
1.55 1.10–
2.18
24.6–27.6 1.47 1.04–
2.08
>27.60 1.80 1.30–
2.50
Post-men g/d 1.00–5.87 1.01 0.79–1.30 5.88–13.4 1.23 0.97–1.56 13.4–
24.55
0.98 0.77–
1.25
24.6–27.6 1.03 0.81–
1.30
>27.60 1.13 0.89–
1.44
Bowlin et al. 1997 20–79 g/d >0<5 1.29 1.00–1.65 ≥5 1.46 1.13–1.89
Pre-men g/d >0<5 1.26 0.71–2.22 ≥5 1.54 0.87–2.74
Post-men g/d >0<5 1.32 0.97–1.80 ≥5 1.51 1.09–2.08
Thun et al. 1997 30–104 d/d <1 1.10 0.90–1.30 1 1.20 1.00–1.60 2–3 1.50 1.20–
1.90
≥4 1.00 0.70–
1.40
Boice et al. 1995 >30 d/w <1 0.86 0.67–1.10 1–6 0.91 0.69–1.20 7–13 0.86 0.61–
1.22
≥14 2.12 1.06–
4.27
Holmberg et al. 1995 40–70 g/d <=0.75 1.2 0.80–1.80 0.76–2.00 1.90 1.20–2.90 >=2.00 1.60 1.00–
2.40
<=50 g/d <=0.75 0.40 0.10–1.50 0.76–2.00 0.70 0.30–1.80 >=2.00 0.80 0.40–
1.40
>50 g/d <=0.75 1.4 0.90–2.30 0.76–2.00 2.10 1.30–3.40 >=2.00 1.80 1.10–
2.90
Longnecker et al.
1995a
<75 g/d ≤5 1.08 0.98–1.19 6–11 1.09 0.96–1.23 12–18 1.17 1.01–
1.37
19–32 1.49 1.24–
1.79
33–45 1.95 1.42–
2.66
≥46 1.96 1.43–
2.67
Pre-men g/d ≤5 1.25 0.97–1.61 6–11 1.25 0.93–1.67 12–18 1.18 0.83–
1.67
19–32 1.43 0.96–
2.13
33–45 1.65 0.88–
3.10
≥46 1.61 0.90–
2.86
Post-men g/d ≤5 1.05 0.94–1.17 6–11 1.07 0.92–1.24 12–18 1.20 1.00–
1.44
19–32 1.59 1.28–
1.98
33–45 2.01 1.37–
2.95
≥46 2.28 1.51–
3.44
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Table B.4 (continued): Risk estimates for studies reviewed to revise aetiological fractions for female breast cancer attributable to alcohol
Reference Age Unit(a) Level 1(b) RR 95% CI Level 2(b) RR 95% CI Level 3(b) RR  95% CI Level 4(b) RR 95% CI Level 5(b) RR  95% CI Level 6(b) RR  95% CI
Longnecker et al. 1995b 55–64 d/w >0–5 1.01 0.84–1.22 6–11 1.21 0.95–1.55 12–18 0.94 0.69–
1.44
19–32 1.63 1.14–
2.33
33–45 2.45 1.22–
4.93
≥46 0.94 0.46–
1.93
Katsouyanni et al. 1994 d/w ≤1 1.30 1.01–1.67 2–6 1.11 0.86–1.43 7–13 0.95 0.65–
1.38
14–20 1.29 0.66–
2.52
21–27 3.01 1.14–
7.95
28+ 3.79 1.05–
13.7
Nasca et al. 1994
Oestrogen
receptor +
20–79 d/d <1.5 1.18 0.88–1.57 1.5–4.9 1.28 0.91–1.80 5.0–14.9 1.28 0.96–
1.70
≥15 1.35 0.99–
1.85
Oestrogen
receptor –
20–79 d/d <1.5 0.92 0.62–1.36 1.5–4.9 1.19 0.77–1.83 5.0–14.9 0.94 0.64–
1.35
≥15 1.05 0.70–
1.59
Swanson et al. 1997 <45 d/w <1 1.35 1.10–1.70 1–2.9 1.01 0.80–1.20 3–6.9 1.03 0.80–
1.30
7–13.9 1.10 0.80–
1.50
≥14 1.79 1.20–
2.60
Haile et al. 1996 <50 d/w 1–3 1.20 0.60–2.30 >3 1.80 1.00–3.40
Royo Bordonada et al.
1997
50–74 g/d 1.7 1.00 0.60–1.67 6.0 1.01 0.60–1.73 20.0 1.18 0.69–
2.03
Freudenheim et al.
1995
40–85 d/w <1 0.90 0.65–1.25 1–4 0.85 0.61–1.18 >4<7 0.91 0.55–
1.50
≥8 0.89 0.62–
1.30
van den Brandt et al.
1995
55–69 g/d >0<5 1.30 0.96–1.95 5–14 1.29 0.89–1.85 15–29 1.28 0.81–
2.03
≥30 1.72 0.90–
3.28
Begg et al. 1983 d/w 1–7 0.90 0.80–1.10 >7 1.40 0.90–2.00
Byers & Funch 1982 30–69 d/m <3 1.11 0.85–1.44 3–8 1.02 0.76–1.33 9–25 1.09 0.77–
1.44
26+ 1.13 0.88–
1.44
(a) Unit of measurement used in the study—drinks per week (d/w), grams per day (g/d), drinks per day (d/d) or drinks per month (d/m).
(b) Studies used different classification schemes for levels of alcohol consumption. These columns present the definitions of these levels for each study, from the lowest (level 1) up to the highest (level 6).
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Table B.5: Studies reviewed to revise aetiological fractions for alcohol exposure and stroke
Reference Age Sex Cases(a) Outcome Country Subjects(b) Adjustments(c) Study type(d)
Numminen et al. 1996 35–74 M+F I All stroke Finland 426/157 C-C
Wannamethee & Shaper 1996 Middle age M I+D All stroke UK 216 Age Coh (prospective)
Beghi et al. 1995 24–87 M+F I All stroke Italy 200/602 Age, sex, pst stk, HT, D,
T
C-C
Iso et al. 1995 40–69 M I+D All stroke Japan 178 Age adjusted Coh (prospective)
Lee et al. 1995 >65 M+F I All stroke Taiwan 155 Age, T, HT,D,Chol Coh (retrospective)
>65 M I All stroke Taiwan 91 Age, T, HT, D, Chol Coh (retrospective)
Donahue et al. 1986 45+ M I+D All stroke US 290 Age, HT, Chol, BMI, T, + Coh (prospective)
Sacco et al. 1999 > 39 M+F I+D First ischaemic stroke US 677/1,139 Matched age, sex, race C-C
>39 M I+D First ischaemic stroke US 299/447 Age, sex, race,
HT,D,IHD+
C-C
>39 F I+D First ischaemic stroke US 378/692 Age, sex, race,
HT,D,IHD+
C-C
Haapaniemi et al. 1996 16–60 M+F I First ischaemic cerebral Finland 535 Unadjusted Case series
Goldberg et al. 1995 55–64 M I+D Thromboembolic stroke US 184 HR, BP, S, Chol, BMI,+ Coh (prospective)
Hillbom et al. 1995 16–40 M+F I First ischaemic stroke Finland 74/133 Age, sex, acuteness, + C-C
16–40 M I First ischaemic stroke Finland 47/83 Age, sex, acuteness, + C-C
16–40 F I First ischaemic stroke Finland 27/50 Age, sex, acuteness, + C-C
Iso et al. 1995 40–69 M I+D First non-haemorrhagic stroke Japan 104 Age adjusted Coh (prospective)
Kiyohara et al. 1995 ≥40 M+F I Cerebral infarction Japan 244 Age, sex Coh (prospective)
Lee et al. 1995 >65 M+F I Cerebral infarction Taiwan 155 Age, T, HT, D, Chol Coh (retrospective)
>65 M I Cerebral infarction Taiwan 91 Age, T, HT, D, Chol Coh (retrospective)
 (continued)
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Table B.5 (continued): Studies reviewed to revise aetiological fractions for alcohol exposure and stroke
Reference Age Sex Cases(a) Outcome Country Subjects(b) Adjustments(c) Study type(d)
Donahue et al. 1986 45+ M I+D Thromboembolic stroke US 190 Age, HT, Chol, BMI, T, + Coh (prospective)
Giroud et al. 1995 M+F I Primary cerebral haemorrhage France 130/130 Matched age, sex C-C
Iso et al. 1995 40–69 M I+D First haemorrhagic stroke Japan 58 Age adjusted Coh (prospective)
Juvela et al. 1995 16–60 M+F I+D First intracerebral haemorrhage Finland 156/332 Age, sex, BMI, T, HT C-C
16–60 M I+D First intracerebral haemorrhage Finland 96/192 Age, sex, BMI, T, HT C-C
16–60 F I+D First intracerebral haemorrhage Finland 60/140 Age, sex, BMI, T, HT C-C
Kiyohara et al. 1995 ≥40 M+F I Cerebral haemorrhage Japan 60 Age, sex Coh (prospective)
Longstreth et al. 1992 >18 M+F I+D Subarachnoid haemorrhage US 149/298 Age, sex, respondent
type
C-C
Donahue et al. 1986 45+ M I+D Total haemorrhagic stroke US 76 Age, HT, Chol, BMI, T, + Coh (prospective)
(a) Cases are classified as incident cases of breast cancer (I) or deaths from breast cancer (D).
(b) Numbers of subjects are presented as m/n, where m is the number of cases and n is the number of controls in a case-control study or the total number of subjects in a cohort study.
(c) This column shows whether results are adjusted for potential confounding. Potential confounders are age, sex, past stroke (Pst stk), Hypertension (HT), Diabetes (D), Tobacco use (T), Cholesterol level (Chol), body mass index
(BMI), previous ischaemic heart disease (IHD) and acuteness of stroke.
(d) Studies are classified as either case-control studies (C-C), cohort studies (Coh) or case series.
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Table B.6: Studies used by English et al. to revise aetiological fractions for alcohol exposure and stroke
Reference Age Sex Cases(a) Outcome Country Subjects(b) Adjustments(c) Study type(d)
Klatsky et al. 1981a Mean (43.3) M+F D All stroke US 50/8,060 Coh
Klatsky et al. 1981b M+F I All stroke US 121/5,535 Coh
Herman et al. 1983 40–74 M+F I All stroke Netherlands 132/239 Age, sex C-C
von Arbin et al. 1985 52–96 M+F I All stroke Sweden 209/209 C-C
Gill et al. 1986 20–70 M I All stroke UK 143/143 T C-C
Gill et al. 1986 20–70 F I All stroke UK 87/87 T C-C
Gordon & Doyle 1987 All (38–55) M D All stroke US 33/1,762 Coh
Oleckno 1988 15–40 M+F I All stroke US 54/864 Age, sex, T C-C
Shaper et al. 1991 40–59 M I All stroke UK 110/7,735 Age, sex, T Coh
Ben–Shlomo et al. 1992 15–69 M+F I All stroke UK 115/84 Age, sex, T C-C
Shinton et al. 1993 35–74 M I All stroke UK Age, T C-C
Shinton et al. 1993 35–74 F I All stroke UK Age, T C-C
Stampfer et al. 1988 34–59 F I Ischaemic stroke US 76/87,526 Age, T Coh
Gorelick et al. 1989 Middle age M I Ischaemic stroke US Age C-C
Gorelick et al. 1989 Middle age F I Ischaemic stroke US Age C-C
Henrich and Morwitz 1989 15–65 M+F I Ischaemic stroke US 89/178 Age, sex C-C
Klatsky et al. 1989 M I Ischaemic stroke US 162/10,552 Age, T Coh
Klatsky et al. 1989 F I Ischaemic stroke US 130/10,552 Age, T Coh
Gill et al. 1991 20–70 M I Ischaemic stroke UK Age, T C-C
Gill et al. 1991 20–70 F I Ischaemic stroke UK Age, T C-C
al-Roomi et al. 1992 35–69 M+F I Ischaemic stroke Australia 91/480 Age, T, sex C-C
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Table B.6 (continued): Studies used by English et al. to revise aetiological fractions for alcohol exposure and stroke
Reference Age Sex Cases(a) Outcome Country Subjects(b) Adjustments(c) Study type(d)
Marini et al. 1993 15–44 M+F I Ischaemic stroke Italy 308/616 Age, T, sex C-C
Palomaki & Kaste 1993 <60 M I Ischaemic stroke Finland 156/153 Age, T C-C
Rogers et al. 1993 M I Ischaemic stroke UK 137/137 Age, T C-C
Rogers et al. 1993 F I Ischaemic stroke UK 172/172 Age, T C-C
Jamrozik et al. 1994 M+F I Ischaemic stroke Australia 360/518 Age, T, sex C-C
Stampfer et al. 1988 34–59 F I Haemorrhagic stroke US 35/87,526 Age, T Coh
Klatsky et al. 1989 M+F I Haemorrhagic stroke US 69/10,459 Age, T, sex Coh
Gill et al. 1991 20–70 M I Haemorrhagic stroke UK Age, T C-C
Gill et al. 1991 20–70 F I Haemorrhagic stroke UK Age, T C-C
Gill et al. 1991 20–70 M I Intracerebral haemorrhage UK Age, T C-C
Gill et al. 1991 20–70 F I Intracerebral haemorrhage UK Age, T C-C
al-Roomi et al. 1992 35–69 M+F I Haemorrhagic stroke Australia 31/480 Age, T, sex C-C
Juvela et al. 1993 15–60 M I Haemorrhagic stroke Finland 145/164 Age, T C-C
Juvela et al. 1993 15–60 F I Haemorrhagic stroke Finland 133/150 Age, T C-C
Jamrozik et al. 1994 M+F I Haemorrhagic stroke Australia 59/279 Age, T, sex C-C
(a) Cases are classified as incident cases of breast cancer (I) or deaths from breast cancer (D).
(b) Numbers of subjects are presented as m/n, where m is the number of cases and n is the number of controls in a case-control study or the total number of subjects in a cohort study.
(c) This column shows whether results are adjusted for potential confounding. Potential confounders are: age, sex, and tobacco use (T).   
(d) Studies are classified as either case-control studies (C-C) or cohort studies (Coh).
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Table B.7: Studies used to revise aetiological fractions for alcohol exposure and stroke with associated relative effect measures
Reference(a) Age Sex Outcome Unit(b) Level 1(c) RR 95% CI Level 2(c) RR  95% CI Level 3(c) RR 95% CI Level 4(c) RR  95% CI Level 5(c) RR  95% CI
Donahue et al. 1986 45+ M Thromboembolic oz/m None 1.0 1–14 1.0 0.9–1.5 15–39 1.3 0.9–1.4 ≥40 1.3 0.9–1.7
45+ M Haemorrhagic oz/m None 1.0 1–14 2.2 1.1–4.2 15–39 2.9 1.4–5.9 ≥40 4.7 2.4–9.5
Stampfer et al. 1988 34–59 F Ischaemic g/d < 1.5 0.70 0.40–
1.60
1.5–4.9 0.40 0.20–
0.90
5–14.9 0.30 0.10–
0.70
≥ 15 0.50 0.20–
1.10
Gorelick et al. 1989 Middle–
age
M Ischaemic g/w 1–99 2.20 0.95–
5.13
100–299 1.86 0.89–
3.92
≥ 300 1.68 0.79–
3.56
Middle–
age
F Ischaemic g/w 1–99 1.06 0.23–
4.86
100–299 2.70 0.75–
9.77
≥ 300 1.77 0.23–
13.4
Klatsky et al. 1989 M Ischaemic d/d < 1 0.58 0.34–
0.98
1–2 0.48 0.27–
0.87
≥ 3 0.50 0.25–
0.98
F Ischaemic d/d < 1 0.63 0.40–
0.98
1–2 0.66 0.36–
1.22
≥ 3 0.11 0.02–
0.84
Gill et al. 1991 20–70 M Haemorrhagic g/w 10–90 0.78 0.30–
1.80
100–390 0.57 0.20–
1.30
≥ 400 1.48 0.60–
3.80
20–70 F Haemorrhagic g/w 10–90 0.71 0.40–
1.30
100–390 0.34 0.10–
0.90
≥ 400 0.00 0.00–
0.00
20–70 M Ischaemic g/w 10–90 0.50 0.20–
1.10
100–390 0.77 0.40–
1.50
≥ 400 2.07 0.90–
4.70
20–70 F Ischaemic g/w 10–90 0.71 0.40–
1.30
100–390 0.45 0.20–
1.20
≥ 400 4.98 0.40–
67.9
Palomaki & Kaste 1993 <60 M Ischaemic g/w > 0–150 0.54 0.28–
1.05
>150–
300
0.86 0.34–
2.18
>300 4.41 1.09–
17.8
Rogers et al. 1993 M Ischaemic g/w < 8.5 0.21 0.08–
0.55
8.5–180 0.31 0.16–
0.59
181–300 0.65 0.24–
1.79
301–430 0.79 0.21–
3.04
≥ 431 1.50 0.37–
6.11
F Ischaemic g/w < 8.5 0.37 0.21–
0.66
8.5–120 0.28 0.16–
0.48
121–220 0.00 0.00–
0.00
221–300 0.00 0.00–
0.00
≥ 301 0.00 0.00–
0.00
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Table B.7 (continued): Studies used to revise aetiological fractions for alcohol exposure and stroke with associated relative effect measures (continued)
Reference(a) Age Sex Outcome Unit(b) Level 1(c) RR 95% CI Level 2(c) RR  95% CI Level 3(c) RR 95% CI Level 4(c) RR  95% CI Level 5(c) RR  95% CI
Juvela et al. 1993 15–60 M Haemorrhagic g/d 1–40 0.34 0.14–
0.81
41–120 2.45 1.10–
5.47
> 120 4.45 1.54–
12.9
15–60 F Haemorrhagic g/d 1–40 0.35 0.16–
0.80
> 40 6.36 2.26–
17.9
Goldberg et al. 1995 55–64 M Thromboembolic  mL/m None 1.0 ≤ 111 1.07 0.66–
1.73
114–714 1.12 0.69–
1.84
≥717 1.18 0.73–
1.91
Hillbom et al. 1995 16–40 M First ischaemic g/w None 1.0 1–150 0.95 0.39–
2.33
151–300 1.20 0.35–
4.16
>300 2.57 0.76–
8.75
16–40 F First ischaemic g/w None 1.0 1–150 1.40 0.52–
3.73
151–300 2.36 0.29–
19.0
>300 No controls
Juvela et al. 1995 16–60 M Intracerebral
haemorrhage
g/w None 1.0 1–150 1.74 0.87–
3.46
151–300 2.47 0.93–
6.53
>300 16.86 7.21–
39.4
16–60 F Intracerebral
haemorrhage
g/w None 1.0 1–150 0.94 0.49–
1.81
151–300 4.17 1.3–13.8 >300 5.21 0.4–59.8
Sacco et al. 1999 > 39 M First ischaemic d/d None 1.0  ≤2 0.54 0.36–
0.80
>2 – <5 0.72 0.38–
1.36
≥5 1.33 0.56–
3.17
> 39 F First ischaemic d/d None 1.0  ≤2 0.49 0.34–
0.71
>2 – <5 0.23 0.05–
1.08
≥5 5.35 0.51–
56.7
(a) Studies used by English et al. (1995) are listed in bold.
(b) Unit of measurement used in the study—grams per week (g/w), grams per day (g/d), drinks per day (d/d), ounces per month (oz/m) and millilitres per month (ml/m).
(c) Studies used different classification schemes for levels of alcohol consumption. These columns present the definitions of these levels for each study, from the lowest (level 1) up to the highest.
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Table B.8: Studies used to revise aetiological fractions for alcohol exposure and fall injuries
Study Age Sex Subjects Cases Exposure criteria Country Outcome Residence
Allander et al. 1998 (a)(b) >49 M 730 72 Clinical judgment alcohol immediate contributor Europe Falls resulting in hip fracture All
>49 F 2,086 50
Hutchison et al. 1998 All M+F 2,416 269 Clinically assessed alcohol <4 hrs before injury UK Falls resulting in facial injury All
Hartshorne et al. 1997 All M 33 19 Ethyl alcohol with toxicology or noted in records US Fatal head injury due to ground-level fall All
All F 15 4
Mosenthal et al. 1995 (a) 18–64 M+F 131 68 Blood alcohol analysis or toxicology +ve alcohol US Fall injuries (non-occupational) All
Borges et al. 1994 15+ M+F 73 8 Breathalyser reading >100 mg/100mL Mexico Fall injuries A&E patients All
Grisso et al. 1994 (a) >44 F 144 37 Alcohol consumed last year = >2 drinks per week US First hip fracture among black women due to falls All
Hussain et al. 1994 15+ M+F 389 109 Clinical notation significant alcohol consumption UK Fall-related craniofacial trauma All
O’  Loughlin et al. 1994 (b) >64 M+F 470 79 Self-report—daily alcohol consumption Canada Indoor or outdoor falls (non-injurious & injurious) Non-inst.
Malmivaara et al. 1993 (a)(b) 20–44(c) M 131 22 Self-report (M ≥1,000g/mth; F≥500 g/mth) Finland Injurious falls leading to hospitalisation or death All
F 61 1
45–64(c) M 124 8
F 124 4
>64 M 50 5
F 138 1
O’Loughlin et al. 1993 (b) >64 M+F 197 12 Self-report (M+F= low ≤ 100g/wk;
haz/harm >110 ≤700g/wk)
Canada Non-injurious falls Non-inst.
>64 M+F 91 9 Self-report (M+F= low ≤ 100g/wk;
haz/harm >110 ≤700g/wk)
Canada Injurious falls Non-inst.
Rivara et al. 1993 18+ M+F 398 151 Admission BAC ≥ 100mg/100 mL US A&E admission with trauma due to fall All
 (continued)
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Table B.8 (continued): Studies used to revise aetiological fractions for alcohol exposure and fall injuries
Study Age Sex Subjects Cases Exposure criteria Country Outcome Residence
Adams et al. 1992 (b) >64 M+F 13 0 Self-report intake within 24 hours before A&E visit US Falls presenting as medical problem to A&E Non-inst
Nelson et al. 1992 (b) >64 M+F 320 3 Self-report (current consumption ≥ 140 g/wk) US Fall injuries Non-inst
Rutledge & Messick 1992 All M+F 142 41 BAC ≥100mg/100 mL US Death within 24 hours of fall
Honkanen & Smith 1991 (a) 15–64 M 587 124 Clinically assessed intoxication or breath test
(BAC ≥0.5 g/l)
Finland Falls resulting in injury and hospitalisation All
Felson et al. 1988 (a)(b) 28–64 M 11 8 Self-report ounces of alcohol per week
(≥7 oz=haz/harm) last examination before fracture
US Falls resulting in hip fracture All
F 30 7
65–74(c) M 12 4
F 50 5
>74(c) M 20 3
F 94 5
Centers for Disease Control
1984
15+ M+F 52 11 BAC ≥0.1g/l US Death within 8 hours of fall All
Wechsler et al. 1969 >15 M+F 272 62 Breathalyser reading >0.01% US Falls injury and admission to hospital A&E All
(a) Study used in revising fraction for ages under 65.
(b) Study used in revising fraction for ages 65 and over.
Notes
Age groups aggregated as weighted averages.
Studies were excluded from revision where data did not allow relevant age and/or sex categorisation.
Studies used by English et al. (1995) are listed in bold.
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